Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRP,Agouti-related protein,39865,-0.205288951007527,0.00501351010543086,-0.215115430814171,-0.195462471200882,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCG,Pro-glucagon,39288,-0.535344241581238,0.0113364409407268,-0.557563665825063,-0.513124817337414,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF9,Protein turtle homolog A,37268,-0.341126495947412,0.00769636651242033,-0.356211374311756,-0.326041617583068,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39693,-0.224947516594524,0.00484003810249004,-0.234433991275404,-0.215461041913643,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFGE8,Lactadherin,39668,-0.221588086662342,0.00396025276963397,-0.229350182090825,-0.21382599123386,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPY,Pro-neuropeptide Y,39836,-0.26306688269322,0.00619673806991398,-0.275212489310251,-0.250921276076189,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37267,-0.164042258611921,0.00375257527315815,-0.171397306147311,-0.156687211076531,0
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS15,Enteropeptidase,39594,-0.311606916648126,0.008470645090064,-0.328209381024651,-0.295004452271601,2.84075823691085e-284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES1,Liver carboxylesterase 1,39663,-0.277506535502977,0.00758067475896959,-0.292364658030557,-0.262648412975396,1.10445109508755e-281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS8,Prostasin,39617,-0.134339116666242,0.00381805878074068,-0.141822511876494,-0.12685572145599,3.82008725943165e-261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYY,Peptide YY,36855,-0.306505749886406,0.00882188464811275,-0.323796643796707,-0.289214855976105,5.30120445963847e-253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN1,CCN family member 1,39564,-0.249861837671515,0.00726117231775885,-0.264093735414322,-0.235629939928708,3.0914128441588e-250
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9,Complement component C9,37277,0.170500194953398,0.00509321072820355,0.160517501926119,0.180482887980677,4.78672458041355e-236
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39743,0.0895541057847401,0.00269929209537215,0.0842634932778107,0.0948447182916696,1.98714786554186e-233
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37203,-0.17564383672434,0.005346891269261,-0.186123743612092,-0.165163929836589,1.17800916861786e-227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,39826,0.377292695204933,0.0118212809682899,0.354122984507085,0.400462405902781,9.60356899616688e-217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FURIN,Furin,39721,-0.10284278512567,0.00324863894751408,-0.109210117462797,-0.0964754527885422,2.47071450046876e-213
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39557,-0.0879812144702049,0.00279496808479836,-0.0934593519164097,-0.0825030770240002,5.83251622321415e-211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPM,Carboxypeptidase M,39763,-0.102968285580221,0.00331575438678977,-0.109467164178329,-0.0964694069821135,1.30725549318961e-205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY1,Aminoacylase-1,39680,-0.183347718586511,0.00594861550064384,-0.195007004967773,-0.171688432205249,1.24156391615751e-202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39673,-0.155692099090323,0.00509338114152733,-0.165675126127717,-0.145709072052929,1.99642147813034e-199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPL,Lipoprotein lipase,39680,0.138671519309322,0.00454337327189316,0.129766507696411,0.147576530922232,7.45459821347907e-199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBC,Inhibin beta C chain,39668,-0.119236946923935,0.00397457835756507,-0.127027120504763,-0.111446773343108,2.3219737260399e-192
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39401,-0.183647643392492,0.00619440452697106,-0.195788676265355,-0.171506610519629,6.00853725061271e-188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHR,Growth hormone receptor,36958,-0.0822230518125978,0.00277615275221028,-0.08766431120693,-0.0767817924182657,1.17195252566866e-186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP1,Neuropilin-1,39756,0.0784120513584443,0.00267335158508473,0.0731722822516782,0.0836518204652104,3.25243302875223e-184
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH,Parathyroid hormone,36877,-0.225571863422578,0.00772915756198397,-0.240721012244066,-0.210422714601089,1.98155055581217e-181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF21,Fibroblast growth factor 21,39817,-0.334051777905455,0.0114947282002041,-0.356581445177855,-0.311522110633055,5.54767802690105e-181
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F7,Coagulation factor VII,39706,-0.0826649202489632,0.00289157318227977,-0.0883324036862315,-0.0769974368116948,2.56976629215964e-175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXT,Oxytocin-neurophysin 1,39817,-0.38217351591442,0.0133808027837789,-0.408399889370627,-0.355947142458214,4.9871939028023e-175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39721,0.0876085968430511,0.00307623324771989,0.0815791796775201,0.0936380140085821,4.92760542871688e-174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL27,C-C motif chemokine 27,39680,-0.171227689919212,0.00604592184498446,-0.183077696735381,-0.159377683103042,3.63082628778749e-172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39756,-0.129241731746475,0.00456570365082304,-0.138190510902089,-0.120292952590862,5.07654895470475e-172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADIPOQ,Adiponectin,37285,0.176100687056684,0.00638389916771715,0.163588244687958,0.188613129425409,5.62167777576131e-163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39452,0.142584418971877,0.00521954630254346,0.132354108218892,0.152814729724862,1.5465664210084e-160
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39401,-0.221737694254423,0.00818552512234983,-0.237781323494229,-0.205694065014617,6.03254536007849e-158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPY,Pancreatic prohormone,39634,-0.26033460391545,0.00970541568914151,-0.279357218666168,-0.241311989164733,5.03375311158334e-155
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOF,Apolipoprotein F,37277,0.0668857845940958,0.00251399824052242,0.0619583480426718,0.0718132211455197,4.99416950681678e-152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39653,-0.217774580080248,0.00824916386625064,-0.233942941258099,-0.201606218902396,2.48285244988596e-150
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG2,Desmoglein-2,39668,0.0681502388228102,0.00258169194912211,0.0630901226025309,0.0732103550430895,2.5993980326133e-150
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37220,-0.196327192672068,0.00746954970468124,-0.210967510093243,-0.181686875250893,1.69901249469379e-148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,39820,0.156882661135345,0.00602798445198971,0.145067811609445,0.168697510661244,2.80703188236991e-146
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPB1,Beta-ureidopropionase,37268,-0.233000104098114,0.00897574402589127,-0.250592562388861,-0.215407645807367,5.3530694486017e-145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUSB,Beta-glucuronidase,39727,-0.14655870596653,0.00570631027166135,-0.157743074098986,-0.135374337834073,1.43592580380438e-142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIP,Gastric inhibitory polypeptide,36880,-0.109331235265131,0.00425546877951399,-0.117671954072978,-0.100990516457284,4.82617576039009e-142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37200,-0.211097580553783,0.00823959392637372,-0.227247184649476,-0.194947976458091,2.33218080470227e-141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MVK,Mevalonate kinase,39401,-0.19570326532576,0.00769051199803259,-0.210776668841904,-0.180629861809616,5.46429616888419e-140
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39594,-0.164385945598831,0.00646350707294269,-0.177054419461799,-0.151717471735864,7.19066909856777e-140
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37088,-0.0632501450496321,0.00248974815406848,-0.0681300514316063,-0.0583702386676579,4.7494794766808e-139
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSD,Cathepsin D,38538,-0.096370599448304,0.00381314375025031,-0.103844361198795,-0.0888968376978134,5.50480620889423e-138
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36673,-0.0777851970819196,0.00311784570695307,-0.0838961746675477,-0.0716742194962916,3.44793967588623e-134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39594,-0.191802196827167,0.00773246507935677,-0.206957828382706,-0.176646565271628,2.85309758304627e-133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39646,-0.068787201661753,0.00278084280661003,-0.0742376535627086,-0.0633367497607973,1.44415611612671e-132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F9,Coagulation factor IX,39715,-0.0437744918551832,0.00177072712802173,-0.0472451170261058,-0.0403038666842607,2.01040309076593e-132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,39836,-0.0811986992610043,0.00330007303116219,-0.0876668424020822,-0.0747305561199264,3.05097241704232e-131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39394,-0.34485377395012,0.0140592020321187,-0.372409809933073,-0.317297737967168,2.17948560879048e-130
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,39817,-0.101845886423064,0.0041538488814665,-0.109987430230738,-0.0937043426153897,2.39727363888753e-130
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39401,-0.11828822692415,0.00485708247964237,-0.127808108584249,-0.108768345264051,1.34371610848005e-128
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,36958,0.0712432647400547,0.00293303827200833,0.0654945097269184,0.076992019753191,1.62223359664242e-127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,39836,-0.0877595214492804,0.00363130634114863,-0.0948768818779317,-0.080642161020629,9.1321308927091e-127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39288,-0.194181497894773,0.00804239303533795,-0.209944588244035,-0.17841840754551,1.8600077384612e-126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39288,-0.178420056511232,0.0074455855089167,-0.193013404108708,-0.163826708913755,1.26060176914272e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,39836,-0.0758926417294013,0.00317344206714902,-0.0821125881810133,-0.0696726952777892,3.23415737762021e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL16,C-C motif chemokine 16,39860,-0.12108000654743,0.00506357467861942,-0.131004612917524,-0.111155400177336,3.43849283982069e-124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39758,-0.0722141868777962,0.0030282864360935,-0.0781496282925395,-0.066278745463053,1.60697074917082e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MME,Neprilysin,39594,-0.182771545215862,0.00767529779485892,-0.197815128893786,-0.167727961537939,3.66589204442818e-123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFM,Afamin,37285,-0.0436717867494319,0.00185485191488474,-0.047307296502606,-0.0400362769962578,3.81565476266952e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP5,Retinol-binding protein 5,39594,-0.128397748008014,0.00546532258808705,-0.139109780280665,-0.117685715735363,5.52111152829655e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHBG,Sex hormone-binding globulin,37277,0.118283718557902,0.00503118511049533,0.108422595741331,0.128144841374473,8.3607228872142e-120
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39594,-0.198254684057518,0.00845080900605762,-0.214818269709391,-0.181691098405645,1.17724704377332e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39738,0.087769582661631,0.00374821580302445,0.0804230796877031,0.0951160856355589,3.02891008461759e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39288,-0.135097348240513,0.00577019234467204,-0.14640692523607,-0.123787771244956,3.73368012616618e-119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37268,-0.0637555875260373,0.00276661863966146,-0.0691781600597738,-0.0583330149923009,2.85364514240876e-115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39288,-0.138136707922623,0.00609462518044077,-0.150082173276287,-0.126191242568959,6.56961953750681e-112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39632,-0.117873736924344,0.00521355200081611,-0.128092298845943,-0.107655175002744,2.06558194104865e-111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39716,-0.0732140525392334,0.00324554108180664,-0.0795753130595744,-0.0668527920188924,6.15303879498836e-111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKB,Creatine kinase B-type,37267,0.12816871745989,0.00568292951293418,0.117030175614539,0.139307259305241,1.40472004079323e-110
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,39860,0.0738032048395018,0.00331446895737998,0.067306845683037,0.0802995639959665,3.3804921896042e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39594,-0.231269913495919,0.0104050399573486,-0.251663791812322,-0.210876035179516,8.59021879088066e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCS1,Neuronal calcium sensor 1,39836,-0.0609359961035766,0.00274244433062771,-0.0663111869916069,-0.0555608052155462,9.46847736319295e-108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA14,Carbonic anhydrase 14,39836,0.0761713514232384,0.00342934704435641,0.0694498312162999,0.082892871630177,1.12474177406346e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39491,-0.100922763698115,0.00454330454490643,-0.109827640606131,-0.0920178867900981,1.17077989296697e-107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39680,-0.0649285328387608,0.00294799001608261,-0.0707065932702827,-0.0591504724072389,6.48888884364848e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCLY,Selenocysteine lyase,39790,-0.105712696432786,0.00480426826272231,-0.115129062227722,-0.0962963306378502,9.87394118580408e-106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC13,Mucin-13,39302,-0.108872126926605,0.00495068122115564,-0.11857546212007,-0.0991687917331402,1.44493694187143e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1A,Meprin A subunit alpha,37215,-0.154035212529646,0.007014144519433,-0.167782935787734,-0.140287489271557,4.8972767630796e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBP,Protein AMBP,39809,-0.0413719600146073,0.00188695834504964,-0.0450703983709046,-0.03767352165831,5.28264536795457e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTR,Transthyretin,37142,-0.053988182166498,0.00246179560364732,-0.0588133015496468,-0.0491630627833493,9.5209178868825e-105
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRP,Gastrin-releasing peptide,36880,-0.111977520600117,0.00511026066663742,-0.121993631506726,-0.101961409693507,1.51977832562973e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HJV,Hemojuvelin,37244,-0.0950794397884481,0.00435270406643799,-0.103610739758667,-0.0865481398182296,5.77645577450504e-104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS1,Protein MTSS 1,37215,-0.230747315370225,0.0108356695195742,-0.25198522762859,-0.209509403111859,5.5227230252534e-99
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG2,Secretogranin-2,39756,-0.0645778489887823,0.00304170790506412,-0.070539596482708,-0.0586161014948566,1.15824789452172e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4R,Reticulon-4 receptor,39836,-0.0685657159214959,0.00323682440222497,-0.0749098917498568,-0.0622215400931349,3.06128584299791e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR3,Anterior gradient protein 3,39275,-0.121979290927874,0.0057645612707719,-0.133277831018587,-0.110680750837161,5.47511329375594e-98
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLTP,Phospholipid transfer protein,39784,0.0741632516296236,0.00351266201851573,0.0672784340733328,0.0810480691859145,1.30642344670197e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,36958,-0.0770712877291398,0.00365042106749969,-0.0842261130214392,-0.0699164624368405,2.5071254589987e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37116,-0.065698034157123,0.00311336403354513,-0.0718002276628714,-0.0595958406513745,3.00922867896918e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH1,Somatotropin,39658,0.371368704225208,0.0176344275570613,0.336805226213368,0.405932182237048,4.04556494337356e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL23,C-C motif chemokine 23,39743,-0.0842734916032703,0.00400804283186171,-0.0921292555537193,-0.0764177276528214,7.8678655637884e-97
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHK,Ketohexokinase,36880,-0.134026734591846,0.0063724206496437,-0.146516679065147,-0.121536790118544,1.33111274911634e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLA,Alpha-galactosidase A,36922,-0.0781287078301561,0.00371732629498174,-0.0854146673683203,-0.0708427482919919,1.78136568055683e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39302,-0.104575307167034,0.00498778494276176,-0.114351365654847,-0.0947992486792207,2.91243673193616e-96
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELE,E-selectin,39860,-0.101229916375006,0.0048778388014532,-0.110790480425854,-0.0916693523241578,2.01125194805856e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37268,-0.131799112683231,0.00635214901479701,-0.144249324752233,-0.119348900614229,3.76795320663841e-94
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39636,-0.100528063353868,0.00486656822762017,-0.110066537080004,-0.0909895896277326,1.4605634684658e-93
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39668,0.0732020805089036,0.00356766630855056,0.0662094545441445,0.0801947064736627,2.35719061948568e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,39817,-0.104833589560889,0.00511997220303217,-0.114868735078832,-0.0947984440429457,5.41064123508542e-92
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39721,-0.069379090664334,0.00340300582144226,-0.0760489820743609,-0.0627091992543072,3.17281969258778e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39594,-0.162571196562859,0.00797707279160717,-0.178206259234409,-0.146936133891309,3.78455067303431e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39358,-0.149332126889923,0.00733427883536807,-0.163707313407244,-0.134956940372601,5.74577226140216e-91
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYNU,Kynureninase,39865,-0.0903809807442941,0.00445020437415676,-0.0991033813176413,-0.0816585801709468,1.46655927612622e-90
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLUL1,Clusterin-like protein 1,39653,0.0889136572675709,0.00442812463772399,0.0802345329776319,0.0975927815575099,1.42351439651445e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN3,Contactin-3,39668,-0.0640327650721251,0.00319361970688494,-0.0702922596976195,-0.0577732704466306,2.51254249559824e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39401,-0.178772937360518,0.00892549543135115,-0.196266908405967,-0.16127896631507,3.93633569197472e-88
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37268,-0.111496893391346,0.00558952213434416,-0.122452356774661,-0.100541430008031,2.89226030793901e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39810,-0.0967532089664948,0.00485729266593021,-0.106273502591718,-0.0872329153412716,3.18360220776095e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39673,-0.0542024779497119,0.00272143869396096,-0.0595364977898754,-0.0488684581095484,3.40055024350737e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11R,Junctional adhesion molecule A,39668,-0.110081247181081,0.00553464635833147,-0.120929154043411,-0.0992333403187518,5.79721661293639e-87
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR2,Cadherin-related family member 2,39594,-0.141493168707419,0.00714759136313658,-0.155502447779167,-0.127483889635672,3.60319262796173e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",36880,-0.111672807619137,0.00564508712361683,-0.122737178381426,-0.100608436856848,7.66959967618557e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39401,-0.105535101114185,0.00534276572164576,-0.116006921928611,-0.0950632802997592,8.52781375379169e-86
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39521,-0.138420101573579,0.00703499382734196,-0.152208689475169,-0.124631513671989,3.69415218880919e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPIND1,Heparin cofactor 2,37257,-0.0544929695102479,0.00276764673837113,-0.0599175571174553,-0.0490683819030405,4.23427390298219e-85
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORD,Sorbitol dehydrogenase,39769,-0.13112101114651,0.00671390247287435,-0.144280259993344,-0.117961762299676,5.88687920603e-84
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPC,C-type natriuretic peptide,39673,-0.0872354101809907,0.00448133065439364,-0.0960188182636022,-0.0784520020983792,2.00043287014719e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOMO1,Nodal modulator 1,39668,-0.0451581543706635,0.00232148260927079,-0.0497082602848342,-0.0406080484564927,2.61968271417285e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,36958,-0.0938720040933983,0.00482920339025251,-0.103337242738293,-0.0844067654485034,5.37143648700107e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,36948,-0.09091570472423,0.00468073790012122,-0.100089951008468,-0.0817414584399924,7.15477354781564e-83
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,39836,-0.244180063232173,0.0126342099312496,-0.268943114697422,-0.219417011766924,2.77042662192325e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,39865,-0.144946203795968,0.00751645600454724,-0.159678457564881,-0.130213950027055,6.23038784033804e-82
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA2,Carboxypeptidase A2,39741,-0.121421370930664,0.00630599629581212,-0.133781123670456,-0.109061618190872,1.09386361368581e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELN,Elastin,37268,-0.0636449202699276,0.00330544217915823,-0.0701235869410777,-0.0571662535987775,1.62215990831161e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37203,-0.0992512639395467,0.00515711716857052,-0.109359213589945,-0.0891433142891485,1.94764450183168e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39557,-0.0674238742462236,0.00350802202106026,-0.0742995974075018,-0.0605481510849455,2.16823297471209e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39668,0.057100781824191,0.00297107409486928,0.0512774765982472,0.0629240870501348,2.17723169825324e-81
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37132,-0.0519680191791516,0.00272223855537922,-0.0573036067476949,-0.0466324316106084,3.60407245046456e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39721,-0.0403081741935763,0.00211422048769705,-0.0444520463494625,-0.0361643020376901,3.86036817594677e-80
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37244,-0.108813022459042,0.00571821617885097,-0.12002072616959,-0.0976053187484945,1.09852584011847e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F10,Coagulation factor X,37277,-0.0496985176894865,0.00261328257062319,-0.054820551527908,-0.0445764838510651,1.35297083373669e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO3,Beta-enolase,36880,-0.113172984816287,0.00595643243136453,-0.124847592381761,-0.101498377250812,2.01277604749631e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39680,-0.0610656802581333,0.00321865180416726,-0.0673742377943011,-0.0547571227219655,2.1905227496497e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA4,Kallistatin,37076,-0.0436008524958121,0.00230099161312752,-0.0481107960575421,-0.0390909089340822,5.03131500949621e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39810,-0.0392113413864487,0.00207525527061503,-0.0432788417168541,-0.0351438410560432,9.12720910727213e-79
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39233,-0.100606567645153,0.00535953471281039,-0.111111255682262,-0.0901018796080449,9.54523010043505e-78
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39401,-0.10002703067552,0.00533131518122737,-0.110476408430726,-0.0895776529203143,1.10971463437546e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3F,Semaphorin-3F,39680,-0.0468419723071225,0.00250400485978485,-0.0517498218323008,-0.0419341227819442,2.96545961040241e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39564,-0.0476842192820673,0.00255124798608414,-0.0526846653347923,-0.0426837732293424,4.05331465777471e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39557,-0.135686966407543,0.00726024221699335,-0.14991704115285,-0.121456891662236,4.1702696592749e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSZ,Cathepsin Z,39672,-0.0568227597041811,0.00304450059299682,-0.0627899808664549,-0.0508555385419073,6.50040573511104e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,36958,-0.139720243640002,0.00747849500255765,-0.154378093845015,-0.125062393434989,6.78610376246627e-77
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGF,Hepatocyte growth factor,39865,-0.0619940974476564,0.00332958371176344,-0.0685200815227127,-0.0554681133726,1.44498057310778e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFI,Complement factor I,37285,-0.0364823714556735,0.00196514197710043,-0.0403340497307904,-0.0326306931805567,5.52364742058222e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREG1,Protein CREG1,39473,-0.0682658551266581,0.0036835027254658,-0.0754855204685711,-0.0610461897847452,7.29573615724847e-76
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39200,-0.034906280645944,0.00189237537339129,-0.0386153363777909,-0.031197224914097,3.66091601213709e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39288,-0.19919900521024,0.0108022679522509,-0.220371450396652,-0.178026560023828,3.98506964869691e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEG1,Protein HEG homolog 1,36958,-0.0493200647418397,0.0026745508443594,-0.0545621843967841,-0.0440779450868953,5.51228222222065e-75
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSO,Cathepsin O,39865,-0.0536699366845605,0.00293334408746301,-0.059419291095988,-0.047920582273133,5.01089135605829e-74
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39557,-0.0567024249254656,0.00310974769833781,-0.0627975304142077,-0.0506073194367235,1.59669861093734e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFASC,Neurofascin,39865,-0.049494370357694,0.00271924279092162,-0.0548240862279004,-0.0441646544874876,2.75103336614005e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39594,-0.0699404248608238,0.003842401540514,-0.0774715318802313,-0.0624093178414164,2.79438578638051e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39673,-0.072011976012846,0.00396723240215032,-0.0797877515210606,-0.0642362005046313,6.83686334234416e-73
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH9,Myosin-9,37267,-0.198243550323047,0.0109737947804574,-0.219752188092744,-0.176734912553351,4.28164093608711e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39288,-0.119415729957386,0.00663054168499642,-0.132411591659979,-0.106419868254793,8.83637567554757e-72
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39557,-0.0950040138723376,0.00530669455828073,-0.105405135206568,-0.0846028925381074,5.70341595754175e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPY30,Protein dpy-30 homolog,39785,-0.104076181439811,0.00581909969055734,-0.115481616833304,-0.0926707460463188,7.57071287475755e-71
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2AP,CD2-associated protein,39680,-0.110906005521565,0.00621772848977052,-0.123092753361516,-0.0987192576816153,1.78399348289613e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,36855,-0.120442535439398,0.00674859732865102,-0.133669786203554,-0.107215284675242,2.10477261118549e-70
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39738,-0.0740583686707357,0.00417732103084668,-0.0822459178911952,-0.0658708194502762,1.18087885920241e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37203,-0.121339550043107,0.00684937378717084,-0.134764322665962,-0.107914777420252,1.98469638212386e-69
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS4,Galectin-4,39675,-0.0902672446451904,0.00516857724932589,-0.100397656053869,-0.0801368332365117,1.14914844279927e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39594,-0.0608666344854589,0.00348522746859333,-0.0676976803239018,-0.054035588647016,1.16656371898065e-67
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39245,-0.147563605016493,0.00852419494943968,-0.164271027117395,-0.130856182915592,1.65283130263917e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,39865,-0.055212639188192,0.00319266013662979,-0.0614702530559864,-0.0489550253203976,2.10805961495071e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39673,-0.107232732911083,0.00621972242344719,-0.11942338886104,-0.0950420769611266,5.26574398561822e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UMOD,Uromodulin,39821,0.0891417076034623,0.00517438553043995,0.0789999119638,0.0992835032431246,6.51195698434947e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM1,Isthmin-1,39673,-0.0674393000843704,0.00391680843721072,-0.0751162446213034,-0.0597623555474373,7.75806718506312e-66
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL16,Pro-interleukin-16,39865,-0.0692617837459382,0.00404502373863686,-0.0771900302736664,-0.0613335372182099,3.82042070447332e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37277,-0.0368908274774804,0.00215421298831668,-0.0411130849345811,-0.0326685700203797,4.74173287474892e-65
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39594,-0.0726770672279351,0.00427023404648582,-0.0810467259590473,-0.0643074084968229,2.21895572935961e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39594,-0.050169867661734,0.00295484712590686,-0.0559613680285114,-0.0443783672949565,4.38166660711516e-64
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EEF1D,Elongation factor 1-delta,37268,-0.152835651883915,0.00902361555121035,-0.170521938364287,-0.135149365403542,1.09588613275765e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MET,Hepatocyte growth factor receptor,39689,0.032431826467169,0.00191751129185378,0.0286735043351356,0.0361901485992025,1.29473175218593e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDUA,Alpha-L-iduronidase,39836,-0.0760995660506313,0.00450148314202285,-0.084922473008996,-0.0672766590922665,1.46362138802307e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FETUB,Fetuin-B,39715,-0.0556107909919776,0.0032948128927949,-0.0620686242618556,-0.0491529577220996,2.32265641317443e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EZR,Ezrin,39817,-0.0397902373517631,0.00235922310869104,-0.0444143146447975,-0.0351661600587286,2.83481298276102e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39738,0.0540692924530372,0.00320933363663913,0.0477789985252245,0.0603595863808499,3.86681960292495e-63
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39668,-0.08656430460889,0.00515728490585145,-0.0966725830243588,-0.0764560261934212,1.09865638880408e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39594,-0.205369925959596,0.0122440623221258,-0.229368288110963,-0.18137156380823,1.34409369415697e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEP,Leptin,39680,-0.111348076000533,0.00664811372966658,-0.12437837891068,-0.0983177730903868,1.99159046444307e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39721,-0.150079810518841,0.00896167540328671,-0.167644694309283,-0.132514926728399,2.05112332967363e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39594,-0.0983710747044768,0.00587413042649022,-0.109884370340398,-0.086857779068556,2.0836280655604e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,39817,-0.0965189310840094,0.00577133865771352,-0.107830754853128,-0.0852071073148909,2.97672379127681e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH2,Cadherin-2,39680,-0.0575694886733222,0.00345064210071716,-0.0643327471907278,-0.0508062301559165,5.82634332676856e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,36958,-0.0356731334633904,0.00213847803141928,-0.0398645504049722,-0.0314817165218087,7.74797501373907e-62
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLB1,Beta-galactosidase,39557,-0.0688965293221068,0.00414494171804511,-0.0770206150894752,-0.0607724435547384,1.62464873877941e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39701,-0.0368027062600278,0.00221828389239928,-0.0411505426891304,-0.0324548698309252,2.67969460088037e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB1,Carboxypeptidase B,39860,-0.093337858977063,0.00564517947042916,-0.104402410739104,-0.0822733072150219,6.67231872527168e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,39848,-0.0625716180063427,0.00378684793538284,-0.0699938399596931,-0.0551493960529923,7.94853342566386e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,39817,-0.108524179660683,0.00656965440586421,-0.121400702296177,-0.0956476570251893,8.55800240106136e-61
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSF,Cathepsin F,39721,-0.0653564974958293,0.00396119193283924,-0.0731204336841942,-0.0575925613074644,1.18994915445345e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39595,0.102655084355832,0.00622278476293561,0.0904584262204787,0.114851742491186,1.25191038997372e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGLN1,Egl nine homolog 1,39673,-0.0866965341071473,0.0052560172134033,-0.0969983278454178,-0.0763947403688769,1.28443044574336e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES3,Carboxylesterase 3,39594,-0.111243263417032,0.00676666155694867,-0.124505920068651,-0.0979806067654124,3.14791670881282e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39715,0.0465062863252278,0.00282903948635616,0.0409613689319698,0.0520512037184859,3.17199469076017e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39288,-0.133955057506423,0.00815497713608773,-0.149938812693155,-0.117971302319691,4.02284675385425e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39288,-0.114392386336514,0.00696838564468944,-0.128050422200105,-0.100734350472923,4.75040804943357e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3B,Protein FAM3B,39594,-0.0577443889996979,0.00351970935932708,-0.064643019343979,-0.0508457586554168,5.45207809907637e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37220,-0.0765183305442944,0.00466189560298061,-0.0856556459261364,-0.0673810151624524,5.90072946215689e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,36896,-0.139330211844971,0.00849665104129103,-0.155983647885902,-0.122676775804041,7.80891975999818e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUMB,Protein numb homolog,36896,-0.136914963220515,0.00835077608578289,-0.153282484348649,-0.12054744209238,8.16597952852218e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THOP1,Thimet oligopeptidase,39612,-0.0489698372045989,0.00299063171974574,-0.0548314753753005,-0.0431081990338972,9.07750013909354e-60
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39594,-0.0710293033365586,0.00433942959764698,-0.0795345853479467,-0.0625240213251706,1.00244856966551e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39302,-0.0832264897994082,0.00508534398315513,-0.0931937640063923,-0.0732592155924242,1.06441966324398e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGF,Placenta growth factor,39865,-0.0413383330555148,0.00252968562904341,-0.0462965168884399,-0.0363801492225897,1.522390385172e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVR,Poliovirus receptor,39817,-0.059594753827349,0.00365534982882157,-0.0667592394918392,-0.0524302681628587,2.81129641731649e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCXR,L-xylulose reductase,39721,-0.0861063022994128,0.00529339855860653,-0.0964813634742816,-0.075731241124544,5.10535627858265e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAB2,Stabilin-2,37267,-0.0449967270307182,0.00276408603823229,-0.0504143356656535,-0.0395791183957829,5.11159673554531e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39594,-0.182314574434067,0.011211300371562,-0.204288723162329,-0.160340425705806,5.58568392053968e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39546,-0.0589501699546708,0.00362505899026898,-0.066055285575598,-0.0518450543337436,5.58901096168799e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FYB1,FYN-binding protein 1,39646,-0.146518864515799,0.00901206500759789,-0.164182511930691,-0.128855217100907,5.89672734103903e-59
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37267,-0.0509167487030823,0.00313721316857256,-0.0570656865134846,-0.0447678108926801,1.12193186374144e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTYMK,Thymidylate kinase,37268,-0.110097617319883,0.00678646721913666,-0.123399093069391,-0.0967961415703751,1.2508982160281e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39673,-0.0804789676447625,0.00497201088600252,-0.0902241089813274,-0.0707338263081976,1.85519212212543e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37221,-0.175255033739484,0.0108349214118297,-0.19649147970667,-0.154018587772298,2.70554825791155e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN1,Dynactin subunit 1,39836,-0.103254911073626,0.00639089079233549,-0.115781057026604,-0.0907287651206485,2.95483125898057e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39594,-0.108592125826874,0.00672728223042659,-0.12177759899851,-0.0954066526552376,3.78575718355254e-58
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POSTN,Periostin,37267,0.0587784383028858,0.0036712152950437,0.0515828563246001,0.0659740202811714,3.64659453990392e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTD,Biotinidase,37285,-0.0324118475613551,0.00202760024072815,-0.0363859440331822,-0.0284377510895279,5.42408681411085e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39785,-0.0901986075692861,0.00565957098993709,-0.101291366709563,-0.0791058484290094,9.57703167500523e-57
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37198,-0.12906047438777,0.00811230571714343,-0.144960593593371,-0.113160355182169,1.80691224477406e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOT,Angiomotin,36958,-0.0648808534112501,0.00407820869393272,-0.0728741424513582,-0.056887564371142,1.84835802853359e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCTN3,Tectonic-3,37268,-0.0462899367269855,0.00291668196816212,-0.0520066333845832,-0.0405732400693877,3.2798715049974e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXLNA,Alpha-taxilin,39557,-0.138905183761953,0.00876681919501023,-0.156088149384173,-0.121722218139733,4.18060697452508e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUOM,Fucose mutarotase,36958,-0.0997065741927758,0.00629060959308129,-0.112036168995215,-0.0873769793903364,4.65765014102655e-56
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BECN1,Beclin-1,36880,-0.0947706624779541,0.0060010185420385,-0.10653265882035,-0.0830086661355587,1.15169676448406e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39529,-0.138953123527532,0.00881097601426649,-0.156222636515495,-0.12168361053957,1.32982495640013e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39594,-0.151470729251301,0.00960741686814299,-0.170301266312861,-0.13264019218974,1.4193192356096e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,36880,-0.132610634155606,0.00840928040300674,-0.1490928237455,-0.116128444565713,1.6434702805164e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39621,-0.0298389752851512,0.00189402381749734,-0.033551261967446,-0.0261266886028564,1.70140441739172e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37215,-0.040346946307266,0.00256206172154232,-0.045368587281489,-0.0353253053330431,2.23627851741182e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS2,Trypsin-2,39738,-0.0793569171218411,0.00504353476038272,-0.0892422452521912,-0.0694715889914909,2.30239037651462e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOD,Apolipoprotein D,36624,0.0669687180948549,0.00426746352897477,0.0586044895780644,0.0753329466116455,5.5207993845788e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADM,Pro-adrenomedullin,39836,-0.0405761654976595,0.00258911027571967,-0.04565082163807,-0.0355015093572489,6.04331365212183e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39179,-0.154513218065785,0.00986426637382244,-0.173847180158477,-0.135179255973093,7.11067035109774e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,36855,-0.0949045091363873,0.00605998017632544,-0.106782070281985,-0.0830269479907895,8.86507037008373e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39801,-0.0876543895525926,0.00560364348354528,-0.0986375307803413,-0.0766712483248438,9.55611158123731e-55
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39398,-0.0607814774280114,0.00389372438570402,-0.0684131772239913,-0.0531497776320315,1.61166219405118e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39288,-0.0757022357303812,0.00485190534243481,-0.0852119702015534,-0.066192501259209,1.82251186863151e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37215,-0.164153002696177,0.0105306473018106,-0.184793071407726,-0.143512933984628,2.63666016158375e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37203,-0.122986408636092,0.00791492474480868,-0.138499661135917,-0.107473156136267,5.64863547875554e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXN,Paxillin,39302,-0.07911755210333,0.00509486005181758,-0.0891034778048925,-0.0691316264017676,5.65866345890306e-54
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLN,Promotilin,39673,-0.135739876377244,0.00876610808376516,-0.152921448221423,-0.118558304533064,1.09179454663867e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39401,-0.129616019911099,0.00838498739588736,-0.146050595207039,-0.11318144461516,1.66404361390419e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39721,-0.0380736254333455,0.00246746722356118,-0.0429098611915255,-0.0332373896751656,2.50076478296618e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39743,-0.0423521341349076,0.00275064849429305,-0.047743405183722,-0.0369608630860932,4.13775415612707e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37215,-0.21461176025267,0.0139474139975036,-0.241948691687777,-0.187274828817563,5.67648311692007e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAST,Gastrin,37220,-0.177072222841769,0.0115104066931153,-0.199632619960275,-0.154511825723263,5.98798138335632e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,39860,-0.102214336227139,0.00665469332783175,-0.115257535149689,-0.0891711373045887,7.26479768627027e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,36877,-0.184284510098623,0.0120021950996112,-0.207808812493861,-0.160760207703385,9.61243131819589e-53
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37268,-0.0444716612250342,0.00289786693400569,-0.0501514804156854,-0.0387918420343831,1.05057744362237e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37268,-0.107788189872434,0.00703130904664192,-0.121569555603852,-0.0940068241410155,1.35061432474146e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37215,-0.0903866694816244,0.00591575039396012,-0.101981540253786,-0.0787917987094626,2.91914346735985e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,39817,-0.144415254588059,0.00947565761949475,-0.162987543522268,-0.125842965653849,4.41922775178813e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFH,Complement factor H,36601,-0.0354812847215028,0.00232840531850084,-0.0400449591457644,-0.0309176102972411,5.63927961971e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37203,-0.0860154784844036,0.005647742909836,-0.0970850545876822,-0.074945902381125,6.1033299829461e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRP2,Neuropilin-2,39668,0.0426567688858389,0.00280598733875621,0.0371570337018767,0.048156504069801,7.96813133340083e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39668,-0.0350326744795572,0.00230505156465574,-0.0395505755462825,-0.030514773412832,8.44153278274429e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBKS,Ribokinase,39314,-0.0736987836082761,0.00484911844924459,-0.0832030557687955,-0.0641945114477567,8.5824092267155e-52
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39643,-0.0292801584194415,0.00192902605194071,-0.0330610494812452,-0.0254992673576377,1.13306759415745e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,36958,-0.0583108226176624,0.00384869603746004,-0.0658542668510841,-0.0507673783842407,2.04032796026647e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OCLN,Occludin,37244,-0.0643169176005583,0.00425139952344719,-0.0726496606665148,-0.0559841745346018,2.79161118107116e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39628,-0.0296558104799628,0.00196194498268126,-0.0335012226460181,-0.0258103983139075,2.92566475827063e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC1,Stanniocalcin-1,39817,-0.0621484517622047,0.00412644692414936,-0.0702362877335375,-0.054060615790872,6.54174887886865e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39668,0.0396130507463859,0.0026308914175843,0.0344565035679207,0.0447695979248511,7.00825977603762e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39569,-0.154760461252411,0.0102924304439624,-0.174933624922578,-0.134587297582245,9.56764654684244e-51
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39288,-0.09438534767802,0.00628832391337025,-0.106710462548226,-0.0820602328078143,1.44456545606369e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK3,NT-3 growth factor receptor,39817,0.0313873937655127,0.00209620668474026,0.0272788286634218,0.0354959588676036,2.40667924734012e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39673,-0.144583435608768,0.00965914438829652,-0.163515358609829,-0.125651512607707,2.60532193993626e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39288,-0.0954671511982052,0.00638228648495448,-0.107976432708716,-0.0829578696876944,3.10006014543446e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39673,-0.108887809912447,0.00730051457292292,-0.123196818475376,-0.0945788013495178,5.74794769531495e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37220,-0.0610251910361064,0.00408934840097556,-0.0690403139020185,-0.0530100681701943,5.89908505981366e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,39860,0.0357989856807812,0.00240535510375596,0.0310844896774195,0.0405134816841429,9.14209083338494e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTSS2,Protein MTSS 2,37203,-0.14698356908754,0.00987187950953439,-0.166332452926227,-0.127634685248853,9.72218084013229e-50
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,36880,0.0891712684805044,0.0059945061404031,0.0774220364453143,0.100920500515694,1.21475258486797e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39721,-0.121364236106961,0.00817095436484065,-0.137379306662049,-0.105349165551873,1.42971216242111e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39673,-0.0535363604236258,0.0036172068041263,-0.0606260857597133,-0.0464466350875382,3.10590806963051e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORT1,Sortilin,39658,-0.0543995873819367,0.00367931418990126,-0.0616110431941431,-0.0471881315697302,3.88477988446089e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAXX,Protein PAXX,36958,-0.0673818616309801,0.00455868750263903,-0.0763168891361526,-0.0584468341258076,4.82426324851957e-49
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN2,Nectin-2,39658,-0.0408370474753644,0.00277977995621004,-0.046285416189536,-0.0353886787611927,1.54442976927232e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMD,Osteomodulin,39743,0.0625976371997662,0.00426978985138736,0.054228849091047,0.0709664253084854,2.38554737845942e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPL,N-acetylneuraminate lyase,37268,-0.0637578534247119,0.00435859198888894,-0.0723006937229342,-0.0552150131264896,4.36212743173307e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOA,Elongin-A,39594,-0.0737144108947575,0.00504339948814514,-0.083599473891522,-0.063829347897993,4.58567989752283e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APCS,Serum amyloid P-component,37166,-0.0502218858062275,0.00343417694343264,-0.0569528726153554,-0.0434908989970995,4.6481489873028e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39673,-0.0625753963330534,0.0042837350736384,-0.0709715170773847,-0.0541792755887222,5.15626901544549e-48
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39302,-0.0391402659249478,0.00268777488601138,-0.0444083047015301,-0.0338722271483655,1.01018134101132e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCHE,Cholinesterase,37042,-0.0395805455247125,0.00271762440356696,-0.0449070893557038,-0.0342540016937213,1.10958889134704e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3C,Protein FAM3C,39658,-0.0413924491936505,0.00285254233881132,-0.0469834321777206,-0.0358014662095803,2.09098969848008e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL15,C-C motif chemokine 15,39860,-0.0619087031602085,0.00427089583390372,-0.0702796589946598,-0.0535377473257572,2.58056256282954e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP20,Centrosomal protein 20,39288,-0.105257626738008,0.00727516305950541,-0.119516946334638,-0.0909983071413772,3.92274332301476e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK1,Dickkopf-related protein 1,39817,-0.0849456626767589,0.0058726692890658,-0.0964560944833279,-0.07343523087019,4.02976102060177e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39401,-0.100593248398841,0.00697661438096579,-0.114267412585534,-0.0869190842121483,7.92242969198645e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUCB2,Nucleobindin-2,39802,-0.0532339847226193,0.00369561213778792,-0.0604773845126836,-0.045990584932555,9.5094979764381e-47
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD5,Programmed cell death protein 5,39817,-0.0821511340333342,0.00570693233471969,-0.0933367214093848,-0.0709655466572836,1.09116190846906e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA1,Carboxypeptidase A1,39860,-0.0838107042707931,0.00582406891081362,-0.0952258793359878,-0.0723955292055984,1.16261581060437e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39401,-0.0591626048305048,0.00411702503315992,-0.0672319738954983,-0.0510932357655114,1.58083041938963e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37005,-0.161822547181708,0.0112655074963281,-0.183902941874512,-0.139742152488905,1.94317639328284e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39594,-0.119377367775163,0.00832900496122594,-0.135702217499166,-0.10305251805116,2.67361192486655e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPH,Hephaestin,37268,-0.037010287375821,0.00258440702900485,-0.0420757251526705,-0.0319448495989714,3.56268682848504e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,36855,-0.106228264461746,0.00742268506742145,-0.120776727193893,-0.0916798017296005,4.16636263008557e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37192,-0.154508969982357,0.0108180703542913,-0.175712387876768,-0.133305552087947,6.13802538249749e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39673,-0.0795961956475725,0.00558310107360616,-0.0905390737518406,-0.0686533175433044,7.8402063450563e-46
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39288,-0.0942037596231394,0.00661918676188213,-0.107177365676428,-0.0812301535698504,1.12962311022034e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37240,0.068159364773736,0.00478883814215192,0.0587732420151182,0.0775454875323537,1.23129917883371e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSE,Cathepsin E,36958,-0.0745457033409337,0.00524046221795401,-0.0848170092881236,-0.0642743973937439,1.39963946020508e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIAE,Sialate O-acetylesterase,39684,-0.0661270917350566,0.00465259834451335,-0.0752461844903027,-0.0570079989798104,1.4525002632375e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,36958,-0.116664581492409,0.00820612247358757,-0.132748581540641,-0.100580581444178,1.57198299261335e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXIN1,Axin-1,39673,-0.133621323406716,0.0094054126936397,-0.15205593228625,-0.115186714527182,1.58330651532657e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39557,-0.0747354263975326,0.00526044765986592,-0.0850459038108698,-0.0644249489841954,1.58648432613562e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39302,-0.111491806655378,0.00785383505395832,-0.126885323361136,-0.0960982899496193,1.87759690727147e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39673,-0.148227352995789,0.0104684682314129,-0.168745550729359,-0.12770915526222,3.08703078943893e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39673,-0.077945364528165,0.00551004485816854,-0.0887450524501754,-0.0671456766061547,3.72433390574494e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUS,RNA-binding protein FUS,39266,-0.0546788442788345,0.00386824332137498,-0.0622606011887294,-0.0470970873689395,4.40198590567953e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNA4,Plexin-A4,39673,-0.1129923535336,0.00799460603235399,-0.128661781357014,-0.0973229257101864,4.43685842173917e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",39860,-0.0675763242270806,0.00478267739819261,-0.0769503719275381,-0.0582022765266231,4.67054388114582e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KITLG,Kit ligand,39680,0.0515672512136029,0.0036510547879248,0.0444111838292703,0.0587233185979355,5.07769696697809e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,36896,-0.111141510273441,0.00788081954302724,-0.126587916577774,-0.0956951039691075,7.79469161587592e-45
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39680,-0.0482272999467239,0.00343091482892196,-0.054951893011411,-0.0415027068820369,1.3004211507666e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37244,-0.13613330732206,0.00970904973795998,-0.155163044808461,-0.117103569835658,2.37840383163291e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39673,-0.127156961141041,0.00907455675086869,-0.144943092372743,-0.109370829909338,2.40843767987702e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39288,-0.0846693297320476,0.00604282206515359,-0.0965132609797486,-0.0728253984843465,2.47646762490446e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37268,-0.105339437890808,0.00751538128845477,-0.120069585216179,-0.0906092905654367,2.53793360729765e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,39816,-0.11345341202618,0.00811431541763069,-0.129357470244736,-0.0975493538076236,3.66427370430736e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39675,-0.0384614347406597,0.00275207132627723,-0.043855494540163,-0.0330673749411563,4.02780413219568e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39594,0.0272547886952682,0.00195125956496919,0.0234303199479286,0.0310792574426079,4.49298267464097e-44
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39809,-0.0449798423830184,0.00323478313867218,-0.0513200173348159,-0.038639667431221,1.06186465860156e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37244,-0.086564133807322,0.00622438443007908,-0.098763927290277,-0.074364340324367,1.1516001688266e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39675,0.0464372694671865,0.00334424803305272,0.0398825433224032,0.0529919956119698,1.39356227251247e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM2,Paralemmin-2,37220,-0.0521647317668372,0.00375505934228723,-0.0595246480777202,-0.0448048154559543,1.42558293203201e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37215,-0.0406864026600302,0.00293866785303941,-0.0464461916519875,-0.034926613668073,2.70779740772488e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST3,Cystatin-C,39705,-0.0362093269962281,0.00261705049899699,-0.0413387459742622,-0.031079908018194,2.76224316020712e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39721,-0.0347092733702943,0.00251094314500802,-0.03963072193451,-0.0297878248060785,3.28803772262037e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELP,P-selectin,39738,-0.0781945295747079,0.00565723749156025,-0.089282715058166,-0.0671063440912499,3.33911920969263e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37220,-0.120935961297032,0.00874833598331332,-0.138082699824326,-0.103789222769738,3.62536194828916e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,36896,-0.0614260344533382,0.00444487347883426,-0.0701379864718534,-0.0527140824348231,3.91361871873198e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37220,-0.0862409994222281,0.0062578255250779,-0.0985063374513808,-0.0739756613930754,6.49073592742948e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39680,-0.117829230285863,0.00857190446111724,-0.134630163029653,-0.101028297542073,9.47903263675464e-43
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROC,Vitamin K-dependent protein C,39715,-0.0349022919632333,0.0025411119379225,-0.0398828713615614,-0.0299217125649052,1.09910695289164e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A4,Protein S100-A4,39721,-0.0767822878125781,0.00559279150373834,-0.0877441591599053,-0.065820416465251,1.19671011700052e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,36880,-0.0991451216688322,0.0072211420874212,-0.113298560160178,-0.0849916831774866,1.33203355612874e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH2,Neutral ceramidase,39557,-0.0707909163769367,0.00516303226804351,-0.080910459622302,-0.0606713731315714,1.53170771882945e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39673,-0.11628312021547,0.00851109953193158,-0.132964875298056,-0.099601365132884,2.95339048277744e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39680,-0.104872512359852,0.00767946573004025,-0.119924265190731,-0.0898207595289732,3.21629010496917e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37268,-0.103393206547961,0.00758438388583479,-0.118258598964197,-0.0885278141317247,4.89917749701664e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEXIM1,Protein HEXIM1,39673,-0.109648364041343,0.00804771522022362,-0.125421885872981,-0.0938748422097042,4.92654771550992e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN1,Pantetheinase,37277,-0.0978088579067182,0.00718197577470165,-0.111885530425133,-0.083732185388303,5.89480306360555e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,39865,-0.101648742651208,0.00746829731559645,-0.116286605389777,-0.0870108799126391,5.92234434998418e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,39817,-0.0360283946964132,0.0026497246118091,-0.041221854935559,-0.0308349344572673,7.13550249045382e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37215,-0.130652018774449,0.00961005901761852,-0.149487734448981,-0.111816303099917,8.098030511334e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39680,-0.0560533294134463,0.00412658981762499,-0.0641414454559913,-0.0479652133709014,8.61186592943183e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39557,-0.069659152314357,0.00512839847538852,-0.0797108133261185,-0.0596074913025955,8.6981938644126e-42
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39720,-0.116172728446469,0.00856043190149339,-0.132951174973396,-0.099394281919542,1.01878717753986e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39790,-0.0966516697783653,0.00713335138814748,-0.110633038499134,-0.0826703010575963,1.36042671404014e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37220,-0.0515411296061938,0.0038101783675194,-0.0590090792065318,-0.0440731800058558,2.02368228644172e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36832,-0.0683162773641178,0.00506117163450409,-0.0782361737677458,-0.0583963809604898,3.04492445707585e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37268,-0.106542284088415,0.00789702110610284,-0.122020445456377,-0.0910641227204539,3.26093575378991e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHBP1,EH domain-binding protein 1,37268,-0.100364315446993,0.00745272971508334,-0.114971665688556,-0.0857569652054293,4.53505503959699e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39401,-0.093416620121912,0.00694363443892286,-0.107026143622201,-0.0798070966216232,4.9780979800975e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C19orf12,Protein C19orf12,39302,-0.0862042530959506,0.0064096598242285,-0.0987671863514385,-0.0736413198404627,5.30083795046728e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",36880,-0.0934129296870507,0.00694807751861392,-0.107031161623534,-0.0797946977505675,6.22337012267652e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39653,-0.0814994250564173,0.00606574178341684,-0.0933882789519143,-0.0696105711609203,6.24102272306892e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100P,Protein S100-P,39401,-0.0697759354778958,0.00519356404646964,-0.0799553210089763,-0.0595965499468153,6.37289401319114e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37220,-0.116097831414956,0.00863950420806897,-0.133031259662771,-0.099164403167141,6.67192974388441e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,36855,-0.0897465672942784,0.00667928782259783,-0.10283797142657,-0.0766551631619866,6.92094318143445e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINH1,Serpin H1,37005,-0.171494949257513,0.0127854274348397,-0.196554387029799,-0.146435511485227,9.36358608312388e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBIN,Erbin,39594,-0.135801952562151,0.0101331504325904,-0.155662927410028,-0.115940977714274,9.87709574616106e-41
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPK2,SRSF protein kinase 2,39673,-0.111144493222918,0.00830311159330788,-0.127418591945802,-0.094870394500035,1.21696676369226e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD63,CD63 antigen,39529,-0.0677318838672362,0.00506863856886269,-0.0776664154622071,-0.0577973522722653,1.65892223009521e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39302,-0.112483559295449,0.00842336367470919,-0.128993352097879,-0.0959737664930192,1.88790596992311e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK14,Kallikrein-14,39836,0.0594068047169294,0.00444964725103324,0.0506854961049042,0.0681281133289545,1.92754629801411e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGRN,Agrin,39743,-0.0427095040231397,0.00320376844101038,-0.0489888901675201,-0.0364301178787594,2.51657944496886e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,36880,-0.0987992040202937,0.00740922127331871,-0.113321277715998,-0.084277130324589,2.67497719224925e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37285,-0.0225029315512512,0.00169298627544223,-0.0258211846511179,-0.0191846784513844,4.6222123134398e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZN,Kazrin,37215,-0.136962799072852,0.0103325693518831,-0.157214635002543,-0.116710963143162,7.49033161537689e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCA,Alpha-synuclein,36958,-0.152605467887347,0.0115166058493141,-0.175178015352003,-0.130032920422691,8.04106638364762e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R9B,Neurabin-2,39865,-0.123661281754815,0.00934070928484683,-0.141969071953115,-0.105353491556516,8.46198431624261e-40
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSA,Arylsulfatase A,39668,-0.0585667668763475,0.00443195057079039,-0.0672533899950966,-0.0498801437575983,1.17177181940027e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,39865,-0.129431207292366,0.00982023356357463,-0.148678865076973,-0.11018354950776,1.83509578075214e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37215,-0.112470990968443,0.00853436625436924,-0.129198348827007,-0.0957436331098793,2.05290474200019e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN2,CCN family member 2,39692,-0.0756716237204584,0.00575068341457879,-0.0869429632130328,-0.064400284227884,2.43938592952925e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP43,Centrosomal protein 43,39293,-0.090709972790028,0.00689719604870959,-0.104228477045499,-0.0771914685345572,2.70620407967216e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,39817,-0.0438300244669358,0.00333714830783674,-0.0503708351502958,-0.0372892137835758,3.35912876974012e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39594,-0.0794951433010091,0.00605851259634463,-0.0913698279898446,-0.0676204586121737,3.99367880881948e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39564,-0.0968153725577987,0.00738322269117627,-0.111286489032504,-0.0823442560830932,4.45702223337837e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37203,-0.0570957781220509,0.00435417077830865,-0.0656299528475358,-0.0485616033965659,4.84206888279601e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGFR,Opioid growth factor receptor,39594,-0.0422143274959989,0.00322478468668158,-0.0485349054818948,-0.035893749510103,5.95521693266349e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39288,-0.065583963335052,0.0050136221895376,-0.0754106628265456,-0.0557572638435583,6.79574702319008e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCR,Breakpoint cluster region protein,39673,-0.118539604012555,0.00906583143414348,-0.136308633623476,-0.100770574401634,7.23783191380175e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37203,-0.0489275143549839,0.00374058895969372,-0.0562590687159836,-0.0415959599939842,7.4112157534992e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39557,-0.074693254067814,0.00571686662270854,-0.0858983126483228,-0.0634881954873053,8.27191624312031e-39
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39738,-0.0354839398775316,0.00272372661145687,-0.0408224440359871,-0.0301454357190761,1.3424350910017e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF15,Growth/differentiation factor 15,39860,-0.0544373702835962,0.00418550001765887,-0.0626409503182076,-0.0462337902489848,1.76835950440934e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37220,-0.13988354459013,0.0107727629981814,-0.160998160066565,-0.118768929113694,2.54068363032581e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37215,-0.0649646084978365,0.00501585777475502,-0.0747956897363563,-0.0551335272593167,3.89159897466331e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37220,-0.0892793705672145,0.00689651260958173,-0.102796535281995,-0.0757622058524343,4.21722157248524e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN1,Perilipin-1,39302,-0.0441727419691752,0.00341774708653384,-0.0508715262587816,-0.0374739576795689,5.15352558068581e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39673,-0.132362823623667,0.0102468428811623,-0.152446635670745,-0.112279011576589,5.58657361890085e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39673,-0.0698851360246378,0.00541356852538264,-0.0804957303343877,-0.0592745417148878,6.2051908355416e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39594,-0.175174859884795,0.0135839140364213,-0.201799331396181,-0.14855038837341,7.39598605812805e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39302,-0.0783876676746438,0.00608635681545361,-0.0903169270329329,-0.0664584083163547,9.21698016552802e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39743,-0.16014320820926,0.0124367503781105,-0.184519238950357,-0.135767177468164,9.41623902796693e-38
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37220,-0.0390611718219527,0.00304271498809507,-0.0450248931986191,-0.0330974504452864,1.68146621030818e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39743,0.0254667525789728,0.00198489884159297,0.0215763508494506,0.029357154308495,1.70425156854939e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39668,-0.0588674301019382,0.00459255878844387,-0.0678688453272882,-0.0498660148765882,1.99681501039307e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37205,-0.0756736084223859,0.00590384589582435,-0.0872451463782016,-0.0641020704665702,2.16890199132265e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39302,-0.0637272613786431,0.00497514246559299,-0.0734785406112054,-0.0539759821460808,2.25868989355926e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39557,-0.119470311232021,0.00933139596020214,-0.137759847314018,-0.101180775150025,2.42371247378192e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS8,Galectin-8,39817,-0.0772931072732203,0.00603868098537272,-0.0891289220045508,-0.0654572925418898,2.51289789143783e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL2,C-C motif chemokine 2,39529,-0.0651950537366222,0.00509469746323969,-0.075180660764572,-0.0552094467086724,2.63166346094957e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39721,-0.0333474993818829,0.00260814163729858,-0.0384594569909881,-0.0282355417727777,3.00132647530016e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLA2,Src-like-adapter 2,37244,-0.133963623439132,0.0104736301962258,-0.154491938623735,-0.113435308254529,3.05822544712594e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37268,-0.0812580907751232,0.00635498049848445,-0.0937138525521528,-0.0688023289980937,3.21657754575682e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QDPR,Dihydropteridine reductase,39604,-0.0547156018834232,0.0042909505223153,-0.0631258649071612,-0.0463053388596852,4.67017709052875e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37203,-0.144742086832757,0.0113536678134219,-0.166995275747064,-0.12248889791845,5.22460934119481e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,39865,-0.0453276698904936,0.00355939297958135,-0.0523040801304731,-0.0383512596505142,5.73570447180652e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN1,Contactin-1,39860,0.0334654693443621,0.00262850888316873,0.0283135919333514,0.0386173467553728,5.95371983514249e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL11,Eotaxin,39865,-0.0477388083236482,0.00375862400447694,-0.055105711372423,-0.0403719052748734,8.77028350068333e-37
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39401,-0.1212939705408,0.00956374761856833,-0.140038915873194,-0.102549025208406,1.12096022620423e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39671,-0.0629617718866761,0.0049678562283288,-0.0726987700942005,-0.0532247736791516,1.24464792374079e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE4,Ribonuclease 4,36888,-0.0326757716294529,0.00257760616264728,-0.0377278797082416,-0.0276236635506643,1.30801058137784e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSB,Cathepsin B,39656,0.0641008888993493,0.00505976206479236,0.0541837552523563,0.0740180225463423,1.32750392075758e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39697,-0.036532475620736,0.00288709988470649,-0.0421911913947607,-0.0308737598467112,1.60353249976313e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39594,-0.0348737377133909,0.00276058225402953,-0.0402844789312888,-0.029462996495493,2.09307570663986e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD6,T-cell differentiation antigen CD6,39848,-0.0652795935696468,0.00517280609782082,-0.0754182935213756,-0.055140893617918,2.44861945147155e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMN,Protein amnionless,39401,-0.0593156957936037,0.0047004151522107,-0.0685285094919367,-0.0501028820952707,2.4928666524835e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15,Interleukin-15,39673,-0.0404183327179968,0.00320388715487912,-0.0466979515415599,-0.0341387138944338,2.59791219636331e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37244,-0.0804824050839668,0.00637706114945248,-0.0929814449368937,-0.06798336523104,2.61669438008432e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASET2,Ribonuclease T2,39784,-0.0317329676843466,0.00251570375730431,-0.0366637470486631,-0.0268021883200302,2.63838815743962e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39490,-0.0451564955231955,0.00358604322423448,-0.0521851402426951,-0.0381278508036959,3.4889094422616e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APLP1,Amyloid-like protein 1,39680,0.0637440323047834,0.00506240430388817,0.0538217198691626,0.0736663447404043,3.50001314611227e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39680,-0.0348914436471563,0.00277230635174932,-0.040325164096585,-0.0294577231977277,3.77079742097507e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO1,Forkhead box protein O1,39673,-0.106650898350972,0.00848589079469865,-0.123283244308581,-0.0900185523933625,4.70694728710611e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,39817,-0.0803839319878194,0.00639979451486564,-0.092927529236956,-0.0678403347386827,5.1605698738918e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,36896,-0.150053511200955,0.0119598589659018,-0.173494834774123,-0.126612187627787,6.70291936700885e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39720,-0.0642522713453587,0.00512793414459314,-0.0743030222687613,-0.0542015204219561,7.57721080679254e-36
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNST,Consortin,39680,-0.133359876896092,0.0106628916033549,-0.154259144438668,-0.112460609353516,1.00973845129151e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39721,-0.116736149220726,0.00933575045675188,-0.135034220115959,-0.0984380783254918,1.04335901156263e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,P4HB,Protein disulfide-isomerase,39585,-0.048030606688315,0.00384202260053987,-0.0555609709853731,-0.0405002423912568,1.0842774171372e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39804,-0.0372248842617515,0.00297883691351717,-0.0430634046122451,-0.0313863639112578,1.14690969097642e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,39860,0.0379729001866694,0.00304235555428209,0.0320098833002765,0.0439359170730623,1.38108248306786e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39282,-0.0727295449452927,0.00582823231096474,-0.0841528802747836,-0.0613062096158018,1.44651019195078e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39594,-0.0945081120317644,0.00757864090596561,-0.109362248207457,-0.0796539758560718,1.59543218018462e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL13,C-C motif chemokine 13,39832,-0.0845259059582607,0.00678057100079907,-0.0978158251198269,-0.0712359867966946,1.67602958711163e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37220,-0.0776018190860773,0.00622487974759524,-0.089802583391364,-0.0654010547807907,1.79327328481e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANG,Angiogenin,39651,-0.0414382294632881,0.00333092854307986,-0.0479668494077246,-0.0349096095188516,2.30864140251939e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,36896,-0.0548415638392941,0.00440628541635417,-0.0634778832553483,-0.0462052444232399,2.3286484967957e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39557,-0.0544319676592196,0.00437893186926561,-0.0630146741229802,-0.045849261195459,2.61990273787254e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37268,-0.072604500125893,0.00584542521824148,-0.0840615335536463,-0.0611474666981397,3.15083609537588e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,36855,-0.0689867904790629,0.00557197531151381,-0.07990786208963,-0.0580657188684958,5.21496119369962e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39521,-0.136702135989141,0.0110511859922269,-0.158362460533906,-0.115041811444376,5.53936832238273e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37203,-0.0594331235559039,0.00480592572933386,-0.0688527379853982,-0.0500135091264095,6.15346138415701e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FEN1,Flap endonuclease 1,39288,-0.0761519886773704,0.0061644497753239,-0.0882343102370052,-0.0640696671177355,6.82590716163496e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39668,-0.062795189896221,0.00508948188280578,-0.0727705743865203,-0.0528198054059217,8.1541029514469e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,39860,-0.0476056727629066,0.00386134964661714,-0.0551739180702762,-0.040037427455537,9.12016920935207e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF23,Fibroblast growth factor 23,39814,-0.0707277811335532,0.00573866455739688,-0.0819755636660511,-0.0594799986010553,9.58787613833209e-35
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,36896,-0.0862114513227788,0.00700066804921689,-0.0999327606992439,-0.0724901419463137,1.17557865344742e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39302,-0.0818247479020274,0.00664836330507869,-0.0948555399799817,-0.0687939558240732,1.19962054589581e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,36855,-0.052240256057887,0.00424385868107314,-0.0605582190727904,-0.0439222930429837,1.2536197540858e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39594,0.0492772101809145,0.0040091372938634,0.0414193010849423,0.0571351192768868,1.45454776410341e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR,GMP reductase 1,39865,-0.0600987761336037,0.00489134519707869,-0.0696858127198779,-0.0505117395473295,1.52697744788261e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37285,-0.0298713273740041,0.00243078311647164,-0.0346356622822886,-0.0251069924657197,1.59535705275045e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTNB,Dystrobrevin beta,37183,-0.0535533010074237,0.00435974089565775,-0.0620983931629129,-0.0450082088519345,1.70499034095969e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP2,Methionine aminopeptidase 2,39817,-0.0698963538319995,0.00569751570046406,-0.0810634846049091,-0.05872922305909,1.92640157826284e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,39817,0.0538621505753449,0.00439166201219877,0.0452544930314353,0.0624698081192545,2.00392791144928e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,39865,-0.0438642512673244,0.00358132054786012,-0.0508836395411302,-0.0368448629935185,2.45126524696698e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREH,Trehalase,37267,-0.0915806570608137,0.00747510315008391,-0.106231859234978,-0.0769294548866492,2.51872538953299e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39783,-0.124556986493617,0.0101792633054917,-0.144508342572381,-0.104605630414853,2.833456224649e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL5,C-C motif chemokine 5,39738,-0.121911364031518,0.00996310876589789,-0.141439057212678,-0.102383670850359,2.83865201763575e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37203,-0.0884222975506197,0.00722883806033194,-0.10259082014887,-0.0742537749523691,3.20234910546447e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,39865,-0.0517044889355751,0.00423325182069513,-0.0600016625041376,-0.0434073153670126,3.71889229992993e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39594,-0.0657030677703324,0.00538359499148131,-0.0762549139536358,-0.055151221587029,4.20421093643963e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNMBP,Dynamin-binding protein,39557,-0.0745903196739646,0.00611880641076971,-0.0865831802390732,-0.062597459108856,4.98717095828279e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MENT,Protein MENT,36958,0.0269538421566923,0.00221029693986875,0.0226216601545496,0.0312860241588351,5.07362832690123e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39510,-0.0331917536065045,0.00272572458315944,-0.038534173789497,-0.027849333423512,5.85491105393916e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD209,CD209 antigen,39693,0.0466431563562501,0.00383376846329935,0.0391289701681834,0.0541573425443168,6.64991087436558e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37244,-0.093605106194146,0.00770266944910303,-0.108702338314388,-0.0785078740739041,8.40359851051573e-34
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN1,Ficolin-1,37262,-0.0677670274474695,0.00558392719749229,-0.0787115247545544,-0.0568225301403846,1.02174385361068e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMIP,C-Maf-inducing protein,37203,-0.100015235189219,0.00824181503147475,-0.11616919265091,-0.0838612777275285,1.03587681343419e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMNL1,Formin-like protein 1,39302,-0.0730343010142575,0.00602146929430369,-0.0848363808310927,-0.0612322211974223,1.05549079737345e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39707,0.0373313823901009,0.00307936293806718,0.0312958310314893,0.0433669337487126,1.12341094433371e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COCH,Cochlin,37268,-0.0549081122804641,0.00453519421869032,-0.0637970929490971,-0.046019131611831,1.44927077025383e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39743,-0.126618490190006,0.0104697602127996,-0.147139220207093,-0.106097760172919,1.60020183885482e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK2,Docking protein 2,39680,-0.1462423789011,0.0121177354513293,-0.169993140385706,-0.122491617416495,2.17294825149951e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF3,Trefoil factor 3,39649,-0.0573957708352824,0.00475698226124773,-0.066719456067328,-0.0480720856032369,2.25090779294778e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA2,Apolipoprotein A-II,37277,0.0569619639682833,0.0047197112653455,0.0477113298882062,0.0662125980483605,2.29381416368354e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39594,-0.0652209846015912,0.00540746138150576,-0.0758196089093425,-0.05462236029384,2.37294396735531e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39680,-0.0755080241227276,0.0062700826626422,-0.0877973861415063,-0.0632186621039489,2.96599911812154e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAG1,Dystroglycan,39743,-0.0574947733800265,0.00478417381927747,-0.0668717540658103,-0.0481177926942426,3.99324088592335e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37268,-0.0864348433045621,0.00719100418799553,-0.100529211513033,-0.0723404750960909,4.1347871748505e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37005,-0.0642371376422358,0.00534457943502411,-0.074712513334883,-0.0537617619495885,4.20405828977902e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,36880,-0.123213802408325,0.0102548596512521,-0.14331332732478,-0.103114277491871,4.42472921657759e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,36958,-0.0930479073646539,0.00774909980728589,-0.108236142986934,-0.0778596717423736,4.83349043660359e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCA,Calcitonin,39521,-0.0719923650214925,0.0060070469846648,-0.0837661771114355,-0.0602185529315495,5.9594684278688e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39782,-0.0805144331554279,0.00672824028202227,-0.0937017841081915,-0.0673270822026642,7.35081667358704e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRAP,BRCA1-associated protein,37083,-0.130866119956322,0.0109478689365313,-0.152323943071923,-0.109408296840721,9.17328722421106e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BID,BH3-interacting domain death agonist,39673,-0.0779774864614759,0.00652999167131001,-0.0907762701372435,-0.0651787027857083,9.95104963976752e-33
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,36958,-0.0266507666107334,0.00223423720169188,-0.0310298715260494,-0.0222716616954173,1.24277434954129e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EREG,Proepiregulin,39521,-0.0936314391386447,0.00787164390659412,-0.109059861195569,-0.0782030170817202,1.7387475087621e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39658,-0.13311055415983,0.0111961026626745,-0.155054915378671,-0.111166192940988,1.85677881479996e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASHC3,WASH complex subunit 3,37220,-0.0895544297332501,0.00753525420594987,-0.104323527976912,-0.0747853314895883,2.06953427302631e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH1,Cadherin-1,39125,-0.0473381953145659,0.00398636622748334,-0.0551514731204332,-0.0395249175086985,2.21596454129299e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37215,-0.0903820466432914,0.00762365972517811,-0.105324419704641,-0.0754396735819423,2.92573733708595e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNCG,Gamma-synuclein,39557,-0.0758162224246212,0.00640690195907762,-0.0883737502644134,-0.0632586945848291,3.58847962667106e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39594,-0.0524585794581705,0.00444081754918326,-0.0611625818545697,-0.0437545770617713,4.57827335685004e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRN,"Attractin, Isoform 2",37285,-0.0190980653443464,0.00161631444529841,-0.0222660416571313,-0.0159300890315615,4.66179346377208e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPA,Apolipoprotein(a),37021,0.205804169532079,0.0174356758382038,0.171630244889199,0.239978094174958,5.42000110786705e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39743,-0.0993590363514338,0.00843286036879513,-0.115887442674272,-0.0828306300285954,6.53463381951436e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,36999,-0.0512205739007008,0.004346632037395,-0.059739972693995,-0.0427011751074066,6.83278530038797e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT2,Omega-amidase NIT2,37208,-0.0883489617628597,0.00750280804379282,-0.103054465528694,-0.0736434579970258,7.50799572285013e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37215,-0.0979743097339242,0.00832892778017692,-0.114299008183071,-0.0816496112847774,8.67350675235506e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,36896,-0.0602268999300136,0.00512195397094493,-0.0702659297130656,-0.0501878701469615,9.22998697251258e-32
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37215,-0.0468658575455861,0.00399049470405255,-0.0546872271655291,-0.0390444879256431,1.08060915076134e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39302,-0.06550905110646,0.00558119404074187,-0.0764481914263141,-0.0545699107866059,1.11663076549517e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH2B3,SH2B adapter protein 3,39288,-0.114025660833453,0.00971879280205019,-0.133074494725471,-0.0949768269414344,1.18389492622315e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAN,Brevican core protein,39557,0.0385307661320602,0.00328656484314212,0.0320890990395016,0.0449724332246187,1.30506409245899e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37244,-0.0646646859412258,0.00551696459179717,-0.0754779365411483,-0.0538514353413034,1.41821965050538e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39738,0.0497929719923501,0.00425068859578294,0.0414616223446155,0.0581243216400847,1.4556282577758e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCN2,Ficolin-2,39619,-0.0467269175075874,0.00399260912132102,-0.0545524313853766,-0.0389014036297982,1.65411288746423e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADD1,Alpha-adducin,36958,-0.0802398633805053,0.00685735716202131,-0.0936802834180671,-0.0667994433429435,1.80041113500374e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37268,-0.0953863813043388,0.00815313892574474,-0.111366533598798,-0.0794062290098791,1.82636157612387e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37220,-0.0896229841780544,0.00766238608540194,-0.104641260905442,-0.0746047074506666,1.89067046707013e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARSB,Arylsulfatase B,39594,-0.0637947852717765,0.00545648591793696,-0.074489497670933,-0.0531000728726201,1.89950751124638e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYAP1,Synapse-associated protein 1,36958,-0.0669918917089392,0.00572863233652699,-0.0782200110885321,-0.0557637723293463,1.95489866680397e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TALDO1,Transaldolase,37245,-0.051882076128753,0.00444019398131242,-0.0605848563321253,-0.0431792959253807,2.16911685423064e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD36,Platelet glycoprotein 4,36896,-0.05297767503077,0.00453634704606563,-0.0618689152410587,-0.0440864348204814,2.35208602251879e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAMBP,STAM-binding protein,39521,-0.0741684312742907,0.00635570606108575,-0.0866256151540188,-0.0617112473945626,2.45769021875165e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39557,-0.0813450101339984,0.00697092169880771,-0.0950080166636615,-0.0676820036043353,2.46725208025298e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOST,Sclerostin,39658,-0.0440650704857035,0.00377703457315545,-0.0514680582490882,-0.0366620827223188,2.53867018741032e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,36877,-0.0844637390493619,0.00723791599283621,-0.0986500543953208,-0.0702774237034029,2.60909387585435e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,39865,-0.0645049268150473,0.00553370906993304,-0.0753509965921161,-0.0536588570379786,2.83657877497547e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RFC4,Replication factor C subunit 4,37203,-0.0248032350999643,0.00212698537533138,-0.0289721264356138,-0.0206343437643148,2.85212090142367e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37244,-0.0888300508767843,0.00761936048528084,-0.103763997427935,-0.0738961043256339,2.94166237877754e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39401,-0.0843072584397219,0.00724014203475438,-0.0984979368278405,-0.0701165800516033,3.30152867122784e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37215,-0.125163178515049,0.0107535415754667,-0.146240120002964,-0.104086237027135,3.67995182600438e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39637,-0.0740567465322601,0.00638724651962146,-0.0865757497107182,-0.0615377433538021,5.86854122234427e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAB2,Disabled homolog 2,39836,-0.127600221183318,0.011012764614652,-0.149185239828036,-0.1060152025386,6.40740034293814e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSNL1,Visinin-like protein 1,37220,-0.0435348348122555,0.00375649722651961,-0.0508975693762339,-0.0361721002482771,6.56901644305216e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39557,-0.0570172317052155,0.00493042937785347,-0.0666808732858083,-0.0473535901246227,8.32611324401741e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39743,-0.118557887075944,0.0102560431490742,-0.13865973164813,-0.0984560425037589,8.74569044048582e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37244,-0.0834640994040636,0.00721882614841629,-0.0976129986549595,-0.0693152001531677,8.9876372017032e-31
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,36924,-0.044354903889775,0.00383967796951006,-0.0518806727100147,-0.0368291350695352,1.02011544929041e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39288,-0.0628448575081515,0.00544642433390236,-0.0735198492026001,-0.0521698658137028,1.12450571996668e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37098,-0.0340563112838143,0.00295606213198957,-0.0398501930625139,-0.0282624295051148,1.44892683540679e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGA,Protein O-GlcNAcase,37215,-0.0815664990741282,0.00708031290160548,-0.095443912361275,-0.0676890857869815,1.45561170456925e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39716,-0.0810781991185712,0.00704376310365614,-0.0948839748017372,-0.0672724234354052,1.54202857007392e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39668,-0.0273076192551515,0.00237348415319584,-0.0319596481954153,-0.0226555903148876,1.64121549316933e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18,Interleukin-18,39609,-0.0514377139873858,0.00448328784983917,-0.0602249581730705,-0.042650469801701,2.37422325926133e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39680,0.0303936177318759,0.00265060944683146,0.0251984232160863,0.0355888122476656,2.55642592607218e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,36877,-0.078463503916798,0.0068471118226051,-0.091883843089104,-0.065043164744492,2.94766731838362e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN3,Ataxin-3,37220,-0.0696241548708209,0.00608731218415165,-0.0815552867517581,-0.0576930229898837,3.74786202330256e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLK1,Protein delta homolog 1,39860,-0.0628882008636236,0.00551285489947013,-0.0736933964665851,-0.0520830052606622,5.00774876433788e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39697,0.0373605682000091,0.00327938256035268,0.0309329783817179,0.0437881580183004,5.9569049181239e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT1,Angiopoietin-1,39607,-0.0946675844013473,0.00831772972885636,-0.110970334669906,-0.0783648341327889,6.77240118380235e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37220,-0.102568964538532,0.00901162465871432,-0.120231748869612,-0.0849061802074519,7.06913007472904e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,39860,-0.0241030571381249,0.00212112665931827,-0.0282604653903887,-0.0199456488858611,8.2837410114939e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39721,-0.0622178308968843,0.00547667759791132,-0.0729521189887905,-0.0514835428049781,8.57307509852324e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39401,-0.0667277433566311,0.00588034824801256,-0.0782532259227357,-0.0552022607905265,9.98103922518602e-30
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD1,COMM domain-containing protein 1,36880,-0.0700264583145074,0.00617473971052157,-0.0821289481471297,-0.0579239684818851,1.13514425410012e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGT,Angiotensinogen,37277,-0.0251316930229515,0.00221638706697887,-0.0294758116742301,-0.020787574371673,1.14711204741674e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTDH,Protein LYRIC,36896,-0.104088605428622,0.00918945962862777,-0.122099946300732,-0.0860772645565112,1.32694604658374e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AAMDC,Mth938 domain-containing protein,36880,-0.0603242100793598,0.00532590641858279,-0.0707629866597821,-0.0498854334989376,1.33338525168965e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37215,-0.115248860239756,0.0101786367820579,-0.13519898833259,-0.0952987321469228,1.38306951246125e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39743,-0.0735134810722046,0.00649530323024778,-0.0862442754034902,-0.0607826867409189,1.38831015012827e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39673,-0.0793656491354757,0.00701276996163541,-0.0931106782602811,-0.0656206200106703,1.4000136101991e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37215,-0.0533505829264841,0.00471605717571811,-0.0625940549908915,-0.0441071108620766,1.54992113914186e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",36863,-0.0898646336121473,0.00794827524318651,-0.105443253088793,-0.0742860141355018,1.67915373189744e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD248,Endosialin,37267,0.0444439164875622,0.00393285064055246,0.0367355292320794,0.052152303743045,1.76963424986045e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37244,-0.0903625474129809,0.00799793416251256,-0.106038498371505,-0.0746865964544562,1.82020488303802e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,36972,-0.0731485041052732,0.00648228367780361,-0.0858537801137683,-0.0604432280967782,2.14149931063332e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39673,-0.0552023276038089,0.00489552221804373,-0.0647975511511746,-0.0456071040564432,2.22988429719739e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39673,0.0431814988958374,0.00383095105570383,0.035672834826658,0.0506901629650169,2.34171713537939e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39401,-0.0664870587797361,0.00591006589775404,-0.078070787939334,-0.0549033296201382,3.01132938493293e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,36958,-0.0652346405312553,0.00580888740294525,-0.076620059841028,-0.0538492212214826,3.93989252957281e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLKB1,Plasma kallikrein,37021,-0.0278180637302549,0.00247810950162944,-0.0326751583534486,-0.0229609691070612,4.14348773338846e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39673,0.0384936805742682,0.00343233515897586,0.0317663036626755,0.0452210574858609,4.43093251806521e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39401,-0.041298958430375,0.0036897964150127,-0.0485309594037999,-0.0340669574569501,5.71106874391715e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39430,-0.0323314700053962,0.00289450072292186,-0.0380046914223231,-0.0266582485884694,7.36424687659333e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL3,Follistatin-related protein 3,39616,-0.0329565457833278,0.00295223451394407,-0.0387429254306582,-0.0271701661359974,7.91368547098392e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NIT1,Deaminated glutathione amidase,36880,-0.0523514958819182,0.00468823750160044,-0.061540441385055,-0.0431625503787813,8.03437805531565e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39689,-0.0432339262887851,0.00387424272940979,-0.0508274420384283,-0.0356404105391419,8.25925453086382e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEC31A,Protein transport protein Sec31A,36880,-0.0855788415170415,0.00767134460260174,-0.100614676938141,-0.0705430060959421,9.07308715259904e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CES2,Cocaine esterase,39594,-0.0596545862769634,0.00535097323539649,-0.0701424938183405,-0.0491666787355863,9.34723782893228e-29
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN4,CCN family member 4,39836,-0.0440231689817655,0.00395657437156417,-0.0517780547500313,-0.0362682832134998,1.18686595069859e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39673,-0.0825609238490192,0.00742010993348704,-0.0971043393186538,-0.0680175083793846,1.18906221232539e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39288,-0.0700546102350258,0.00629808661165416,-0.0823988599938679,-0.0577103604761836,1.24362567802932e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37244,-0.0858931084064541,0.00772707518756587,-0.101038175774083,-0.070748041038825,1.40087604238287e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39594,0.0469843561873835,0.00422825086354371,0.0386969844948378,0.0552717278799292,1.40095483163978e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39662,-0.062100044641381,0.00560083528165555,-0.0730776817934258,-0.0511224074893361,1.83425009995906e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39743,-0.0447991704801135,0.00404247685482889,-0.0527224251155782,-0.0368759158446489,1.94786005111597e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBN,Nibrin,39401,-0.0565154111509852,0.00510086045774965,-0.0665130976481745,-0.0465177246537959,2.01369963551778e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39809,-0.0656260878458963,0.00592384413905369,-0.0772368223584415,-0.0540153533333511,2.0299873158957e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39668,0.0427512177818341,0.00386113603682988,0.0351833911496476,0.0503190444140207,2.17670168693115e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPE,Carboxypeptidase E,39713,0.0422472904919641,0.00381639324913089,0.0347671597236676,0.0497274212602606,2.22971779861474e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDT,D-dopachrome decarboxylase,37267,-0.0439769926155588,0.00397909006005706,-0.0517760091332706,-0.0361779760978469,2.83886064524377e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39650,-0.0906847537721534,0.00820922560548136,-0.106774835958897,-0.0745946715854099,2.8868477258176e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39557,-0.0626513390211859,0.005675864027561,-0.0737760325152055,-0.0515266455271664,3.17495655289965e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39288,-0.0640033086149415,0.00580129812116925,-0.0753738529324332,-0.0526327642974497,3.39213618042894e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBPL,FK506-binding protein-like,37215,-0.0652912097642026,0.00592034480577912,-0.0768950855835296,-0.0536873339448755,3.69269523264449e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39594,-0.0921861133783034,0.0083643112101363,-0.108580163350171,-0.0757920634064362,3.82109492537182e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,36855,-0.0401194110992214,0.0036455383573797,-0.0472646662796856,-0.0329741559187571,4.80379026438073e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39617,-0.123624281050845,0.0112497920382436,-0.145673873445803,-0.101574688655888,5.45320489000591e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,36958,-0.0302406350293452,0.00275239427012728,-0.0356353277987946,-0.0248459422598957,5.84369591181399e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37244,-0.0719371113501504,0.00654900557266892,-0.0847731622725814,-0.0591010604277193,5.97682207522672e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39288,-0.0594085342967926,0.00541199863871813,-0.0700160516286802,-0.0488010169649051,6.24160134153036e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37268,-0.11759072677891,0.0107167401187947,-0.138595537411748,-0.0965859161460725,6.80032601152681e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PENK,Proenkephalin-A,36958,-0.0317050032844738,0.00288983670390405,-0.0373690832241257,-0.0260409233448218,6.95088057310673e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39557,-0.0851053501626327,0.00776105903302156,-0.100317025867355,-0.0698936744579104,7.05285770809719e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,36896,-0.0348859936067119,0.00318033563754273,-0.0411194514562956,-0.0286525357571281,7.10875110714151e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,39860,-0.0434600501884248,0.00396949039048096,-0.0512402513537675,-0.0356798490230821,8.47624513076836e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39401,-0.0821303223965906,0.00750477054822228,-0.0968396726711062,-0.0674209721220749,8.99087160856336e-28
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39288,-0.0606493016348911,0.00555811707341702,-0.0715432110987885,-0.0497553921709937,1.27654137839107e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39401,-0.101473328482866,0.00930119185672379,-0.119703664522045,-0.0832429924436877,1.30438897206679e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37244,-0.051805870411647,0.004752834892596,-0.0611214268011352,-0.0424903140221589,1.50468902928308e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,36880,-0.0835463863100672,0.00766536046331049,-0.0985704928181558,-0.0685222798019786,1.52883982359884e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP10,Caspase-10,39302,-0.0770796263155496,0.00707593941873959,-0.0909484675762792,-0.0632107850548201,1.56410525024192e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP1,Interstitial collagenase,39127,-0.0983678243408792,0.00906616696798009,-0.11613751159812,-0.0805981370836383,2.50923192918529e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37220,-0.0336824647950313,0.00310633230188227,-0.0397708761067205,-0.027594053483342,2.79153006520885e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39594,-0.0348742976380929,0.00322596258240516,-0.041197184299607,-0.0285514109765788,3.82356458971572e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN2,Dynactin subunit 2,39594,-0.101341279217644,0.00937825457739556,-0.119722658189339,-0.0829599002459487,4.01536066566776e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB6,Heat shock protein beta-6,39836,-0.0399513273643012,0.00369824383903047,-0.0471998852888009,-0.0327027694398015,4.14313175390755e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37244,-0.09085137556999,0.0084122926460095,-0.107339469156169,-0.0743632819838114,4.45853790596012e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDHD2,Phospholipase DDHD2,37244,-0.0714925410320746,0.00664250903226844,-0.0845118587353207,-0.0584732233288285,6.64018092172401e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,36877,-0.0857107455055072,0.00797140056847363,-0.101334690619715,-0.0700868003912988,7.49497263037808e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,39865,-0.0719961440552366,0.00670366424372599,-0.0851353259729395,-0.0588569621375336,8.16692479294206e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39668,-0.0281449475544976,0.0026207158574828,-0.0332815506351639,-0.0230083444738314,8.22421389387384e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA9,Serpin A9,39523,-0.0770349387597449,0.00717375860929565,-0.0910955056339643,-0.0629743718855254,8.32740893631632e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRKL,Crk-like protein,39693,-0.113296732293359,0.010561186868217,-0.133996658555064,-0.0925968060316534,9.32909644383095e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39288,-0.0829228677768833,0.00773011990067983,-0.0980739027822157,-0.0677718327715508,9.4221672060657e-27
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USO1,General vesicular transport factor p115,39594,-0.0950575757405873,0.00886886692685234,-0.112440554917218,-0.0776745965639567,1.03480749359419e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLB,Beta-klotho,39302,0.0778476655593436,0.00727221760285601,0.0635941190577459,0.0921012120609414,1.19841263266026e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5E,5'-nucleotidase,39721,-0.0584063739102954,0.00546367408708311,-0.0691151751209783,-0.0476975726996125,1.39726118339197e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM13A,Protein FAM13A,37215,-0.0719273036667858,0.00673025534844185,-0.0851186041497318,-0.0587360031838398,1.49658838212922e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39667,-0.0825534603404871,0.0077284673648394,-0.0977012563755723,-0.0674056643054019,1.52660041323431e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GLB2,Endophilin-B2,37220,-0.070084477945054,0.00656743880504219,-0.0829566580029367,-0.0572122978871713,1.76869166559194e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37268,-0.107418701920946,0.0100833089525291,-0.127181987467903,-0.0876554163739892,2.1499811574228e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MITD1,MIT domain-containing protein 1,39557,-0.102200150525933,0.00960058746561154,-0.121017301958532,-0.0833829990933347,2.25845834752669e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39673,-0.106723791036407,0.0100287878849467,-0.126380215290903,-0.0870673667819115,2.33961408830983e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39673,-0.119043206828287,0.0111895719617752,-0.140974767873366,-0.0971116457832074,2.41511668989204e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOLM2,Protein GOLM2,39817,-0.0232181237480645,0.00218543977619166,-0.0275015857094002,-0.0189346617867289,2.82089419455169e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37244,-0.0638372193839084,0.00600683628012427,-0.075610618492952,-0.0520638202748648,2.82730991048856e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPBP,Platelet basic protein,37204,-0.0896261827860003,0.0084341310641836,-0.1061570796718,-0.0730952859002005,2.8541868783594e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37244,-0.112442184388754,0.0106152987964444,-0.133248170029785,-0.0916361987477225,4.09757077056155e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39673,-0.0766226331591548,0.00724122273690568,-0.0908154297234899,-0.0624298365948196,4.44075712332695e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39288,-0.096694188592854,0.00913813139156821,-0.114604926120328,-0.0787834510653803,4.46548171106013e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMT,Catechol O-methyltransferase,39220,-0.0889063909992984,0.00841614060597698,-0.105402026587013,-0.0724107554115835,5.38514831144625e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39581,-0.0484267883869239,0.00458767422565921,-0.0574186298692159,-0.0394349469046318,5.83008202188698e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F12,Coagulation factor XII,37285,-0.043445923185628,0.00411490476866787,-0.051511136532217,-0.035380709839039,5.88477130662566e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,39860,-0.074861630206062,0.0070946758420578,-0.0887671948564953,-0.0609560655556287,6.06362562578933e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AP2B1,AP-2 complex subunit beta,36877,-0.0517304961612057,0.00490232527787763,-0.0613390537058458,-0.0421219386165655,6.31207898017148e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRB1,Chymotrypsinogen B,39668,-0.0555618990947705,0.00526742036466851,-0.0658860430095208,-0.0452377551800202,6.31280650784615e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39668,-0.0312877867935244,0.00296833496916315,-0.0371057233330842,-0.0254698502539647,6.84777634457548e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SBSN,Suprabasin,37250,0.0355970693789245,0.00337693304782486,0.0289782806051877,0.0422158581526612,7.04137007714122e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37244,-0.098100893389778,0.00932034080385786,-0.116368761365339,-0.0798330254142166,8.31631114903045e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NADK,NAD kinase,39680,-0.0555651086663498,0.00528126057219463,-0.0659163793878513,-0.0452138379448483,8.39602549143775e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39721,-0.0639241769265974,0.00607979633920947,-0.075840577751448,-0.0520077761017469,9.03285003702319e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",36880,-0.101856694112224,0.00969101906013179,-0.120851091470082,-0.0828622967543657,9.80535127646179e-26
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39738,-0.0430140147777375,0.00409893098901738,-0.0510479195162116,-0.0349801100392634,1.11747030357104e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPPK1,Epiplakin,36880,-0.0779375011252676,0.0074282355136042,-0.0924968427319318,-0.0633781595186033,1.18914293077397e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAN,Neurocan core protein,39817,0.0380289207124041,0.00362809276073323,0.030917858901367,0.0451399825234413,1.26865903361054e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA4,Ephrin-A4,39529,-0.0285830964025864,0.00273270673901053,-0.0339392016110471,-0.0232269911941258,1.60642468606037e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37220,-0.042212657443517,0.00403721079892036,-0.0501255906094009,-0.0342997242776331,1.72691973029415e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,39817,-0.0708545607230395,0.00677913285871191,-0.0841416611261148,-0.0575674603199642,1.7365623377426e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM3,Junctional adhesion molecule C,36958,-0.0526866469386715,0.00504240473520557,-0.0625697602196744,-0.0428035336576686,1.87004211615206e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMA,Granzyme A,39865,-0.034899657373549,0.00334224942039959,-0.0414504662375322,-0.0283488485095658,1.92502655083992e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39669,-0.044010945932292,0.00421719502344435,-0.052276648178243,-0.0357452436863411,2.05225769994607e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39303,-0.0388328544218073,0.00372196239636976,-0.046127900718692,-0.0315378081249226,2.11907376587047e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNMT,Histamine N-methyltransferase,39478,-0.0477106374503456,0.00457305578924808,-0.0566738267972718,-0.0387474481034194,2.12439166734897e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL17,C-C motif chemokine 17,39648,-0.0926939201493183,0.00888531645321034,-0.110109140397611,-0.075278699901026,2.13625063048648e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,36896,-0.1008913181,0.00969927200500579,-0.119901891229812,-0.0818807449701891,3.04941397510956e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL25,C-C motif chemokine 25,39865,-0.0512704883887816,0.00493167259363448,-0.0609365666723052,-0.041604410105258,3.10561505760859e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,36896,-0.0565378638289836,0.00544693987794036,-0.0672138659897468,-0.0458618616682205,3.84128206844365e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39680,-0.0745588788756079,0.00718815043442884,-0.0886476537270884,-0.0604701040241274,3.98281688391445e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,36896,-0.0514652919324627,0.00496657579493302,-0.0611997804905314,-0.041730803374394,4.60258857901373e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39557,-0.0397796949606708,0.00384419897481529,-0.0473143249513087,-0.0322450649700328,5.14355360519062e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39594,0.0245758444582764,0.00237714502943098,0.0199166402005917,0.0292350487159612,5.67898904077445e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA11,Integrin alpha-11,39673,0.0347303682699506,0.00336062870079468,0.028143536016393,0.0413172005235082,5.90784005456214e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39296,-0.0292967602209635,0.00283507840949981,-0.0348535139035832,-0.0237400065383439,5.98459311515911e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,36896,-0.0935548243767764,0.0090524228234027,-0.111297573110646,-0.0758120756429072,6.12237685080268e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39790,-0.0605259353659649,0.00585918407204795,-0.0720099361471789,-0.0490419345847509,6.17436266158762e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39721,0.0306741314113908,0.00296983252407708,0.0248532596641997,0.0364950031585818,6.27746045624596e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL3,C-C motif chemokine 3,39673,-0.0637869742462212,0.00618078463888056,-0.0759013121384271,-0.0516726363540153,6.84900525819513e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RWDD1,RWD domain-containing protein 1,39817,-0.0650961052028867,0.00630780219314077,-0.0774593975014426,-0.0527328129043308,6.85710024249914e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WDR46,WD repeat-containing protein 46,37203,-0.0370517809559015,0.00358944833235072,-0.0440870996873089,-0.0300164622244941,6.92236381172567e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS9,Galectin-9,39671,-0.0319971819747355,0.00310525230791343,-0.0380834764982458,-0.0259108874512252,8.08057985807712e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PF4,Platelet factor 4,37217,-0.0986094417921916,0.00957761436700508,-0.117381565951522,-0.0798373176328617,9.10675622368568e-25
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFA,Protransforming growth factor alpha,39673,-0.0466875573602138,0.004540528811437,-0.0555869938306303,-0.0377881208897973,1.01197551663746e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,39817,-0.0478751117412422,0.00466503818598866,-0.05701858658578,-0.0387316368967045,1.23982364432645e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39653,-0.0986979954831123,0.00963804915686327,-0.117588571830564,-0.0798074191356602,1.55854075967518e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TADA3,Transcriptional adapter 3,37203,-0.0403714653468973,0.0039431262925406,-0.0480999928802769,-0.0326429378135177,1.64320851201894e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A14,Protein S100-A14,37244,-0.0519736391792325,0.00507736641237595,-0.0619252773474893,-0.0420220010109756,1.67795269832019e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39288,-0.0457316150544774,0.00447226895596095,-0.0544972622081609,-0.036965967900794,1.82273806870087e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36711,-0.0546262247382865,0.00534133446980192,-0.0650952402990983,-0.0441572091774747,1.86088167449749e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39720,0.0778193225672085,0.00761330124868454,0.0628972521197868,0.0927413930146302,1.89175540342287e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39668,-0.0402878543840525,0.00395381850349636,-0.0480373386509054,-0.0325383701171997,2.62330985452599e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39557,-0.081848558500044,0.0080337493155393,-0.097594707158501,-0.066102409841587,2.66752810791251e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39743,-0.0381428145118009,0.00374575884170718,-0.0454845018415469,-0.0308011271820548,2.80608295634221e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSM,Oncostatin-M,39592,-0.0719041709218484,0.00706394245981625,-0.0857494981430882,-0.0580588437006085,2.92461078141621e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6AP2,Renin receptor,39288,-0.0409571776332048,0.00402476768172859,-0.0488457222893928,-0.0330686329770167,3.01835997791916e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39401,-0.0345547574195957,0.00339730066661324,-0.0412134667261577,-0.0278960481130338,3.17371593690671e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,36855,-0.0633052836480747,0.00622344884114745,-0.0755032433767237,-0.0511073239194257,3.25635830459411e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,36931,-0.0286605416873455,0.00282033665257443,-0.0341884015263913,-0.0231326818482996,3.59955961071198e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF19,Fibroblast growth factor 19,39743,-0.0766259656745013,0.00754760727130371,-0.0914192759262565,-0.061832655422746,3.83303519149495e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ING1,Inhibitor of growth protein 1,39266,-0.0451873333486493,0.00445446034089705,-0.0539180756168075,-0.036456591080491,4.18264849560061e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39474,-0.03616146193748,0.00356805071445722,-0.0431548413378161,-0.0291680825371438,4.59597953983378e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39288,-0.0342101118617988,0.00337766207004243,-0.0408303295190819,-0.0275898942045156,4.91759758637691e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,36863,-0.0581487430916621,0.00574103746788608,-0.0694011765287188,-0.0468963096546054,5.06407622976843e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37268,-0.091430702062424,0.00902870217081446,-0.10912695831722,-0.0737344458076277,5.13303604097668e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPACT,Protein IMPACT,37220,-0.0556081626176294,0.0055029632372765,-0.0663939705626914,-0.0448223546725675,6.38998208064137e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39401,-0.0558293252360457,0.00552802629149111,-0.0666642567673683,-0.0449943937047231,6.59241723820017e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL22,C-C motif chemokine 22,39500,-0.0501397096356122,0.00496493899258509,-0.059870990061079,-0.0404084292101455,6.62329294279716e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD69,Early activation antigen CD69,39597,-0.0877463505036824,0.00868920152444914,-0.104777185491603,-0.0707155155157621,6.64565270025511e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,36896,-0.0790316320257143,0.00782818095362719,-0.0943748666948236,-0.063688397356605,7.05818825033229e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39594,-0.0898786773668913,0.00890593022175609,-0.107334300601533,-0.0724230541322494,7.08498221032529e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39727,-0.0330908048179454,0.00328112934695569,-0.0395218183379785,-0.0266597912979122,7.58037551173186e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37244,-0.0625785364823595,0.00620846327016745,-0.0747471244918877,-0.0504099484728313,8.2732877485045e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TF,Serotransferrin,37285,-0.0218337542465535,0.00216642809577343,-0.0260799533142694,-0.0175875551788375,8.37987073673384e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36682,-0.0328769656052795,0.00326238353943475,-0.0392712373425716,-0.0264826938679874,8.51114178449039e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPSE,Heparanase,37137,-0.0940811355828702,0.00934941608165559,-0.112405991102915,-0.0757562800628253,9.81437426353356e-24
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX15,Sorting nexin-15,36958,-0.0539596362833739,0.00536429016301871,-0.0644736450028905,-0.0434456275638572,1.02183142310487e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINK1,Misshapen-like kinase 1,37220,-0.0929772226587371,0.00924866145885228,-0.111104599118088,-0.0748498461993866,1.08131554861823e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,36958,-0.0694192389457157,0.00690957756497416,-0.0829620109730651,-0.0558764669183664,1.15580785100971e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39680,-0.0802366152309622,0.00798998677387532,-0.0958969893077578,-0.0645762411541666,1.17120699535531e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37244,-0.0757738249020933,0.00754584170770485,-0.0905636746491948,-0.0609839751549918,1.21056190219564e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,36958,-0.0680361014798599,0.00678338892606449,-0.0813315437749463,-0.0547406591847735,1.37140424603213e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37220,-0.0821992372164134,0.00819776097342639,-0.0982668487243291,-0.0661316257084977,1.40480597165877e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL4,C-C motif chemokine 4,39694,-0.0614846989410491,0.00613945085327988,-0.0735180226134777,-0.0494513752686205,1.54366749869108e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39288,-0.0843789516988975,0.00842639287461965,-0.100894681733152,-0.067863221664643,1.56648767692263e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,36880,-0.0293224947911294,0.00293036224992336,-0.0350660048009792,-0.0235789847812796,1.73603381032516e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APP,Amyloid-beta precursor protein,39640,-0.0656499013835527,0.00657215658016162,-0.0785313282806695,-0.0527684744864359,1.99688029325534e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLG,Plasminogen,36995,-0.0224690122829706,0.00224965357310194,-0.0268783332862504,-0.0180596912796908,2.08966484930776e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSN,Gelsolin,37215,0.0184983686670505,0.00185254314477808,0.0148673841032854,0.0221293532308155,2.13318451437741e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37215,-0.146464928190872,0.0146775964989558,-0.175233017328826,-0.117696839052919,2.27841853004972e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,36896,-0.0877057235689956,0.0087938315527918,-0.104941633412467,-0.0704698137255236,2.41244458654944e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39721,-0.033971444168797,0.0034080737163327,-0.0406512686528091,-0.0272916196847849,2.46628314337924e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPHN1,Oligophrenin-1,37220,-0.107141677266333,0.0107494446260458,-0.128210588733383,-0.0860727657992831,2.5590522870225e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39288,-0.0440431120648343,0.00442385500834098,-0.0527138678811826,-0.0353723562484859,2.79595904104097e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39288,-0.0286065905906475,0.00287980975276831,-0.0342510177060733,-0.0229621634752216,3.49358873290413e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBNL,Drebrin-like protein,39743,-0.0911698511416678,0.0091812626134089,-0.109165125863949,-0.0731745764193864,3.60147062228102e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39673,-0.102662925374868,0.0103604968223336,-0.122969499146642,-0.0823563516030946,4.43836522235493e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37244,-0.066888447108742,0.00675360296405223,-0.0801255089182843,-0.0536513852991996,4.79479079003975e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39288,-0.0962182509300244,0.0097175319283084,-0.115264613509509,-0.07717188835054,4.80334804366479e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMPR2,GMP reductase 2,36958,-0.06607087494491,0.0066767986333002,-0.0791574002661784,-0.0529843496236416,5.23864784538086e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARC,SPARC,39721,-0.0688746017089192,0.00696439348501729,-0.082524812939553,-0.0552243904782853,5.38700484657191e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39408,-0.0221221625718741,0.00223705934180591,-0.0265067988818137,-0.0177375262619345,5.43508666131231e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AREG,Amphiregulin,39594,-0.0456000387363282,0.00461254283574581,-0.05464062269439,-0.0365594547782664,5.58086301590518e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICA1,Islet cell autoantigen 1,39401,-0.0783833955477418,0.00793310035250146,-0.0939322722386446,-0.0628345188568389,5.90772925969299e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37244,-0.112585387258623,0.0114080564899252,-0.134945177978876,-0.0902255965383695,6.79538251958776e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39697,-0.0456908872981579,0.00463191367552447,-0.0547694381021858,-0.0366123364941299,6.91551907510118e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37223,-0.0194276514338205,0.00197332271587646,-0.0232953639569383,-0.0155599389107026,8.5992991751935e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37244,-0.117388908931325,0.0119251947831744,-0.140762290706347,-0.0940155271563037,8.71428950261274e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37277,0.0250353109822645,0.00254366865882389,0.0200497204109696,0.0300209015535593,8.84626200915243e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37203,-0.0820854398385292,0.00834423233439754,-0.0984401352139484,-0.06573074446311,9.28622111891525e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH15,Cadherin-15,39781,-0.0522146706204016,0.00531034344672735,-0.0626229437759872,-0.041806397464816,9.45653990511126e-23
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR5,Cadherin-related family member 5,39680,-0.0375905870236277,0.00382570839989475,-0.0450889754874214,-0.030092198559834,1.0127575373929e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39673,-0.0588127419102401,0.00598726534914112,-0.0705477819945567,-0.0470777018259235,1.04131435775125e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BIN2,Bridging integrator 2,39668,-0.086895253406042,0.00885462235258576,-0.10425031321711,-0.0695401935949739,1.14275809530659e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,36855,-0.0656480593997751,0.00669091251748798,-0.0787622479340516,-0.0525338708654987,1.20376557784042e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTPBP2,GTP-binding protein 2,36877,-0.0791265995798116,0.00808194351159612,-0.09496720886254,-0.0632859902970832,1.47904519814875e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39810,-0.0307943139417342,0.00315185417234785,-0.036971948119536,-0.0246166797639324,1.74741118155793e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39720,0.0433955975904444,0.00445059972478496,0.0346724221298658,0.0521187730510229,2.12168534121079e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36600,-0.0481070836822463,0.00493362698754419,-0.0577769925778329,-0.0384371747866597,2.19042819599146e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39521,-0.0226427270459755,0.0023261761731196,-0.0272020323452899,-0.0180834217466611,2.50094819296154e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39673,-0.0928433534629017,0.00954199821327133,-0.111545669960914,-0.0741410369648899,2.5948402513744e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",36922,-0.0837990094708945,0.00861147665818028,-0.100677503720928,-0.0669205152208612,2.64546477309695e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA4,Apolipoprotein A-IV,37285,-0.0341637951703076,0.00351172894733009,-0.0410467839070746,-0.0272808064335406,2.70080944766444e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,39860,-0.0300342993584011,0.00309133942593464,-0.036093324633233,-0.0239752740835692,2.97999224072592e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39673,-0.0582859371657124,0.00601469200108642,-0.0700747334878418,-0.046497140843583,3.80973130138613e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39557,-0.076236939783154,0.00786954448164923,-0.0916612469671865,-0.0608126325991215,3.92674885190513e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37005,-0.102666928208097,0.010601328078707,-0.123445531242363,-0.0818883251738318,4.16589863306871e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,36848,-0.0825663898812489,0.00853218565221953,-0.0992894737595992,-0.0658433060028987,4.48093162880624e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP10,Stromelysin-2,39669,0.0559320873049307,0.0057953610170736,0.0445731797114665,0.067290994898395,5.58711478667956e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39288,-0.0564630141256096,0.00585049705973877,-0.0679299883626976,-0.0449960398885217,5.6175002641577e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX8,Syntaxin-8,39673,-0.0465423516960581,0.00482357394967557,-0.0559965566374222,-0.037088146754694,5.7099860235522e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGF,Pro-epidermal growth factor,39621,-0.0986450822342124,0.0102271624689392,-0.118690320673333,-0.0785998437950916,5.91165387304279e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39738,-0.0434136305030379,0.00450317798522219,-0.0522398593540734,-0.0345874016520024,6.18286052731689e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN2,Centrin-2,39302,-0.0646554483306065,0.00670634164025193,-0.0777998779455003,-0.0515110187157128,6.19036517476063e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LARP1,La-related protein 1,37203,-0.0615170937143033,0.00638214278295795,-0.0740260935689009,-0.0490080938597057,6.45358734191455e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39720,-0.072743649607067,0.00756440545126633,-0.087569884291549,-0.057917414922585,7.80690288303401e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRAS,Ras-related protein R-Ras,36877,-0.126561830346595,0.0131602057147477,-0.1523558335475,-0.100767827145689,8.0092875238808e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL7,C-C motif chemokine 7,39673,-0.0554433782678428,0.00576732617474809,-0.066747337570349,-0.0441394189653365,8.05627230582078e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,36958,-0.0691341080845401,0.0071908540399532,-0.0832281820028484,-0.0550400341662318,8.22318861609002e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37215,-0.0622508723547775,0.00648045193944645,-0.0749525581560925,-0.0495491865534625,8.87397655684866e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37244,-0.0649007779822825,0.00676110387808706,-0.0781525415833331,-0.0516490143812318,9.4723648524602e-22
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39673,-0.0798016689961944,0.00833943806756042,-0.0961469676086128,-0.063456370383776,1.23310610942164e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRD2,Protein ZNRD2,37215,-0.0647184494232748,0.00676450873217228,-0.0779768865383324,-0.0514600123082171,1.28645972537553e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD226,CD226 antigen,36896,-0.0398493399376979,0.00416522557977785,-0.0480131820740624,-0.0316854978013333,1.29399395001693e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39594,-0.110648817692888,0.0115744376052585,-0.133334715399194,-0.0879629199865811,1.35103050871039e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39668,-0.0261075945679887,0.00273157745201926,-0.0314614863739465,-0.020753702762031,1.37714646193227e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX2,Heme oxygenase 2,39302,-0.0448245198421425,0.00469077961334616,-0.0540184478843009,-0.035630591799984,1.40588202217708e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,36880,-0.0569271263509309,0.00596544951932484,-0.0686194074088076,-0.0452348452930542,1.63460896454096e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX4,Syntaxin-4,39594,-0.0558816227997528,0.00586023808525833,-0.0673676894468592,-0.0443955561526465,1.7013915105487e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXJ3,Forkhead box protein J3,36896,-0.0424303633490776,0.00445660852957779,-0.05116531606705,-0.0336954106311051,2.01778507525955e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS2,Thrombospondin-2,39668,-0.0339059288052607,0.0035632753711376,-0.0408899485326904,-0.026921909077831,2.06591623587483e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39743,-0.103387823136762,0.0108712802389794,-0.124695532405162,-0.0820801138683626,2.16995115117107e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39324,-0.0740451697670038,0.0077977773071825,-0.0893288132890815,-0.0587615262449261,2.50114144233048e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39721,0.0223408060510354,0.00235283359873579,0.0177292521975133,0.0269523599045575,2.50233639145376e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,36880,-0.0866983708582455,0.00914135503508208,-0.104615426727006,-0.0687813149894846,2.86097144293625e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39673,0.0491922606514022,0.00518951558941254,0.0390208100961537,0.0593637112066508,2.91913655229852e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPO,Erythropoietin,39673,-0.0720379224849174,0.00760016880179502,-0.0869342533364357,-0.0571415916333992,2.93863837249843e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YJU2,Splicing factor YJU2,37203,-0.0306193811454958,0.00323406874012781,-0.0369581558761463,-0.0242806064148453,3.33251390521595e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN8,Tetraspanin-8,37215,-0.0921223959434836,0.00973500304750163,-0.111203001916587,-0.0730417899703804,3.48600690074215e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39668,-0.0538019961106562,0.00569095784189838,-0.064956273480777,-0.0426477187405353,3.71102193890155e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,36896,-0.0550468121708525,0.00582488298659562,-0.0664635828245799,-0.0436300415171251,3.94818109695763e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37277,-0.0445827824776677,0.00472946109792178,-0.0538525262295944,-0.035313038725741,4.91992033884481e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37005,-0.0632324786658787,0.00671280152520249,-0.0763895696552756,-0.0500753876764818,5.26931149367318e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,39817,-0.0609713853613521,0.00647669275345117,-0.0736657031581164,-0.0482770675645878,5.41548658582308e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA2,Annexin A2,36716,-0.0654759664678655,0.00695394350535055,-0.0791056957383525,-0.0518462371973784,5.49246801494771e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37215,-0.0851618120367045,0.00904791365758912,-0.102895722805579,-0.0674279012678298,5.63624545193345e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F13B,Coagulation factor XIII B chain,37213,-0.023831818990462,0.00253229870770944,-0.0287951244575725,-0.0188685135233515,5.69928808200384e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBS,Cystathionine beta-synthase,36880,-0.0478673589576326,0.00508882185350928,-0.0578414497905108,-0.0378932681247545,5.98459957432621e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOK1,Docking protein 1,37220,-0.128446248600658,0.0136626949495286,-0.155225130701735,-0.101667366499582,6.25773095566196e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37215,-0.0833860765269542,0.00887106973670773,-0.100773373210901,-0.0659987798430071,6.34501833462507e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEPR,Leptin receptor,39680,0.0285461503786725,0.003043960576776,0.0225799876481916,0.0345123131091535,7.61793287931309e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOXO3,Forkhead box protein O3,39288,-0.0904799353992622,0.00965371909797052,-0.109401224831284,-0.07155864596724,8.04226552238967e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASC3,Protein CASC3,36877,-0.0392840083974298,0.00419513801768264,-0.0475064789120877,-0.0310615378827718,8.90819917877024e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLG4,Disks large homolog 4,37220,-0.0668795339752545,0.00714329514326489,-0.0808803924560536,-0.0528786754944553,9.00984294583481e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39594,-0.0821760207008496,0.00877943396960752,-0.0993837112812803,-0.0649683301204188,9.02371321064349e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLF4,Krueppel-like factor 4,36827,-0.03680235923829,0.00393327090394659,-0.0445115702100253,-0.0290931482665547,9.56405816839278e-21
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39302,-0.057523489676663,0.00616253733077957,-0.069602062844991,-0.045444916508335,1.15133771621516e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEXN,Nexilin,37277,-0.0639544264719669,0.00685467524445855,-0.0773895899511056,-0.0505192629928281,1.22193086859505e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSNAX,Translin-associated protein X,36855,-0.0364722334963934,0.00390920185781543,-0.0441342691377117,-0.0288101978550752,1.22996601360337e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XCL1,Lymphotactin,39836,-0.0505957167864005,0.00542493213614843,-0.0612285837732514,-0.0399628497995496,1.23440202096999e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,39817,-0.0516472837187752,0.00554090925463895,-0.0625074658578675,-0.0407871015796828,1.29909059273868e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39637,-0.0627521324061294,0.00673722732787399,-0.0759570979687624,-0.0495471668434963,1.38708322999727e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM3,Dynamin-3,37244,-0.0508397867952885,0.00546253177422958,-0.0615463490727785,-0.0401332245177985,1.51670571906942e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39721,-0.0273650416994629,0.00294127244124372,-0.0331299356843006,-0.0216001477146252,1.52834267165594e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINE2,Glia-derived nexin,37268,-0.0596870672101425,0.00642418257778597,-0.072278465062603,-0.047095669357682,1.76088048608309e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,36958,-0.0492711290516457,0.00530386097152521,-0.0596666965558351,-0.0388755615474563,1.78876488254336e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37268,-0.0432659436676835,0.00465948493956536,-0.0523985341492316,-0.0341333531861354,1.85249941010524e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL14,C-C motif chemokine 14,39651,-0.035706321111365,0.00384756770350418,-0.0432475538102332,-0.0281650884124968,1.90614831533795e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39644,-0.0327500271285805,0.00353001033021646,-0.0396688473758047,-0.0258312068813562,1.9536409105312e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDA,Cytidine deaminase,37253,-0.0429151301464661,0.00462517492174942,-0.051980472993095,-0.0338497872998373,1.97719985294767e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB3,Plexin-B3,39624,-0.0437064199751237,0.00471709710399699,-0.0529519302989578,-0.0344609096512896,2.1866955654701e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA5,Integrin alpha-5,39668,-0.0226919265339115,0.00244933863439139,-0.0274926302573186,-0.0178912228105043,2.206883408231e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST13,Hsc70-interacting protein,36958,-0.0509845253324167,0.00550216521845683,-0.0617687691605921,-0.0402002815042413,2.22491993749457e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPLAH,5-oxoprolinase,36880,-0.0640430403234574,0.00691597779444501,-0.0775983568005696,-0.0504877238463452,2.35710214288308e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGN,Biglycan,39259,0.10901669961083,0.0117759098681389,0.0859359162692777,0.132097482952382,2.36098031378987e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39401,-0.0338119517625857,0.0036541732415106,-0.0409741313159465,-0.0266497722092249,2.46233908328636e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39401,-0.0443589062826311,0.00479928172591149,-0.0537654984654176,-0.0349523140998446,2.70608909859699e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39192,-0.112124105466315,0.0121692059337475,-0.13597574909646,-0.0882724618361696,3.54994049510744e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGLL,Monoglyceride lipase,39720,-0.0794263192791858,0.00862554979987706,-0.0963323968869449,-0.0625202416714268,3.72059543880142e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSG,Basigin,39848,-0.0177111986949637,0.00192410626089524,-0.0214824469663184,-0.0139399504236091,3.83487343995335e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39675,-0.0469431734999093,0.00510035349268002,-0.0569398663455621,-0.0369464806542565,3.87504456454949e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39302,-0.0459538451371116,0.00499390344947046,-0.0557418958980737,-0.0361657943761495,3.95542400211997e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39680,0.0355164704303162,0.00386637311609075,0.0279383791227783,0.043094561737854,4.5734214383625e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39557,-0.0304599433684396,0.00331814543914084,-0.0369635084291556,-0.0239563783077235,4.84659444058e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37203,-0.0327484218676032,0.00357116885463825,-0.0397479128226942,-0.0257489309125122,5.40295251974937e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37267,0.0235697746594455,0.00257073372083173,0.0185311365666153,0.0286084127522757,5.4859789648847e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,36880,-0.0397499663569662,0.00433756195086676,-0.0482515877806651,-0.0312483449332674,5.73435676369642e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,36958,-0.0384409175969335,0.00419863143797879,-0.0466702352153719,-0.030211599978495,6.19860328103601e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37098,-0.0503516374767573,0.00550773712849847,-0.0611468022486143,-0.0395564727049003,7.01443459677621e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37197,-0.037890640905409,0.00414918772604958,-0.0460230488484662,-0.0297582329623519,7.67608058513113e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37244,-0.0476220693074563,0.00521779156997947,-0.057848940784616,-0.0373951978302965,8.0475661193517e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,36880,-0.028573900935119,0.00313083737589271,-0.0347103421918687,-0.0224374596783693,8.096737840352e-20
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL32,Interleukin-32,39673,0.0384754692664702,0.00423081146010945,0.0301830788046557,0.0467678597282847,1.06489659034001e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,36880,-0.0283764722621574,0.00311976439980399,-0.0344912104857733,-0.0222617340385416,1.07447259492989e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39401,-0.0432873746617404,0.00476049186620122,-0.0526179387194948,-0.033956810603986,1.0773927572321e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASS1,Argininosuccinate synthase,36855,-0.0722965171237053,0.0079608197365531,-0.0878997238073493,-0.0566933104400612,1.22330513850639e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE6,Ribonuclease K6,37220,-0.0249489176027027,0.00275027096386325,-0.0303394486918747,-0.0195583865135307,1.33660674429505e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TWF2,Twinfilin-2,37267,-0.076322816621265,0.00841677730227364,-0.0928197001337213,-0.0598259331088086,1.37936416122656e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39680,-0.0610642736445848,0.00673801420917506,-0.074270781494568,-0.0478577657946017,1.41952160756148e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPP,Lipoma-preferred partner,36855,-0.060674929200904,0.00669476170022358,-0.0737966621333422,-0.0475531962684658,1.44814596377339e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2,Microtubule-associated protein 2,37220,-0.041548715499144,0.00458640433326843,-0.0505380679923501,-0.0325593630059379,1.49570272065038e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39622,-0.080166997611464,0.00885264730335848,-0.0975181863260467,-0.0628158088968814,1.51290288730103e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,36896,0.0286949942295198,0.00317354780414182,0.0224748405334019,0.0349151479256378,1.7543434581768e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39738,0.026794990100255,0.0029694448607168,0.0209748781732501,0.0326151020272599,2.02534561514184e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39721,-0.0647234275705694,0.00718403829488573,-0.0788041426285454,-0.0506427125125933,2.30492293890028e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,36877,-0.0392145423959045,0.00435325199846533,-0.0477469163128965,-0.0306821684789124,2.38525337508435e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37203,-0.0765844782076845,0.00850578836507565,-0.0932558234032328,-0.0599131330121363,2.47213690924212e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FN1,Fibronectin,37285,-0.0237311801772689,0.00264152641046399,-0.0289085719417783,-0.0185537884127595,2.95806652366699e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39668,-0.068740032267645,0.00768116599952474,-0.0837951176267135,-0.0536849469085765,3.97277402157823e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39401,-0.0820125093936713,0.00916459003309751,-0.0999751058585425,-0.0640499129288002,3.99131582272022e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37244,-0.0428903767571499,0.00479698116491059,-0.0522924598403747,-0.0334882936739252,4.35180214651757e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASN,Vasorin,39452,0.0241827700111772,0.00270927359326124,0.0188725937683852,0.0294929462539693,4.90420133499183e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSS,Cathepsin S,36390,-0.021605651404642,0.00242279033263486,-0.0263543204566064,-0.0168569823526777,5.41644527444723e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39721,-0.0640623807703943,0.00718712747940462,-0.0781491506300274,-0.0499756109107612,5.47423500893069e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37215,-0.0680806400986376,0.0076438514790276,-0.0830625889975317,-0.0530986911997435,5.93532406158544e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39675,-0.0822505367899201,0.00924005175067033,-0.100361038221234,-0.0641400353586063,6.09642423724893e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39673,-0.0684382283775323,0.00771096238452747,-0.0835517146512062,-0.0533247421038585,7.69986536625956e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA11,Annexin A11,39636,-0.0585953452200172,0.00660254270445069,-0.0715363289207406,-0.0456543615192938,7.75571680980985e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST2,Bone marrow stromal antigen 2,39817,-0.0467756698299576,0.00527161957824977,-0.0571080442033271,-0.036443295456588,7.85513212823857e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,39860,-0.0280860774571794,0.00316747724156975,-0.0342943328506562,-0.0218778220637027,8.29254550995764e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK3,Dickkopf-related protein 3,39860,0.025191293345229,0.00284338575875242,0.0196182572580743,0.0307643294323838,8.85952022510954e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPART,Spartin,36958,-0.0688911647413279,0.00778069619170421,-0.0841413292770681,-0.0536410002055877,9.5087807541636e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CETN3,Centrin-3,37215,-0.0696459811605519,0.00786810441269065,-0.0850674658094256,-0.0542244965116782,9.6944831503088e-19
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39680,-0.072917071792227,0.00826148126811437,-0.0891095750777312,-0.0567245685067228,1.19499259692394e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPD52L2,Tumor protein D54,36958,-0.095972162998165,0.0108778016131072,-0.117292654159855,-0.074651671836475,1.25683761341343e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39680,-0.112050689763304,0.0127186146433554,-0.13697917446428,-0.0871222050623273,1.37967144020223e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOM,Apolipoprotein M,39715,0.0231756617962953,0.00263128161186945,0.0180183498370311,0.0283329737555594,1.40694313826704e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39557,-0.0826358627469234,0.00938293185063953,-0.101026409174177,-0.0642453163196699,1.41716358848932e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED8,Protein TMED8,37215,-0.0908331486111418,0.0103132523649716,-0.111047123246486,-0.0706191739757975,1.43677802016407e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA3,Annexin A3,39793,-0.0608252355502969,0.00691033221785078,-0.0743694866972844,-0.0472809844033093,1.47890572938357e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39288,-0.0740614313071542,0.00841402261764473,-0.0905529156377379,-0.0575699469765706,1.48261176396459e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37215,-0.0570024123498422,0.00647642114469808,-0.0696961977934504,-0.0443086269062339,1.51379188679963e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39646,-0.0738157849158169,0.00839420082930613,-0.090268418541257,-0.0573631512903769,1.5947614472388e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G1B,Phospholipase A2,39841,0.0353819033842977,0.00402394222289825,0.0274949766274171,0.0432688301411782,1.6044812956214e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53,Cellular tumor antigen p53,39288,-0.0383943617170628,0.00437112901812343,-0.0469617745925847,-0.0298269488415409,1.74692660847471e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37285,0.0222054905736416,0.00252855658637219,0.0172495196643521,0.0271614614829311,1.80023749099874e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37005,-0.0436696983926345,0.00497927538597704,-0.0534290781491495,-0.0339103186361195,1.99918964461876e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,36958,-0.075277095583629,0.00858586567417641,-0.0921053923050148,-0.0584487988622433,2.04882709366298e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39288,-0.0521350057242578,0.0059511746504381,-0.0637993080391165,-0.0404707034093991,2.14396427069415e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARK7,Parkinson disease protein 7,39668,-0.0454054906119966,0.00518405870820259,-0.0555662456800737,-0.0352447355439196,2.17284002585848e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37215,-0.0464036437705986,0.00529844455039381,-0.0567885950893705,-0.0360186924518268,2.22472844720994e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39743,-0.111985069961017,0.0127913943887808,-0.137056202963028,-0.0869139369590068,2.24904359090489e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPARCL1,SPARC-like protein 1,39679,0.0235908690343945,0.00269528709720043,0.0183081063238817,0.0288736317449073,2.29162411899824e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39741,-0.0972627060446238,0.0111213865414357,-0.119060623665838,-0.0754647884234098,2.43837741614762e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C3,Complement C3,36653,-0.0400271507358569,0.00458065314777149,-0.0490052309054891,-0.0310490705662248,2.65854313273423e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37220,-0.0852923268387685,0.00976458542485977,-0.104430914271494,-0.0661537394060433,2.72683053904806e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,39842,-0.0200581827904836,0.0022995763383372,-0.0245653524136245,-0.0155510131673426,2.98388030900961e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDC,Nuclear migration protein nudC,39865,-0.0553999386053333,0.00636156917246801,-0.0678686141833705,-0.042931263027296,3.37463456334893e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39668,-0.0236236273468108,0.00271363197565409,-0.0289423460190928,-0.0183049086745288,3.46848220225026e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39673,-0.0532866733445417,0.00613764602529113,-0.0653164595541123,-0.0412568871349711,4.26527159024011e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37203,-0.0461323336389564,0.00531260806342924,-0.0565450454432777,-0.035719621834635,4.27726579415699e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39721,-0.0291010538210302,0.00335723919417657,-0.0356812426416163,-0.0225208650004441,4.81064389024979e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLO1,Lactoylglutathione lyase,39401,-0.0495097490527751,0.00571534094797149,-0.0607118173107992,-0.038307680794751,5.05879977424515e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN5,Contactin-5,39706,0.0307638218734659,0.00355898040970288,0.0237882202704482,0.0377394234764835,5.93993516718591e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37277,-0.0229215771563778,0.00265134275919386,-0.0281182089643978,-0.0177249453483578,5.97076613121891e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASPN,Asporin,37268,0.0232497821181127,0.00268959030465784,0.0179781851209833,0.0285213791152421,6.01885648431994e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39594,-0.0293017422705325,0.00339564511533836,-0.0359572066965957,-0.0226462778444693,6.76052767022459e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,36896,-0.0388887623059874,0.00450590527937058,-0.0477203366535537,-0.030057187958421,6.80353974044435e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXNB2,Plexin-B2,39792,-0.0200966211192292,0.00233536370175058,-0.0246739339746603,-0.0155193082637981,8.30906245399007e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,39860,-0.0364328212253328,0.00423617873836397,-0.0447357315525262,-0.0281299108981394,8.67059800085731e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,36896,-0.0408531571581655,0.00475150762890685,-0.0501661121108229,-0.031540202205508,9.03485050118754e-18
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39288,-0.055676953941086,0.00648863438405719,-0.0683946773338381,-0.0429592305483339,1.03180821400062e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37285,-0.0257441152117537,0.00300212677597581,-0.0316282836926663,-0.0198599467308411,1.09563161004984e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37230,-0.0343524396976919,0.00400875206282378,-0.0422095937408265,-0.0264952856545573,1.15373097398974e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37244,-0.0315348602057259,0.00368424231037804,-0.0387559751340669,-0.0243137452773849,1.25728995824653e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39401,-0.0343047093244533,0.00401105946387311,-0.0421663858736446,-0.026443032775262,1.31513062201186e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GET3,ATPase GET3,37268,-0.0477126942058254,0.00558508970112167,-0.0586594700200239,-0.0367659183916269,1.44937453428037e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH5,Cadherin-5,39860,0.0257280668994839,0.00301658891359561,0.0198155526288365,0.0316405811701313,1.60856628081937e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMTN,Smoothelin,37174,-0.0818367624081317,0.00959518434157916,-0.100643323717627,-0.0630302010986365,1.63505240451162e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39557,-0.085438128879293,0.010023299754214,-0.105083796397552,-0.0657924613610335,1.68066573535722e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YWHAQ,14-3-3 protein theta,36958,-0.0630960244483471,0.00740762627059886,-0.0776149719387209,-0.0485770769579733,1.80364024417784e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39288,-0.0444431725076341,0.0052195014988732,-0.0546733954454256,-0.0342129495698427,1.82042474674943e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICALL2,MICAL-like protein 2,36877,-0.0578522553719133,0.00679948377933032,-0.0711792435794008,-0.0445252671644259,1.95605830179528e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX,Glutaredoxin-1,39585,-0.0471542203347757,0.00554536102973584,-0.0580231279530579,-0.0362853127164935,2.00544069158507e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37203,-0.0914148238755241,0.0107621390589709,-0.112508616431107,-0.0703210313199411,2.20396805987282e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39649,-0.0548608096260913,0.00647669396751899,-0.0675551298024285,-0.0421664894497541,2.65634770021981e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",36880,-0.0314188560450705,0.00370951986945142,-0.0386895149891952,-0.0241481971009457,2.72011077897009e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN8,Septin-8,37189,-0.0268198306556171,0.00316732147454696,-0.0330277807457291,-0.020611880565505,2.76335566009198e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",36958,-0.0882674364883325,0.0104302864525611,-0.108710797935352,-0.0678240750413128,2.8903054018628e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASAH1,Acid ceramidase,37172,-0.039758095924006,0.00469928133161051,-0.0489686873339626,-0.0305475045140494,2.93898274505959e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39614,-0.0223176440386409,0.00264982496830887,-0.0275113009765263,-0.0171239871007555,4.00618648881337e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37215,-0.0858981014193506,0.0102024294318023,-0.105894863105683,-0.0659013397330181,4.16777860166976e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBXN1,UBX domain-containing protein 1,36958,-0.0582581006272924,0.0069235846822104,-0.0718283266044248,-0.04468787465016,4.3542467148762e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSTB,Cystatin-B,39430,-0.0352999957084875,0.00419719480803494,-0.043526497532236,-0.027073493884739,4.43769314987219e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL8,C-C motif chemokine 8,39809,-0.0502208777534416,0.0059729161790217,-0.0619277934643242,-0.0385139620425591,4.51550824969686e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37220,-0.0839039925799455,0.00997963855710492,-0.103464084151871,-0.0643439010080199,4.60877094475306e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39302,-0.0619415005097048,0.00736999591531818,-0.0763866925037284,-0.0474963085156812,4.66581464731218e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37215,-0.0488155446662123,0.00581320036081912,-0.0602094173734178,-0.0374216719590068,5.02316280250547e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39680,-0.0553014769498485,0.00660055369010485,-0.068238562182454,-0.042364391717243,5.81561849226947e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39658,-0.056864000173031,0.00679195781203841,-0.0701762374846262,-0.0435517628614357,6.12169827759372e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP1,Guanylate-binding protein 1,37208,-0.0530064520157191,0.00633669253595031,-0.0654263693861817,-0.0405865346452565,6.60369882241602e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,36896,-0.0477631667811982,0.00571427759846618,-0.058963150874192,-0.0365631826882045,6.98771430315151e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37277,-0.0508169640561796,0.00608556410094644,-0.0627446696940346,-0.0388892584183246,7.46450182226766e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCOF1,Treacle protein,37268,-0.0253925931467498,0.00304285299834582,-0.0313565850235076,-0.0194286012699919,7.81331763678182e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF6,SLAM family member 6,39288,-0.0311151459048268,0.0037328509606774,-0.0384315337877545,-0.0237987580218991,8.36238531257068e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EHD3,EH domain-containing protein 3,36880,-0.0977887270950636,0.0117314016402079,-0.120782274309871,-0.0747951798802562,8.47640654228763e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39302,-0.0558542950248648,0.00670525680152158,-0.0689965983558471,-0.0427119916938825,8.76249042721051e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39302,-0.053170945716932,0.00638572848046344,-0.0656869735386404,-0.0406549178952237,9.01646530205572e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164,Sialomucin core protein 24,39668,-0.0216147526660415,0.00259645895820742,-0.0267038122241281,-0.016525693107955,9.13888808734827e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12A_IL12B,Interleukin-12,39594,-0.0606090812826593,0.00728181538865697,-0.0748814394444269,-0.0463367231208916,9.24704112535269e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP7,Caspase-7,37220,-0.0699813198140496,0.00840849502740603,-0.0864619700677654,-0.0535006695603338,9.42772710366952e-17
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF2,Fibroblast growth factor 2,39673,-0.0548661082284363,0.00660506347483721,-0.0678120326391173,-0.0419201838177554,1.063229085379e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37267,0.0270782943507366,0.00326051154812179,0.0206876917164179,0.0334688969850553,1.09395599329351e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39594,-0.0465180917861866,0.00560341654674934,-0.0575007882178153,-0.0355353953545579,1.10859001524215e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBI,Acyl-CoA-binding protein,39604,-0.065603181224157,0.00790648522438354,-0.0810998922639487,-0.0501064701843653,1.14967698451019e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37268,-0.0736422107484165,0.00888986554140236,-0.0910663472095651,-0.0562180742872679,1.3050428272985e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,36896,-0.0741958035834185,0.00896414821834098,-0.0917655340913668,-0.0566260730754702,1.38589394352365e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAX,Protein max,39302,-0.0864522204729015,0.010448826158753,-0.106931919744057,-0.0659725212017457,1.40178607390764e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37005,-0.0357094866723669,0.00431671212786265,-0.0441702424429777,-0.0272487309017561,1.43868072957834e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPL14,60S ribosomal protein L14,36880,-0.0334317097100491,0.00404135111237603,-0.0413527578903062,-0.0255106615297921,1.43959881698074e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39680,0.0636332899334322,0.00769970759775411,0.0485418630418342,0.0787247168250303,1.51460439088522e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,36958,-0.0341267939230075,0.00412970679972099,-0.0422210192504606,-0.0260325685955544,1.54681117815739e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTF2,Transcription termination factor 2,36877,-0.0406464296059053,0.00491908557417095,-0.0502878373312804,-0.0310050218805302,1.55710560910699e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,36867,-0.0298970783709543,0.0036266161366974,-0.0370052459988812,-0.0227889107430274,1.82736988188029e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37215,-0.0393586795272061,0.00477565637828702,-0.0487189660286487,-0.0299983930257636,1.85783662082261e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37268,-0.0511776313529358,0.00621329344486091,-0.0633556865048631,-0.0389995762010084,1.93162949423e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39296,-0.0393820895777903,0.00478274647540841,-0.0487562726695908,-0.0300079064859898,1.95116154815571e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39594,-0.0166677461476109,0.00202675870585699,-0.0206401932110906,-0.0126952990841312,2.12348233360407e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A12,Protein S100-A12,39423,-0.0608145726895824,0.00739521222296201,-0.075309188646588,-0.0463199567325769,2.13118069438499e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37268,-0.0719649276233428,0.0087615203844064,-0.0891375075767793,-0.0547923476699062,2.33892935191903e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37268,-0.0196558153378262,0.00239308179243592,-0.0243462556510006,-0.0149653750246518,2.34182693651399e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39673,-0.030410369450764,0.00370542997504037,-0.0376730122018432,-0.0231477266996849,2.44163748927559e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37220,-0.0440437745987661,0.00536697427734292,-0.0545630441823582,-0.0335245050151739,2.48565624980768e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37268,-0.032717267221123,0.00398768928030956,-0.0405331382105298,-0.0249013962317163,2.52380133548321e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM17,Splicing factor 45,37244,-0.0625961359469523,0.00763631523669961,-0.0775633138108835,-0.047628958083021,2.68371092878412e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37244,-0.0384066390831477,0.00468921163744608,-0.047597493892542,-0.0292157842737534,2.83755161964379e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39571,-0.0229295569324247,0.00280322051095079,-0.0284238691338883,-0.0174352447309612,3.06095500145356e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37244,-0.0402837539457729,0.00492516088033791,-0.0499370692712352,-0.0306304386203106,3.11395741539429e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,36880,-0.07542995187187,0.0092302658110812,-0.0935212728615892,-0.0573386308821509,3.31116295138966e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOC,Brother of CDO,39401,0.0189196336858521,0.00231654921929573,0.0143791972160325,0.0234600701556717,3.39806263774557e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39401,-0.0534238855946932,0.0065420965124097,-0.0662463947590162,-0.0406013764303702,3.42594123409133e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39521,-0.0616783820235504,0.00755385659204583,-0.0764839409439602,-0.0468728231031405,3.45297272099482e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,36880,0.0283171315034214,0.00346869335936059,0.0215184925190746,0.0351157704877681,3.54840151497786e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39697,-0.0215097901323083,0.00263615507310769,-0.0266766540755993,-0.0163429261890172,3.61385005286417e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY4,Protein canopy homolog 4,39594,-0.0610936228551114,0.00748915320512642,-0.0757723631371592,-0.0464148825730636,3.67313572460682e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39721,-0.0546513746406074,0.00670124855441704,-0.0677858218072648,-0.04151692747395,3.73856373975461e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39401,-0.0752072714639351,0.00922573798557851,-0.093289717915669,-0.0571248250122012,3.85371675499737e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37203,-0.0413899132694796,0.00508457465016086,-0.0513556795837949,-0.0314241469551643,4.29083597090921e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39401,-0.0455922097076058,0.00560541223179835,-0.0565788176819305,-0.034605601733281,4.47958397085853e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THTPA,Thiamine-triphosphatase,37180,-0.0715739293007599,0.00880136913943747,-0.0888246128140573,-0.0543232457874624,4.58877794464394e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB6,Serpin B6,39778,-0.0483934645042546,0.00595538376771146,-0.060066016688969,-0.0367209123195401,4.76014407147968e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39668,-0.0302187342044476,0.0037207872420919,-0.0375114771989477,-0.0229259912099475,4.93786785564604e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGRN,Neugrin,37220,-0.0172421978463226,0.00212399754015216,-0.0214052330250209,-0.0130791626676244,5.15997970993417e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39668,0.041803744418178,0.00515163438376838,0.0317065410259919,0.051900947810364,5.22716239241458e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37244,-0.0631180314168646,0.0077822339228807,-0.0783712099057108,-0.0478648529280184,5.47615239604654e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36827,-0.0528622693342536,0.00652139952022018,-0.0656442123938851,-0.040080326274622,5.69952133255512e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39302,-0.0465961688949423,0.00575077604401134,-0.0578676899412045,-0.03532464784868,5.78008909647241e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP3,Caspase-3,39860,-0.0713911357041836,0.00881371545318185,-0.0886660179924201,-0.0541162534159472,5.88894885324808e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37244,-0.0690927136737004,0.00852850501204939,-0.0858085834973172,-0.0523768438500836,5.90169027505916e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,36880,-0.0441722429676983,0.00546147692103066,-0.0548767377329184,-0.0334677482024782,6.60104352826187e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39288,-0.0348024930753066,0.00430543046667146,-0.0432411367899826,-0.0263638493606305,6.76291482396374e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,36880,-0.0592786997690698,0.00733272864484151,-0.0736508479129592,-0.0449065516251805,6.8113461910956e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39680,-0.0235603005647642,0.00291698133742031,-0.029277583986108,-0.0178430171434204,7.11610764506125e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37267,0.0174544161199731,0.00216297606858042,0.0132149830255554,0.0216938492143907,7.64778226556859e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPR,Nucleoprotein TPR,36855,-0.0379547948802287,0.00470470122129179,-0.0471760092739606,-0.0287335804864968,7.80682239049669e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39288,-0.0544339563574795,0.00674998087268068,-0.0676639188679336,-0.0412039938470253,7.90231509449945e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39288,-0.0613143931219221,0.00760379650411585,-0.0762178342699892,-0.0464109519738551,7.94477438939688e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39668,0.0341049605903022,0.004236980374767,0.0258004790557588,0.0424094421248455,8.91093367997048e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA2,Carbonic anhydrase 2,39631,-0.0538921806522204,0.00669580716410052,-0.0670159626938574,-0.0407683986105834,8.96395115427234e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39594,-0.0433982476434609,0.0053961258117832,-0.053974654234556,-0.0328218410523659,9.42623345636289e-16
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12B,Interleukin-12 subunit beta,39865,-0.0415513739648232,0.00517500178413062,-0.0516943774617192,-0.0314083704679271,1.04840729902245e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39743,-0.0213040649609556,0.00265432540461147,-0.0265065427539941,-0.0161015871679172,1.07548493389317e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IST1,IST1 homolog,37122,-0.0798471418836892,0.00995140443741139,-0.0993518945810155,-0.0603423891863629,1.11178922268671e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37220,-0.0520128826827939,0.00649163029452527,-0.0647364780600634,-0.0392892873055243,1.21869500403043e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,36880,-0.0377004711390588,0.00471184579900003,-0.0469356889050989,-0.0284652533730188,1.33579578167783e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37268,-0.0787677268071666,0.0098486851770516,-0.0980711497541877,-0.0594643038601455,1.37002980070346e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA,Adenosine deaminase,39865,-0.0274918066241914,0.00343952686661592,-0.0342332792827586,-0.0207503339656242,1.40727655851358e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD2,Polycystin-2,36855,-0.0475043177767268,0.00594532581997607,-0.0591571563838799,-0.0358514791695737,1.46031690925632e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIAPIN1,Anamorsin,39721,-0.0498039428481963,0.00623719535845188,-0.062028845750762,-0.0375790399456306,1.50106548713522e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OPTC,Opticin,39594,0.0348255388435096,0.00436191464710433,0.0262761861351851,0.0433748915518341,1.51388000702478e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP2,Retinol-binding protein 2,39594,0.060331551230458,0.00755800665639273,0.0455178581839282,0.0751452442769878,1.53274443903233e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS3,Galectin-3,39710,-0.0232638691618255,0.00291543225991193,-0.0289781163912529,-0.0175496219323981,1.56837819640399e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK13,Kallikrein-13,39302,-0.0332786419308837,0.00417168409529507,-0.041455142757662,-0.0251021411041053,1.60042846537514e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACYBP,Calcyclin-binding protein,36922,-0.0825887890599509,0.010354193200392,-0.102883007732719,-0.0622945703871826,1.63202550126607e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKK4,Dickkopf-related protein 4,39526,-0.0356833795148038,0.00447691000455512,-0.0444581231237318,-0.0269086359058758,1.68805384032772e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37203,-0.0751986687751862,0.00943911254430848,-0.0936993293620309,-0.0566980081883416,1.76102511895766e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,39865,-0.0262694837856874,0.00330092772305455,-0.0327393021228743,-0.0197996654485005,1.86162237163961e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAP3,Cytosol aminopeptidase,39401,-0.0382859340550881,0.0048136801193807,-0.0477207470890743,-0.028851121021102,1.93620254425434e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,36958,-0.0655758964367833,0.00825789542609989,-0.081761371471939,-0.0493904214016275,2.16847056908015e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39288,-0.0308744695133628,0.00389261596218715,-0.0385039967992496,-0.023244942227476,2.31192280582628e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,36896,-0.0718085436049236,0.0090755771026006,-0.0895966747260208,-0.0540204124838264,2.73018724015088e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPB1,Heat shock protein beta-1,39434,-0.0544269981314974,0.00689082116895463,-0.0679330076226485,-0.0409209886403463,3.01078495577741e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39668,0.022001362907605,0.0027890086869835,0.0165349058811174,0.0274678199340927,3.25488551903375e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,39860,0.0223306489452254,0.00283124295061296,0.016781412762024,0.0278798851284268,3.28822167876894e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA4,Carbonic anhydrase 4,39860,0.0182542008268178,0.00231710311627156,0.0137126787189256,0.0227957229347101,3.53847246889771e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CX3CL1,Fractalkine,39557,0.0258345075464389,0.00328289125692855,0.019400040682859,0.0322689744100189,3.79356783063081e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37220,0.0514882594178658,0.00654223872852474,0.0386654715099573,0.0643110473257743,3.81436414215823e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB9,Serpin B9,39557,-0.0259363972101342,0.00330011994007195,-0.0324046322926752,-0.0194681621275931,4.11455890867172e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTF1,Cardiotrophin-1,39401,-0.0658754639638135,0.00838309231724254,-0.0823063249056089,-0.0494446030220181,4.15311996583006e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39716,-0.0393114612570545,0.00500291369918081,-0.0491171721074489,-0.0295057504066601,4.16182995774402e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CERT,Ceramide transfer protein,39302,-0.0479879979116417,0.00610842200640196,-0.0599605050441895,-0.0360154907790938,4.22458933005557e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,36959,-0.0411796241218301,0.00525073910958117,-0.0514710727766092,-0.030888175467051,4.75223390891586e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37215,-0.0689061984929705,0.00879746502480258,-0.0861492299415835,-0.0516631670443574,5.14206829252768e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL8,Interleukin-8,39559,-0.0511006765124933,0.00653606202207217,-0.0639113580757547,-0.0382899949492318,5.69397882771419e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37005,-0.0261913427086306,0.00335155935863098,-0.0327603990515473,-0.0196222863657139,5.92794097095428e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB10,Ras-related protein Rab-10,37268,-0.0417567651915872,0.00534441230163525,-0.0522318133027922,-0.0312817170803821,5.99056320312389e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFP,Properdin,37285,-0.0179479654007541,0.0023035154640743,-0.0224628557103398,-0.0134330750911685,7.10364562106392e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37244,-0.0365426965093973,0.00469045367928393,-0.0457359857207938,-0.0273494072980008,7.14380495299558e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37220,-0.0277820953634633,0.00356870114394209,-0.0347767496055898,-0.0207874411213367,7.48659239326583e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELL,L-selectin,37285,0.0175122257129902,0.0022507088885952,0.0131008362913436,0.0219236151346367,7.7338953310404e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37215,-0.0746100680934674,0.00960580169563524,-0.0934374394169125,-0.0557826967700223,8.60804465716511e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39652,-0.0725246660571014,0.00934361832484,-0.0908381579737878,-0.054211174140415,8.8736981757718e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39288,-0.044248716615772,0.00571032016278132,-0.0554409441348234,-0.0330564890967207,9.84412222575986e-15
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39288,-0.0437943423823637,0.00565811045765962,-0.0548842388793765,-0.0327044458853508,1.05474038285873e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACAN,Aggrecan core protein,39543,0.0215501269736755,0.00279017281810083,0.0160813882501978,0.0270188656971531,1.1991596320368e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,36855,-0.0514119625194677,0.00665940257776215,-0.0644643915718815,-0.0383595334670539,1.24612942542297e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37203,-0.0336157375393996,0.00435524550248678,-0.0421520187242737,-0.0250794563545255,1.26104631321626e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37261,-0.036922638372124,0.0048053624546018,-0.0463411487831435,-0.0275041279611044,1.6535830376148e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37220,-0.0352615327105948,0.00458964104018011,-0.0442572291493478,-0.0262658362718418,1.66398757858692e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39673,-0.0765414686535552,0.00996934874280288,-0.0960813921894488,-0.0570015451176615,1.71436738685512e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDK,Midkine,39651,-0.0384096883037573,0.00500458786659696,-0.0482186805222873,-0.0286006960852273,1.75201811462325e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP2,Caspase-2,39673,-0.0519398747994073,0.00677063041907494,-0.0652103104207941,-0.0386694391780204,1.80081579148342e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNR,Tenascin-R,39557,0.0318094238655017,0.00414659601580342,0.023682095674527,0.0399367520564764,1.80347326485576e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB8,Serpin B8,39865,-0.0418339214044848,0.00546077608022014,-0.0525370425217163,-0.0311308002872533,1.95318389286953e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37268,-0.0201560489272368,0.00263372587628769,-0.0253181516447607,-0.0149939462097129,2.09637195204992e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39673,-0.0620674093696845,0.0081226035731266,-0.0779877123730126,-0.0461471063663563,2.27299207822906e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39302,-0.0852807320838062,0.0111698841683862,-0.107173705053843,-0.0633877591137693,2.39226032761642e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIFBP,KIF-binding protein,39594,-0.0626980911270473,0.00822212818950529,-0.0788134623784776,-0.0465827198756169,2.56882536213188e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AZU1,Azurocidin,39162,-0.0577055492010631,0.00756939931621635,-0.0725415718608472,-0.0428695265412791,2.61287955954241e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,39836,-0.047904536134992,0.00630167807025988,-0.0602558251527013,-0.0355532471172826,3.08053920835882e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36827,-0.075538016442968,0.0099353457959243,-0.0950112942029796,-0.0560647386829563,3.09320269758888e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37267,-0.0270281240555916,0.00355862661933174,-0.0340030322294818,-0.0200532158817014,3.27883552930558e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39673,0.0193113618656609,0.00254769860890985,0.0143178725921976,0.0243048511391242,3.64891698650878e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,36896,-0.0605302730594001,0.00799931019856247,-0.0762089210485825,-0.0448516250702176,4.077369200091e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37267,-0.0621214004995806,0.00820987488090462,-0.0782127552661536,-0.0460300457330075,4.07845094665299e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DMD,Dystrophin,36880,-0.0391435993608851,0.00517640016510893,-0.0492893436844986,-0.0289978550372716,4.2369362130801e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC79,Protein unc-79 homolog,36795,-0.042554373792315,0.00562913019929229,-0.0535874689829279,-0.0315212786017021,4.31281301479629e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ULBP2,UL16-binding protein 2,39557,-0.027275727768854,0.00361081780126536,-0.0343529306593341,-0.0201985248783739,4.45670720678791e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,36855,-0.0509691146534891,0.00676533196568852,-0.0642291653062386,-0.0377090640007396,5.25126690255828e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPB2,Carboxypeptidase B2,37257,-0.0169017373452393,0.00224614212988451,-0.021304175919813,-0.0124992987706657,5.61707992418007e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL21,C-C motif chemokine 21,39743,-0.0291028463581546,0.00386980865076299,-0.0366876713136501,-0.0215180214026592,5.7484969581064e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEFTY2,Left-right determination factor 2,39817,-0.0396456558646106,0.00527376714547982,-0.0499822394697511,-0.0293090722594702,5.87849774568397e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,36896,-0.0272853338501651,0.00363273643127802,-0.0344054972554701,-0.0201651704448602,6.2512745379403e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39743,-0.0194037686212178,0.00258742705470724,-0.024475125648444,-0.0143324115939916,6.75693658163736e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39508,-0.0220418745184483,0.00294390534988262,-0.0278119290042183,-0.0162718200326784,7.40526974660412e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37241,0.0535813967462489,0.00715978007566832,0.039548227797939,0.0676145656945588,7.67865759124639e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37267,-0.0173107359580594,0.00231317576555453,-0.0218445604585463,-0.0127769114575725,7.68523458210513e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37203,-0.0530456961862941,0.0070901199230193,-0.066942331235412,-0.0391490611371763,7.79902017383868e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CIT,Citron Rho-interacting kinase,36877,-0.0338942943652705,0.00453124116208916,-0.0427755270429653,-0.0250130616875758,7.90019657157987e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37244,-0.0442848147769009,0.00592352654482076,-0.0558949268047496,-0.0326747027490522,8.13223189922878e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,36880,-0.0763904518950748,0.0102183689245071,-0.0964184549871086,-0.0563624488030409,8.16396860293836e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39645,-0.0711813287423479,0.0095299870961605,-0.0898601034508225,-0.0525025540338733,8.49027681450037e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,36855,-0.0483663487729696,0.00647439682141713,-0.0610561665429472,-0.035676531002992,8.50527934851544e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37244,-0.0741537097751405,0.00993652794171468,-0.0936293045409012,-0.0546781150093797,8.99677976395778e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RP2,Protein XRP2,39594,-0.0308849570238755,0.00414179419942969,-0.0390028736547577,-0.0227670403929933,9.31926515768906e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37005,-0.0545973831180416,0.00732265044161647,-0.0689497779836099,-0.0402449882524733,9.47998238148321e-14
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,36877,-0.0455507490933454,0.00612178611137943,-0.0575494498716491,-0.0335520483150418,1.06383045899856e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_E,,39673,-0.020122514177405,0.00271322812263494,-0.0254404412977695,-0.0148045870570405,1.26401087019784e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,39836,-0.0396360443436759,0.00534698002490597,-0.0501161251924916,-0.0291559634948602,1.29859422379335e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39401,0.01573061778819,0.00212276289195045,0.0115700025199671,0.0198912330564129,1.32349451369748e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR3,Small proline-rich protein 3,37220,-0.0482593323829139,0.0065161866835282,-0.0610310582826292,-0.0354876064831987,1.37890510668619e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,39817,-0.056875812562931,0.00769917141878379,-0.0719661885437473,-0.0417854365821148,1.57288985310482e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,36880,0.0154171006441566,0.00208693681997293,0.0113267044770097,0.0195074968113036,1.58807384621675e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37268,-0.0220708669151346,0.0029895585209712,-0.0279304016162381,-0.016211332214031,1.64311390547562e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37220,-0.0454944859329875,0.00616792554273858,-0.0575836199967551,-0.0334053518692199,1.72755399559351e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37005,-0.0412101234421029,0.0055878483982875,-0.0521623063027464,-0.0302579405814594,1.74246488963305e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS22,Brain-specific serine protease 4,36896,-0.0246650122634811,0.00334784671328955,-0.0312267918215286,-0.0181032327054336,1.84416694798591e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39680,-0.0238208177136087,0.00323387169329614,-0.0301592062324692,-0.0174824291947483,1.8443963459889e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL7,Interleukin-7,39673,-0.04748726180894,0.00645263347282282,-0.0601344234156728,-0.0348401002022073,1.93871740988821e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRGN,Neurogranin,37277,-0.0671976375849964,0.00914226180099571,-0.085116470714948,-0.0492788044550448,2.09326861797929e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,36958,-0.0875950610177114,0.0119187024424394,-0.110955717804893,-0.0642344042305303,2.1093089954646e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37139,-0.022168786729988,0.00302071751938354,-0.0280893930679797,-0.0162481803919963,2.27844267565043e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39594,-0.0688403963606036,0.00939535287644005,-0.0872552879984261,-0.0504255047227812,2.46655373569735e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39671,-0.0684650051580587,0.00935730466305794,-0.0868053222976523,-0.0501246880184651,2.66256031697162e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39721,-0.0605666274760853,0.00828089818199353,-0.0767971879127927,-0.044336067039378,2.71661234254369e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,36880,-0.0563716076729364,0.00770979644577385,-0.0714828087066531,-0.0412604066392196,2.7921900503794e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",36880,-0.0334744725598065,0.00458463787501874,-0.0424603627948433,-0.0244885823247698,3.01230663691187e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID2,Nidogen-2,39668,-0.0524342424608479,0.00718828439765448,-0.0665232798802506,-0.0383452050414451,3.14214945880587e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAV,Integrin alpha-V,39836,0.0119382852408045,0.00163784160468518,0.00872811569562159,0.0151484547859875,3.26787006744208e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMSB10,Thymosin beta-10,39668,-0.0556963468593706,0.00764611711119938,-0.0706827363973214,-0.0407099573214198,3.38682407709175e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUGT1,Protein SGT1 homolog,39288,-0.0584079416424128,0.00802026205316824,-0.0741276552666225,-0.0426882280182031,3.43397966033354e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39557,-0.0339922135924821,0.00466873654942407,-0.0431429372293532,-0.0248414899556109,3.4753908168123e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX16,Syntaxin-16,39288,-0.0418270440657855,0.0057610889972103,-0.0531187785003177,-0.0305353096312533,4.04761151381685e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39631,-0.0204313154898228,0.00281494434759223,-0.0259486064111036,-0.0149140245685421,4.10678734143117e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MESD,LRP chaperone MESD,39668,-0.0877229059934908,0.0120877150195004,-0.111414827431711,-0.0640309845552701,4.13563056487817e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,36880,-0.0332048550822619,0.00458261915053777,-0.0421867886173159,-0.0242229215472078,4.54018316501157e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39594,-0.0428818067413371,0.0059204505967895,-0.0544858899110445,-0.0312777235716297,4.59206668309466e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSTN,Growth/differentiation factor 8,39401,-0.0371087032482992,0.00512605084374381,-0.0471557629020371,-0.0270616435945613,4.72334712013277e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37215,-0.0545892421181921,0.00755650985355917,-0.0694000014311681,-0.0397784828052161,5.31639294128471e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37220,-0.0326480995180544,0.00453772406994915,-0.0415420386951548,-0.0237541603409541,6.58778898072443e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMBS,Porphobilinogen deaminase,39836,-0.0304706234688695,0.00423780069307142,-0.0387767128272895,-0.0221645341104495,6.7563152018177e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRIB,Protein scribble homolog,36880,-0.0647210603121787,0.00900513801449606,-0.082371130820591,-0.0470709898037664,6.97752468949362e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36827,-0.0550560614397027,0.00766429345483096,-0.0700780766111714,-0.040034046268234,7.16864284194785e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,36855,-0.048533244002333,0.00676025389997589,-0.0617833416462858,-0.0352831463583803,7.39298863098281e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39401,-0.0798171267912323,0.0111207355510759,-0.101613768471341,-0.0580204851111236,7.43040811215749e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37267,-0.0439613220990984,0.00612533234601865,-0.055966973497295,-0.0319556707009018,7.50215653078244e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39680,-0.0444199743690483,0.00619297171677156,-0.0565581989339205,-0.032281749804176,7.6822359526619e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39401,-0.0376220673932683,0.0052467566655445,-0.0479057104577355,-0.027338424328801,7.80695900877262e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFB,Complement factor B,37053,-0.0235465657774193,0.00328755759823399,-0.0299901786699579,-0.0171029528848807,8.35238204219832e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSL,Cathepsin L1,39680,-0.0169020486313495,0.00236378273674837,-0.0215350627953764,-0.0122690344673227,9.02952711004836e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH9,Protocadherin-9,37215,-0.023683484796217,0.00331241894359054,-0.0301758259256544,-0.0171911436667795,9.13525361180744e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39401,-0.0626685724675887,0.00877226590712073,-0.0798622136455453,-0.045474931289632,9.47164910190085e-13
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN4,Contactin-4,39668,0.0168343928082371,0.00235902563609353,0.0122107025614938,0.0214580830549804,1.00140484897005e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFC1,Cryptic protein,39288,-0.0329244332187714,0.00461648398696443,-0.0419727418332217,-0.0238761246043212,1.03368891689187e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALY,RNA-binding protein Raly,37203,-0.0345706857037502,0.00485147045992888,-0.0440795678052109,-0.0250618036022896,1.08778240602153e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,36855,-0.0426326968983547,0.00598420170913751,-0.0543617322482642,-0.0309036615484451,1.10197983483225e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39288,-0.0239083039534085,0.0033578601504671,-0.030489709848324,-0.017326898058493,1.12606918716361e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39668,-0.0292597444810784,0.00411274095362689,-0.0373207167501871,-0.0211987722119697,1.17211271905221e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37268,-0.0202005635984766,0.00284255738358195,-0.0257719760702972,-0.0146291511266559,1.25059871550084e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37244,0.0318179819808322,0.00448307229644688,0.0230311602797963,0.040604803681868,1.33566442212202e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39721,0.028621756491507,0.00403860553565178,0.0207060896416295,0.0365374233413845,1.42780671231125e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,36896,-0.0609104218713193,0.0085938113656066,-0.0777542921479083,-0.0440665515947304,1.43368357276353e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37058,-0.0094879644339814,0.00133956137290222,-0.0121135047248697,-0.00686242414309305,1.4833417779224e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39521,-0.0514044367006795,0.00725992021534992,-0.0656338803227653,-0.0371749930785936,1.49654765052033e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GMFG,Glia maturation factor gamma,37268,-0.0508480154660676,0.00718816585643979,-0.0649368205446896,-0.0367592103874456,1.58167629747163e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39401,-0.0301294262465291,0.00426247698923696,-0.0384838811454336,-0.0217749713476247,1.63250724220279e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39594,-0.037788068508674,0.00535352396675008,-0.0482809754835042,-0.0272951615338439,1.75288923800711e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100G,Protein S100-G,37244,0.031550970950583,0.00447096446645823,0.0227878805963249,0.0403140613048411,1.78689845694758e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37244,-0.0409592996192257,0.00581340310194,-0.0523535696990281,-0.0295650295394233,1.93603450263934e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2R,Proteinase-activated receptor 1,39720,-0.0406715768403208,0.00577378100411651,-0.0519881876083892,-0.0293549660722524,1.94218724599763e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37267,-0.0376766800292894,0.00534810694198237,-0.0481589696355749,-0.027194390423004,1.947040641158e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACYP1,Acylphosphatase-1,36907,-0.0460984652891189,0.00655115137922085,-0.0589387219923918,-0.033258208585846,2.06682461619026e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37244,-0.0471825847142252,0.00670829292056772,-0.0603308388385379,-0.0340343305899125,2.11242707624135e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBCA,Tubulin-specific chaperone A,36958,-0.0605805492957451,0.00862693147859492,-0.0774893349937912,-0.0436717635976991,2.29079942070229e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD40LG,CD40 ligand,39865,-0.0539415769597784,0.00769492377940306,-0.0690236275674084,-0.0388595263521484,2.47799047524174e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENR,Density-regulated protein,36896,-0.0402906815295674,0.00575692470824683,-0.0515742539577312,-0.0290071091014036,2.71088076969918e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR2,Folate receptor beta,39817,0.0199254548109516,0.00285198007232799,0.0143355738691887,0.0255153357527144,2.92897969935542e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,39848,-0.0347043269841968,0.00496732958280467,-0.0444402929664939,-0.0249683610018996,2.92913026472319e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDHB,Succinate dehydrogenase,37215,-0.0489060510032482,0.00700903706636314,-0.06264376365332,-0.0351683383531765,3.14487127834967e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,36855,-0.0190573056746431,0.00273521488916268,-0.024418326857402,-0.0136962844918843,3.38439038780643e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF2,Trefoil factor 2,39720,-0.0391949181593826,0.00562689335206097,-0.0502236291294221,-0.0281662071893431,3.39759832206892e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD72,B-cell differentiation antigen CD72,36958,-0.0287740567970713,0.00413264762098811,-0.036874046134208,-0.0206740674599346,3.49925566093364e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOE,Apolipoprotein E,37285,-0.0500243331254379,0.00719733066608842,-0.0641311012309713,-0.0359175650199047,3.810662750992e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMS,Spermine synthase,36827,-0.044517637690434,0.00640868803904358,-0.0570786662469594,-0.0319566091339086,3.92466648215859e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39668,0.0196164214290333,0.00282764088088955,0.0140742453024898,0.0251585975555768,4.14932980464628e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37268,-0.0512415752941251,0.00739526653684163,-0.0657362977063347,-0.0367468528819155,4.4327323214517e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37244,-0.0287389875343192,0.00415050516906173,-0.0368739776656802,-0.0206039974029582,4.58400164025458e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6L,Seizure 6-like protein,39721,0.0183893914074586,0.00266223465864598,0.0131714114765125,0.0236073713384047,5.12007860336088e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37005,-0.0524316026002913,0.00759724459717522,-0.0673222020107547,-0.0375410031898278,5.3854666175753e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39594,-0.0477961534900984,0.00692986678706655,-0.0613786923927488,-0.034213614587448,5.50868184950792e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFR,Epidermal growth factor receptor,39860,0.0109491132106337,0.00158912590922947,0.00783442642854394,0.0140637999927235,5.78637414409476e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39521,-0.0657685869835989,0.00955832083558819,-0.0845028958213518,-0.047034278145846,6.17874061711174e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPF,Centromere protein F,37005,-0.037079164524991,0.00539427407333425,-0.0476519417087261,-0.0265063873412558,6.53343902038652e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39721,0.0183416848195808,0.00266967142274192,0.0131091288310066,0.0235742408081549,6.64080037459295e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39538,-0.0644295775446394,0.009382397208465,-0.0828190760732308,-0.046040079016048,6.79957552988364e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,36855,-0.0421689505600481,0.00614683651473801,-0.0542167501289346,-0.0301211509911616,7.18443609536006e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMB1,Laminin subunit beta-1,36880,-0.0208200575115295,0.00303643807038602,-0.0267714761294861,-0.0148686388935729,7.3629470750112e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39288,-0.034657192208373,0.00505706758607598,-0.0445690446770819,-0.0247453397396641,7.49413783493452e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37215,-0.0327671857218218,0.00478231036766771,-0.0421405140424505,-0.0233938574011931,7.61507123975782e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REN,Renin,39680,-0.0446583649497322,0.00653177734882209,-0.0574606485534235,-0.0318560813460409,8.37728251114675e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39557,-0.0389764741239531,0.00570419135625291,-0.0501566891822088,-0.0277962590656973,8.62435488803807e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MBL2,Mannose-binding protein C,37090,0.0730780638164219,0.0106974689696168,0.052111024635973,0.0940451029968709,8.7802981879088e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39594,0.0179346286206122,0.00262585634252312,0.0127879501892669,0.0230813070519575,8.8018124193906e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39557,0.0745519813022761,0.0109233502462593,0.0531422148196079,0.0959617477849443,9.11376208469556e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA12,Serpin A12,39220,-0.0798865795778601,0.0117108142533631,-0.102839775514452,-0.0569333836412684,9.33901021836528e-12
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMVK,Phosphomevalonate kinase,39293,-0.0748279015994248,0.0110013480536774,-0.0963905437846326,-0.053265259414217,1.07188465785171e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39649,-0.042682267014304,0.00628485983619398,-0.0550005922932442,-0.0303639417353638,1.15105827338331e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLIN3,Perilipin-3,39680,-0.028893361687007,0.00425806233213665,-0.0372391638579948,-0.0205475595160192,1.19736628461085e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37268,-0.0331787107602617,0.00489021391521039,-0.042763530034074,-0.0235938914864493,1.21197639465931e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP6,Platelet glycoprotein VI,39646,-0.0594213542287465,0.00877495137213328,-0.0766202589181277,-0.0422224495393652,1.31766780438037e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39601,-0.0301045396815847,0.00444952362438618,-0.0388256059853816,-0.0213834733777878,1.37259406368316e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,39832,0.0234693460408243,0.00347472059625794,0.0166588936721587,0.0302797984094899,1.48467537225986e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39557,-0.0277514812069031,0.00410924769815934,-0.0358056066952954,-0.0196973557185108,1.49467904106799e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,39817,-0.0314705581916598,0.00466081647500658,-0.0406057584826727,-0.0223353579006469,1.50689726974646e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37267,-0.0283128346379452,0.00419733813390995,-0.0365396173804087,-0.0200860518954817,1.58836488468178e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMPD3,AMP deaminase 3,37220,-0.0475117398850645,0.00704433696532005,-0.0613186403370918,-0.0337048394330371,1.5968379898439e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,36855,-0.0473066036420982,0.00701981080095326,-0.0610654328119666,-0.0335477744722298,1.66191055947633e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLTA,Clathrin light chain A,39401,-0.0310579764150897,0.00460962570057504,-0.0400928427882167,-0.0220231100419626,1.66641166445064e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,36896,-0.0379443765251445,0.00563580848402128,-0.0489905611538262,-0.0268981918964627,1.73483601831735e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,39865,-0.0304421042125547,0.00452742639843199,-0.0393158599534814,-0.021568348471628,1.82868992069935e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG2,Bone marrow proteoglycan,37267,0.0339409581120352,0.00504782614732142,0.0240472188632853,0.0438346973607852,1.84118423676088e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,36958,-0.0848840034138915,0.0126321376883559,-0.109642993283069,-0.060125013544714,1.89649208533486e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,36958,-0.0406700503546396,0.00605266226546705,-0.052533268394955,-0.0288068323143242,1.900657469581e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD93,Complement component C1q receptor,39050,0.0204322809246928,0.00305013202037254,0.0144540221647626,0.026410539684623,2.17494805126011e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36801,-0.03710262947923,0.00554093582678555,-0.0479628636997297,-0.0262423952587304,2.22902419361216e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POF1B,Protein POF1B,36896,-0.0300457783114443,0.00449194926742751,-0.0388499988756022,-0.0212415577472864,2.34179986914317e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39480,-0.0781310647849603,0.0116843186144751,-0.101032329269332,-0.055229800300589,2.35789694619601e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO1A,Coronin-1A,39333,-0.0591894729726247,0.00885537577185237,-0.0765460094854554,-0.0418329364597941,2.40429146927352e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,36880,-0.0337395496177695,0.00504753158845536,-0.043632711531142,-0.023846387704397,2.41377232847645e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM3D,Protein FAM3D,37215,-0.0554857445997975,0.00830739684574348,-0.0717682424174547,-0.0392032467821403,2.49969866202105e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39630,-0.0727154634663243,0.0108918108095316,-0.0940634126530064,-0.0513675142796423,2.5347220346116e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39673,0.0328748468357007,0.00492630983716054,0.023219279554866,0.0425304141165353,2.58388239708168e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,36855,-0.0462860825613138,0.00693568891675949,-0.0598800328381624,-0.0326921322844652,2.59711810316093e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD83,CD83 antigen,39673,-0.0216607940358628,0.00324887951791839,-0.0280285978909828,-0.0152929901807427,2.69438015778534e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39680,-0.0375135143702672,0.00562908331258482,-0.0485465176629335,-0.026480511077601,2.74842564213219e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD302,CD302 antigen,39594,-0.0191585457309883,0.00287744277467276,-0.0247983335693469,-0.0135187578926297,2.86405646224077e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39266,-0.043664712569121,0.00656158071422058,-0.0565254107689934,-0.0308040143692487,2.93650823282833e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37220,-0.0255407224436409,0.00384011589336481,-0.0330673495946359,-0.0180140952926458,3.02376106639988e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37005,-0.0492167195737435,0.00740535038773635,-0.0637312063337067,-0.0347022328137802,3.12825661792406e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPP1,Osteopontin,39820,0.0295776133432342,0.004451107692972,0.0208534422650091,0.0383017844214593,3.13029693750334e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFF1,Trefoil factor 1,39600,-0.0493740258025553,0.00743344024290101,-0.0639435686786413,-0.0348044829264693,3.19270098881854e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTBDN,Retbindin,39594,-0.0192944959428124,0.00290508299579722,-0.0249884586145749,-0.0136005332710498,3.20392583626543e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,36877,-0.0446582321069059,0.0067300331648278,-0.0578490971099683,-0.0314673671038434,3.35836024440515e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,36872,-0.018477242931645,0.00278856921098472,-0.0239428385851751,-0.013011647278115,3.58326586657271e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39755,0.0167064181134033,0.00252378280963262,0.0117598038065233,0.0216530324202832,3.71715503118005e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37158,-0.0404570964627368,0.00611132603337636,-0.0524352954881544,-0.0284788974373191,3.72934366198082e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39288,-0.0289060252756338,0.00436941736024147,-0.0374700833017071,-0.0203419672495605,3.82399526310616e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX9,Sorting nexin-9,39680,-0.0453884598628712,0.00687306773925729,-0.0588596726318155,-0.0319172470939269,4.13479248063539e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37005,-0.04416158297228,0.00668697531215438,-0.0572680545841026,-0.0310551113604574,4.15266577895739e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAX,Apoptosis regulator BAX,39269,-0.0600321998811568,0.00909129063780407,-0.0778511295312528,-0.0422132702310608,4.15356352739028e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,39860,0.0161756170495794,0.00245124468077205,0.0113711774752662,0.0209800566238926,4.27111990717824e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37285,-0.0215672083218712,0.00327630955663086,-0.0279887750528676,-0.0151456415908747,4.78907274890304e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39594,-0.0562189016477323,0.00855922033467985,-0.0729949735037048,-0.0394428297917598,5.25144884663543e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37244,-0.0832953527005652,0.0126869838447196,-0.108161841036216,-0.0584288643649148,5.38010762102819e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37244,-0.0247442824969217,0.00377198019111841,-0.0321373636715138,-0.0173512013223296,5.5776971140973e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPOCK1,Testican-1,39557,0.0164694498686722,0.00251185949226792,0.0115462052638271,0.0213926944735173,5.67375309412212e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37220,-0.0316019845909515,0.00481928115044668,-0.041047775645827,-0.022156193536076,5.67652284077213e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37158,0.0175337324406291,0.00267679954777416,0.0122872053269918,0.0227802595542665,5.95501893868928e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39673,-0.0239547603396347,0.00366970297185464,-0.0311473781644698,-0.0167621425147997,6.88153085917274e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNC,Tenascin,39738,0.0304232937035004,0.00466322165943498,0.0212833792510078,0.0395632081559929,7.04834412345715e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39302,-0.0240585556112797,0.00368934413740345,-0.0312896701205905,-0.016827441101969,7.19646305159802e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37175,-0.0313436326253574,0.00480857910192345,-0.0407684476651274,-0.0219188175855874,7.36841054460116e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,39817,-0.018799472398345,0.00288840496752575,-0.0244607461346954,-0.0131381986619945,7.81159338948373e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37203,-0.0448220198201544,0.00688767222059236,-0.0583218573725154,-0.0313221822677934,7.91037154628382e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39269,-0.0454141493606389,0.00698370497041521,-0.0591022111026527,-0.0317260876186251,8.12256126058984e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39401,-0.0421540900032559,0.00648391253251938,-0.0548625585669939,-0.0294456214395179,8.20371902028739e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37203,-0.0187571063446543,0.00288667217971112,-0.0244149838168881,-0.0130992288724205,8.43802133379508e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39695,-0.0771212301952472,0.0118723262067101,-0.100390989560399,-0.0538514708300954,8.50094499983822e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39401,-0.0235491197824168,0.00362753561901322,-0.0306590895956827,-0.0164391499691509,8.74061050606054e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOA1,Apolipoprotein A-I,37285,0.0175755377623364,0.00270942054685383,0.0122650734905029,0.0228860020341699,9.073680538129e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,36958,-0.0731425402089144,0.0112858315048535,-0.0952627699584273,-0.0510223104594016,9.44315433304196e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39594,0.0416736169517889,0.00643796939190725,0.0290551969436507,0.0542920369599271,9.88539289717919e-11
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHPS,Deoxyhypusine synthase,37203,-0.0264170034979915,0.00408339868808667,-0.0344204649266414,-0.0184135420693416,1.01848815068475e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39743,-0.0770185482631161,0.0119248257226945,-0.100391206679597,-0.053645889846635,1.08693971766358e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37195,-0.0457759635284843,0.00708753181042771,-0.0596675258769226,-0.031884401180046,1.09297900920139e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39401,-0.0462571836790117,0.00716398604340295,-0.0602985963240814,-0.0322157710339419,1.10035910587448e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39743,-0.0562557870801456,0.00872187238349754,-0.0733506569518008,-0.0391609172084905,1.15107726768071e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37203,-0.0352926884565718,0.00548127230674709,-0.0460359821777961,-0.0245493947353475,1.24564764643785e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPG,Macrophage-capping protein,39548,-0.037016381884248,0.0057573811801355,-0.0483008489973136,-0.0257319147711824,1.31828987534614e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39384,-0.0265256988442606,0.0041309770977619,-0.0346224139558739,-0.0184289837326473,1.39161792162433e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH7,Protocadherin-7,37215,-0.0214605221973719,0.00334256704132744,-0.0280119535983737,-0.0149090907963701,1.40540762732721e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOBR,Apolipoprotein B receptor,36880,0.0272688442405611,0.00424746097302252,0.0189438207334369,0.0355938677476852,1.4097200581773e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37220,-0.0140735726647836,0.00219286444459314,-0.0183715869761861,-0.00977555835338103,1.42837038506192e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37215,-0.0633079095056815,0.00986889209502298,-0.0826509380119265,-0.0439648809994364,1.45670521748901e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTD,Deoxycytidylate deaminase,36958,-0.0612762079860297,0.00955964711396074,-0.0800131163293928,-0.0425392996426667,1.50624483324216e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37268,-0.0457129810065419,0.00713405773536691,-0.0596957341678611,-0.0317302278452228,1.52658603386149e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDN1,Endothelin-1,36880,-0.0179319782486446,0.00280290484233926,-0.0234256717396295,-0.0124382847576597,1.6319665578031e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THPO,Thrombopoietin,39401,-0.024098762952734,0.0037674808552482,-0.0314830254290205,-0.0167145004764475,1.63502871037973e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAM,Integrin alpha-M,39668,0.0199286036551113,0.00311583956966375,0.0138215580985704,0.0260356492116523,1.64085162325263e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAP,Prosaposin,37177,-0.0178161539446913,0.00278810876602233,-0.023280847126095,-0.0123514607632875,1.71352897069055e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,37846,0.0194078383461471,0.00304005748875329,0.0134493256681906,0.0253663510241035,1.77923527802416e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGMN,Legumain,39743,-0.022636129556091,0.00354769946954186,-0.029589620516393,-0.015682638595789,1.81386540466956e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39567,-0.0379891467817821,0.00595406887299803,-0.0496591217728583,-0.026319171790706,1.81609797875099e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37005,-0.0223633822968966,0.0035076091668208,-0.0292382962638653,-0.0154884683299278,1.88247296519631e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,36880,-0.0511854572376917,0.00802966440335478,-0.0669235994682671,-0.0354473150071163,1.89698006579454e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACHE,Acetylcholinesterase,36958,-0.0208073763169881,0.00326511023447335,-0.0272069923765559,-0.0144077602574203,1.92023320512312e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHISA5,Protein shisa-5,37267,-0.014499279143251,0.00227606157690616,-0.0189603598339871,-0.0100381984525149,1.94774309591416e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI2,Serpin I2,37215,-0.0363298935640848,0.00570399829991544,-0.0475097302319191,-0.0251500568962506,1.96246344807585e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,36880,-0.0393516236210362,0.00618226874012809,-0.0514688703516872,-0.0272343768903851,2.01525050832341e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37267,-0.0170113459492227,0.00267537001487215,-0.0222550711783722,-0.0117676207200733,2.10336380879792e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RILPL2,RILP-like protein 2,37268,-0.0626597797149539,0.00985579081675332,-0.0819771297157905,-0.0433424297141174,2.11486633643775e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPA33,Cell surface A33 antigen,39594,-0.082636318100281,0.0130037574260891,-0.108123682655416,-0.0571489535451463,2.14434548817807e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39203,-0.0367093106691548,0.00578146694524907,-0.048040985881843,-0.0253776354564666,2.2211956934783e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39673,-0.0276449137679332,0.00435571346148161,-0.0361821121524371,-0.0191077153834292,2.2580248043154e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37220,-0.0181181024461835,0.00286208856968661,-0.0237277960427692,-0.0125084088495977,2.5238072394631e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD46,Membrane cofactor protein,39585,-0.0177575649270802,0.00280788074545564,-0.0232610111881732,-0.0122541186659871,2.61442276622583e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39738,-0.0185028489525011,0.00292618034368873,-0.0242381624261311,-0.0127675354788712,2.63033208024622e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRBP,Acrosin-binding protein,37203,-0.0242196236912496,0.00383308795709826,-0.0317324760871622,-0.016706771295337,2.72388986322748e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39653,-0.037887736378169,0.00599781467067801,-0.0496434531326979,-0.0261320196236401,2.73962733910132e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP1,Dipeptidase 1,39521,0.0295746846578088,0.00468586593464477,0.020390387425905,0.0387589818897125,2.83839322418241e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37195,-0.025465529321504,0.00404279641373356,-0.0333894102924218,-0.0175416483505862,3.09003524847582e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB1,Beta-crystallin B1,37268,-0.0418017490833339,0.00664579815943723,-0.0548275134758309,-0.028775984690837,3.27427908083145e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP7,Matrilysin,39379,-0.030769443731202,0.00490020776844194,-0.0403738509573482,-0.0211650365050558,3.49346461128081e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,36958,-0.0552778805781039,0.00880852826471382,-0.072542595976943,-0.0380131651792648,3.59505915990496e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA6,Integrin alpha-6,39673,-0.0330001532924869,0.00526078394887029,-0.0433112898322726,-0.0226890167527011,3.63695465345543e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39546,-0.0298509860496891,0.00476123013068297,-0.0391829971058278,-0.0205189749935505,3.71456905820111e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39288,-0.0330915750414038,0.0052801529725041,-0.0434406748675118,-0.0227424752152957,3.77453147174214e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLVRB,Flavin reductase,39668,-0.0397776433598483,0.00636761826775261,-0.0522581751646434,-0.0272971115550531,4.2949058235978e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD6,Programmed cell death protein 6,39680,0.0431602097260779,0.00691260063989664,0.0296115124718805,0.0567089069802754,4.38240431707435e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHAD,Chondroadherin,36958,0.0312457871055107,0.00501530448881052,0.021415790307442,0.0410757839035793,4.80448841032263e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF22,Kinesin-like protein KIF22,36855,-0.075020537384171,0.0120808721600708,-0.0986990468179098,-0.0513420279504322,5.46474743558537e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37268,-0.0207556076165543,0.0033437176249678,-0.0273092941614912,-0.0142019210716175,5.54756524516055e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37244,0.0158953659285344,0.00256152545166763,0.0108747760432658,0.0209159558138029,5.61564034607317e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS1,Galectin-1,39680,-0.0206298365663988,0.0033256600580176,-0.0271481302801133,-0.0141115428526843,5.6691212578111e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,36896,-0.0202092598508398,0.0032584081023478,-0.0265957397314415,-0.0138227799702381,5.73666284697605e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39268,-0.0469750135502566,0.00758252476015211,-0.0618367620801547,-0.0321132650203585,5.97023269508881e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENAH,Protein enabled homolog,39401,-0.0294038074676976,0.00475476087366686,-0.0387231387800846,-0.0200844761553105,6.40292484934835e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL19,C-C motif chemokine 19,39817,-0.0708087198988739,0.0114521107596969,-0.0932548569878799,-0.048362582809868,6.4413959942782e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FADD,FAS-associated death domain protein,39680,-0.0471031855418395,0.00762259461973407,-0.0620434709965183,-0.0321629000871607,6.5914861757372e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIT2,Slit homolog 2 protein,39302,-0.0315305539945215,0.00510465392027056,-0.0415356756782518,-0.0215254323107912,6.70423203560734e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37215,0.0180037871009118,0.00291683577399031,0.0122867889838908,0.0237207852179328,6.92210561392591e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37277,-0.0137573962957473,0.00222908510318253,-0.0181264030979851,-0.00938838949350957,6.94748832389782e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD70,CD70 antigen,39673,0.0258422896985773,0.00418816736619394,0.0176334816608372,0.0340510977363175,6.98167492897774e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",36880,-0.0538628979726185,0.00873164461422118,-0.070976921416492,-0.036748874528745,7.08933046211214e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,36958,-0.0227919881195919,0.00369708233796792,-0.030038269502009,-0.0155457067371748,7.26184648757106e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39476,0.0232384839301559,0.00377403670793862,0.0158413719825962,0.0306355958777156,7.57292525187437e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37220,0.0223798927105708,0.0036351712115509,0.0152549571359311,0.0295048282852106,7.65049196468893e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36795,-0.0303953654194,0.00494029672239484,-0.0400783469952939,-0.0207123838435061,7.85029048326875e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WIF1,Wnt inhibitory factor 1,39836,0.020371901242361,0.00331541523371431,0.013873687384281,0.0268701151004411,8.2066381884442e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37244,-0.0405724968933341,0.00660438759263442,-0.0535170965748976,-0.0276278972117707,8.31338887567517e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN2,Matrilin-2,39697,-0.0180466625333857,0.00293879935488309,-0.0238067092689565,-0.0122866157978148,8.40516764246451e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39738,0.0351476061539105,0.00572486660527577,0.02392686760757,0.046368344700251,8.47704352439277e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37244,-0.0236132582242381,0.00384583156370573,-0.0311510880891014,-0.0160754283593749,8.48757590534399e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39302,-0.0233303675084067,0.00380195176774273,-0.0307821929731824,-0.0158785420436309,8.64634017752494e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37203,-0.031026640007672,0.00505586354221364,-0.0409361325504108,-0.0211171474649333,8.66037902710586e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39557,-0.0177096564854203,0.00288704901387162,-0.0233682725526087,-0.012051040418232,8.76564991654334e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37056,-0.0341272391290117,0.00556504912898599,-0.0450347354218242,-0.0232197428361992,8.90212146024599e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37236,-0.0375645595686288,0.00613988252286267,-0.0495987293134396,-0.0255303898238179,9.73255724025287e-10
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39721,0.0238940391133058,0.00391119300662097,0.0162281008203287,0.0315599774062829,1.0250628923759e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39288,-0.0291872787737075,0.00478926635972652,-0.0385742408387715,-0.0198003167086436,1.1252389875068e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39673,-0.0501931603614377,0.00824238201712632,-0.0663482291150053,-0.0340380916078702,1.15780446328128e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6,Interleukin-6,39594,-0.0426546124206951,0.00700715640065991,-0.0563886389659885,-0.0289205858754017,1.17501368833147e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,36855,-0.0217845421678102,0.00358316416415137,-0.0288075439295468,-0.0147615404060735,1.23786448813174e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1B,Lithostathine-1-beta,39860,-0.0327287003685579,0.00538939932500903,-0.0432919230455756,-0.0221654776915402,1.28547314928119e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO2,Gamma-enolase,39817,-0.0397927250093054,0.00655403409963134,-0.0526386318445828,-0.026946818174028,1.29602714946e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,36880,-0.034532363666707,0.00570295217577733,-0.0457101499312305,-0.0233545774021834,1.4412767951641e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS27,Serine protease 27,39630,-0.0240633151677816,0.00397711615000372,-0.0318584628217889,-0.0162681675137743,1.47713951642587e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDGF,Hepatoma-derived growth factor,39820,-0.0561898994017273,0.00929009102165204,-0.0743984778041653,-0.0379813209992893,1.4958360483072e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37215,-0.0305837077394664,0.00505936758956475,-0.0405000682150133,-0.0206673472639195,1.53423683575783e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABHD14B,Protein ABHD14B,39495,-0.0343570082332422,0.00569425020468727,-0.0455177386344292,-0.0231962778320551,1.63931808337275e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39401,-0.0401323207905365,0.00666663977263689,-0.0531989347449048,-0.0270657068361682,1.78480962641778e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,36896,-0.0217151902178411,0.0036113512139204,-0.0287934385971251,-0.0146369418385571,1.86948672500756e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELOB,Elongin-B,36855,-0.0235781775364917,0.00392784032913933,-0.0312767445816048,-0.0158796104913787,1.99069375385575e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,36880,-0.0248006303490372,0.00413328909477412,-0.0329018769747944,-0.0166993837232799,2.02286931201466e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP8,Neutrophil collagenase,39793,-0.0423773002332583,0.0071011094969624,-0.0562954748473046,-0.0284591256192119,2.45719606290352e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTN6,Dynactin subunit 6,39302,-0.0419681270905632,0.00704608015432808,-0.0557784441930462,-0.0281578099880802,2.63715120984935e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BOLA1,BolA-like protein 1,36827,-0.0325494137918056,0.00548200662145305,-0.0432941467698536,-0.0218046808137576,2.96804614284817e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAN,Versican core protein,39817,0.017348732316945,0.00292388825819121,0.0116179113308902,0.0230795533029997,3.02779701405124e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SWAP70,Switch-associated protein 70,37215,-0.0212281644415288,0.00358463499946812,-0.0282540490404863,-0.0142022798425712,3.25890414052936e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37220,-0.0630176735446736,0.0106413556713679,-0.0838747306605547,-0.0421606164287925,3.25943949210835e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COLEC12,Collectin-12,39675,-0.0145211972853044,0.00245477592872042,-0.0193325581055965,-0.00970983646501243,3.37719729155061e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37203,-0.0199584957622406,0.00337425964654519,-0.0265720446694692,-0.0133449468550121,3.40154071003155e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,39836,-0.0173971616336257,0.00294245216838088,-0.0231643678836523,-0.0116299553835992,3.43882519560227e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37267,-0.0291947568058313,0.0049385955333974,-0.0388744040512902,-0.0195151095603724,3.47141222633507e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPO,Myeloperoxidase,39668,-0.0264584297027303,0.00448189240554525,-0.035242938817599,-0.0176739205878616,3.63363340201874e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NID1,Nidogen-1,39700,-0.021969466513114,0.00372260460845479,-0.0292657715456854,-0.0146731614805426,3.67254481424619e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37240,0.00848720630936933,0.00143859315002561,0.00566756373531915,0.0113068488834195,3.73061006500302e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP10,Bone morphogenetic protein 10,36958,0.016568288878758,0.00280988099398006,0.0110609221305571,0.022075655626959,3.80584610982757e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37203,-0.0285729681477083,0.00485316458649759,-0.0380851707372436,-0.019060765558173,4.01525676363008e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH17,Cadherin-17,39680,-0.0385773715113986,0.00657082625453966,-0.0514561909702964,-0.0256985520525009,4.41826406995437e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39594,-0.0612736306432464,0.0104490043320538,-0.0817536791340719,-0.040793582152421,4.60723818465128e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLNK,B-cell linker protein,36896,-0.0228696304310721,0.00390122544568658,-0.0305160323046178,-0.0152232285575264,4.67923356169336e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST7,Cystatin-F,39694,-0.0533373377523324,0.00914373095622023,-0.0712590504265241,-0.0354156250781408,5.54301615040985e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PER3,Period circadian protein homolog 3,36896,-0.0682928933160852,0.0117069175133445,-0.0912384516422405,-0.04534733498993,5.55481120710346e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCN,Decorin,39401,0.0125479055102779,0.00215128249529103,0.00833139181950747,0.0167644192010483,5.56024576795324e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39288,-0.042010156484852,0.00720283929614989,-0.0561277215053058,-0.0278925914643983,5.57143040239528e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL18,C-C motif chemokine 18,39524,-0.0408344816549239,0.00700367750073002,-0.0545616895563547,-0.027107273753493,5.63712113435201e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PZP,Pregnancy zone protein,37285,-0.0317721210964358,0.00545841740253387,-0.0424706192054022,-0.0210736229874694,5.99198950444964e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAL,Integrin alpha-L,36896,-0.0246811913471455,0.0042566173358981,-0.0330241613255058,-0.0163382213687853,6.85386448903389e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",39865,-0.0397302761916766,0.00685841432020431,-0.0531727682592771,-0.0262877841240762,7.04698790114749e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37244,-0.0396930591929869,0.00685677080526901,-0.0531323299713142,-0.0262537884146597,7.24439900828968e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAT,Catalase,37086,-0.0303929312043136,0.00525218964651732,-0.0406872229114876,-0.0200986394971397,7.34022234787339e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39288,-0.0300580407481332,0.00519746816837488,-0.040245078358148,-0.0198710031381185,7.47077303884317e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",36880,-0.0366872440245484,0.00634324745941103,-0.049120009044994,-0.0242544790041028,7.47679575787829e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37268,-0.0185102214363109,0.00320135588157005,-0.0247848789641882,-0.0122355639084336,7.54648968667053e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39675,-0.0214729180049626,0.00371544107352179,-0.0287551825090653,-0.0141906535008599,7.63914764247904e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,39860,0.0172513432718238,0.00298579785726255,0.0113991794715892,0.0231035070720584,7.70905085499978e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,36880,-0.0139605857792641,0.00241752966499633,-0.0186989439226569,-0.00922222763587126,7.88358578578566e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,36958,-0.0227880756970038,0.00394641402184322,-0.0305230471798166,-0.0150531042141911,7.89919710120149e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,36855,-0.0689738411523971,0.0119484476229682,-0.0923927984934148,-0.0455548838113793,7.98318592132295e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,39817,-0.026102948735976,0.00452256281278178,-0.0349671718490283,-0.0172387256229237,7.99247951478694e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39288,-0.0269319952036333,0.00467156511028396,-0.0360882628197899,-0.0177757275874767,8.31743618606408e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLFM4,Olfactomedin-4,36492,-0.0707960926262616,0.012282682277908,-0.0948701498909613,-0.0467220353615619,8.41155538246463e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39633,0.0144571173802405,0.00250964147964877,0.00953822008012895,0.0193760146803521,8.53622950805022e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FST,Follistatin,39720,-0.0292409774715287,0.00508576816700687,-0.0392090830788621,-0.0192728718641952,9.11170143096128e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCRN1,Secernin-1,39673,-0.0319989430627021,0.00557733557561856,-0.0429305207909144,-0.0210673653344897,9.794816618315e-09
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPQ,Carboxypeptidase Q,37260,-0.0214259500003673,0.00374117045586562,-0.0287586440938639,-0.0140932559068707,1.04373300791942e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP8,Caspase-8,39790,-0.0350128742152759,0.00611518055828916,-0.0469986281095227,-0.0230271203210292,1.04946491035961e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGA4,Pepsin A-4,37277,-0.0355061592924875,0.00620985867644756,-0.0476774822983247,-0.0233348362866503,1.10271046868501e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1F,Protein phosphatase 1F,37268,-0.0304096019386509,0.00531968158489834,-0.0408361778450516,-0.0199830260322501,1.11101012009494e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHCY,Adenosylhomocysteinase,39680,-0.0384386232380822,0.00672496999052074,-0.0516195644195028,-0.0252576820566615,1.11153189515302e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37244,-0.051379265640524,0.00900488915009961,-0.0690288483747193,-0.0337296829063288,1.18315244536537e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39743,-0.0366643648594974,0.00643634486646911,-0.0492796007977768,-0.0240491289212179,1.24489246628392e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39570,-0.0150694750723352,0.00264764980394466,-0.0202588686880667,-0.00988008145660363,1.28069542747435e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39700,-0.0198114436719197,0.0034871131886408,-0.0266461855216556,-0.0129767018221837,1.3600008242368e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX7,Syntaxin-7,36896,-0.0278427573834854,0.00491019269684221,-0.0374667350692961,-0.0182187796976747,1.45489309136258e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37005,-0.0402767677578318,0.00711874453711979,-0.0542295070505866,-0.026324028465077,1.56483132225183e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDS,Iduronate 2-sulfatase,39865,0.00504429005148213,0.000892111132980559,0.00329575223084024,0.00679282787212403,1.59127507272068e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37168,-0.027262833983938,0.00482482260517787,-0.0367194862900866,-0.0178061816777894,1.63228950054754e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,39865,0.0145052646927568,0.00256798830201972,0.00947200762079816,0.0195385217647155,1.64612731438878e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,36877,-0.0347140265243761,0.00614530960845353,-0.046758833356945,-0.0226692196918072,1.64893790975524e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37277,0.0342787880805864,0.00608002716502001,0.0223619348371472,0.0461956413240256,1.75573612359444e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPK2,Death-associated protein kinase 2,36896,-0.0299241101625269,0.0053107163878305,-0.0403331142826747,-0.0195151060423791,1.79031502998128e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCG3,Secretogranin-3,39697,0.018075827103431,0.00320961170142014,0.0117849881686475,0.0243666660382144,1.81389268812825e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37215,-0.0665558800521185,0.011833161923105,-0.0897488774214044,-0.0433628826828327,1.89756083844363e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",36880,-0.0282735163853732,0.00503113179553541,-0.0381345347046226,-0.0184124980661238,1.95200673093113e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39401,-0.0293858444514249,0.00523329878936567,-0.0396431100785816,-0.0191285788242682,1.99734121822433e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37215,-0.0234846343701101,0.00419115436889937,-0.0316992969331529,-0.0152699718070674,2.1436804241863e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBN1,Drebrin,36896,-0.0292583871208155,0.00522357167519553,-0.0394965876041988,-0.0190201866374323,2.17152297450966e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4D,Semaphorin-4D,39817,-0.0166009473267148,0.00296430883371713,-0.0224109926408004,-0.0107909020126292,2.1754092482819e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,36855,-0.0196441519930094,0.00350850478640488,-0.026520821374363,-0.0127674826116558,2.19949261059564e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39594,-0.0297827030530568,0.00532370193471164,-0.0402171588450916,-0.019348247261022,2.25126926465554e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIT,Vitrin,37268,-0.020522682248476,0.00367181204301147,-0.0277194338527785,-0.0133259306441735,2.3249811660058e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTC,Probetacellulin,39288,-0.0408762557636474,0.00732389359592043,-0.0552310872116515,-0.0265214243156434,2.42859955974019e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD244,Natural killer cell receptor 2B4,39865,-0.0147538528424918,0.0026448575043099,-0.0199377735509392,-0.00956993213404437,2.46789997823924e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39721,-0.0140870373308962,0.00252585548322918,-0.0190377140780253,-0.00913636058376696,2.48504449071514e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNXB,Tenascin-X,39668,0.0141904897265653,0.00254533250695154,0.00920163801294031,0.0191793414401904,2.51431373544782e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37203,-0.033153747012414,0.00596098252117249,-0.0448372727539121,-0.0214702212709159,2.7215167763702e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAL,Galanin peptides,39743,0.0353524413090535,0.00635837720249138,0.0228900219921703,0.0478148606259366,2.74154422589954e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39680,-0.0480534839540672,0.00864550381286214,-0.064998671427277,-0.0311082964808574,2.76966109533326e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39697,0.0130639448317247,0.00235312201854825,0.0084518256753701,0.0176760639880792,2.87367468600663e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39743,-0.0142817994764918,0.00257657779363751,-0.0193318919520213,-0.00923170700096227,3.02180589897867e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BGLAP,Osteocalcin,37267,-0.0476399488924518,0.00860067384760669,-0.0644972696337609,-0.0307826281511427,3.09763874704982e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,36880,-0.0235570628905877,0.00426502586955503,-0.0319165135949156,-0.0151976121862598,3.39050978096106e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39302,-0.0352702162816383,0.00640730998669838,-0.0478285438555671,-0.0227118887077094,3.7572581430187e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39632,0.0257385212832266,0.00468120325564849,0.0165633629021556,0.0349136796642976,3.8949162642875e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39557,0.0195770482160818,0.00356129398713426,0.0125969120012986,0.0265571844308649,3.91947061165648e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39529,-0.0215109689809953,0.00391383384922067,-0.0291820833254678,-0.0138398546365228,3.94260156351364e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB2,Lamin-B2,37220,-0.0149976813664562,0.00272936731076082,-0.0203472412955474,-0.00964812143736498,3.9802457127771e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JAM2,Junctional adhesion molecule B,39817,-0.0136221764718455,0.00248065947293658,-0.0184842690388012,-0.00876008390488983,4.04959510355919e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37203,-0.0343936675965755,0.00626303267705187,-0.0466692116435971,-0.0221181235495538,4.05742808097052e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,36880,-0.0286618987003664,0.00521974232233359,-0.0388925936521402,-0.0184312037485925,4.07026133141952e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,36855,-0.0241676252937006,0.00441290143117649,-0.0328169120988065,-0.0155183384885947,4.41674993469484e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGCR6,Protein DGCR6,36827,-0.023649548087371,0.00432975757371528,-0.0321358729318529,-0.015163223242889,4.79222760829107e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37005,-0.028847344304067,0.00528471403977549,-0.039205383822027,-0.0184893047861071,4.88502600338269e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39401,-0.0284807561948905,0.00523279572554138,-0.0387370358169516,-0.0182244765728294,5.32616310786952e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HYAL1,Hyaluronidase-1,39554,-0.0123171586460323,0.00226331233728227,-0.0167532508271055,-0.00788106646495901,5.3447528483377e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,36855,-0.0275045176445759,0.00505490403405545,-0.0374121295513245,-0.0175969057378272,5.38954712711636e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39673,-0.0658352365094303,0.0121367283753621,-0.0896232241251401,-0.0420472488937206,5.89831972601071e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,39860,0.0136051524757644,0.00250877462402951,0.00868795421266655,0.0185223507388622,5.94482698240067e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,38834,-0.0192073314694042,0.00355185494706497,-0.0261689671656516,-0.0122456957731569,6.48219032965199e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39673,-0.0647208190610742,0.0119708890057433,-0.0881837615123311,-0.0412578766098174,6.51942406487197e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPEP2,Dipeptidase 2,39594,0.0155218135121619,0.00288146337967944,0.00987414528799021,0.0211694817363336,7.27615885462162e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,36958,-0.0345602638570555,0.00642400038516761,-0.047151304611984,-0.021969223102127,7.58232758783043e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39673,-0.0493054665397351,0.00916945332409364,-0.0672775950549586,-0.0313333380245116,7.67515990022041e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37277,-0.0391674741916851,0.00728657333869327,-0.0534491579355239,-0.0248857904478463,7.77371797980076e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,39836,-0.0204788151677358,0.00381769055657589,-0.0279614886586245,-0.012996141676847,8.24458103796616e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB2,Calretinin,39302,-0.0154812195416255,0.0028878442587287,-0.0211413942887337,-0.00982104479451722,8.40348147312345e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39288,-0.0249122940220211,0.00464778605260117,-0.0340219546851194,-0.0158026333589228,8.44024051850758e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37268,-0.028863902880329,0.00539357558106182,-0.0394353110192102,-0.0182924947414479,8.86470458094897e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39673,-0.017600391226147,0.00329153734588941,-0.0240518044240902,-0.0111489780282037,9.05843572544928e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B2M,Beta-2-microglobulin,37285,-0.016392966207109,0.00306899563146809,-0.0224081976447865,-0.0103777347694315,9.3697114211285e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39288,-0.0405837487362577,0.00760142320647211,-0.055482538220943,-0.0256849592515723,9.48011876837113e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA13,Carbonic anhydrase 13,39470,-0.0558973401517846,0.0104786320158885,-0.076435458902926,-0.0353592214006432,9.71915660128168e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39715,0.014088086202316,0.00264275748699733,0.00890828152780127,0.0192678908768308,9.91047129718729e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX6,Syntaxin-6,39288,-0.0359663047894037,0.00674833725130208,-0.0491930458019558,-0.0227395637768516,9.97837354944669e-08
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36780,0.0329884977472094,0.00619464097092983,0.0208470014441869,0.0451299940502319,1.02459636146112e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,39836,-0.017416457087782,0.00327611661635161,-0.0238376456558311,-0.0109952685197328,1.0738744869967e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL26,C-C motif chemokine 26,39673,-0.0449260814248332,0.00848360145377166,-0.0615539402742256,-0.0282982225754407,1.20188703722266e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,36855,-0.0399527996938977,0.00755514857501167,-0.0547608909009206,-0.0251447084868748,1.2555920590164e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,36880,-0.028088387274031,0.00531590189344852,-0.0385075549851901,-0.0176692195628719,1.28542673102425e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39401,-0.0192970618497347,0.00365292663730264,-0.0264567980588479,-0.0121373256406216,1.29059510886836e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39673,-0.018644461052772,0.0035388163872987,-0.0255805411718774,-0.0117083809336666,1.39302825690655e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA4C,Semaphorin-4C,39594,0.0147795292240901,0.00280743172935194,0.00927696303456032,0.0202820954136199,1.42472822115133e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,36896,-0.0339226993584983,0.00644795280261211,-0.046560686851618,-0.0212847118653785,1.45541176050609e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPL,Periplakin,36896,-0.0168097095586465,0.00319900185883022,-0.0230797532019537,-0.0105396659153393,1.50625464518314e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39681,-0.0298817840630933,0.00568823623261355,-0.0410307270790158,-0.0187328410471707,1.51367368350191e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39743,-0.0129407930380792,0.00246751434362085,-0.0177771211515761,-0.00810446492458233,1.58746931375784e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",36880,-0.0135878569638163,0.00259664958997571,-0.0186772901601687,-0.00849842376746389,1.69516116891655e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37215,0.0367105220309974,0.00702335582523489,0.022944744613537,0.0504762994484578,1.74954651559476e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,36877,-0.025233986131971,0.00483075183337857,-0.034702259725393,-0.015765712538549,1.78171010315589e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39302,-0.0227435840053478,0.00435873715605217,-0.03128670883121,-0.0142004591794855,1.83275147125723e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANGPT2,Angiopoietin-2,39836,-0.019636944936282,0.00376588370558777,-0.0270180769992341,-0.01225581287333,1.86680686621354e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLGN,Calmegin,36877,-0.0226884278319297,0.00435185134114456,-0.0312180564605731,-0.0141587992032864,1.88136418298576e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST5,Cystatin-D,39368,-0.0279560805687591,0.0053674232646496,-0.0384762301674724,-0.0174359309700459,1.92836511377496e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39680,-0.0251371634714856,0.00484905533908932,-0.0346413119361007,-0.0156330150068705,2.19933156092984e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN3,CCN family member 3,39850,-0.0166177967687493,0.00321037049701765,-0.0229101229429039,-0.0103254705945947,2.29087060014637e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39627,-0.0166885644905899,0.00322774933980865,-0.0230149531966148,-0.0103621757845649,2.3652441023924e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39594,-0.0161607883631778,0.00312761700436196,-0.0222909176917272,-0.0100306590346284,2.40627912230718e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39634,-0.0140978115739955,0.00273075032682516,-0.0194500822145728,-0.00874554093341818,2.46483207704146e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A11,Protein S100-A11,39518,-0.0232793236807261,0.00451082286913442,-0.0321205365042295,-0.0144381108572226,2.48941330935036e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX5,Sorting nexin-5,36880,-0.0156876740537849,0.00304363653243658,-0.0216532016573605,-0.00972214645020916,2.58372334776123e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39265,0.022258627690887,0.00432324422379545,0.013785069012248,0.0307321863695261,2.65678191072306e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39688,0.0249701658771478,0.00487166514403956,0.0154217021948302,0.0345186295594653,3.00097608070096e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA6,Carbonic anhydrase 6,39628,0.0322249333037213,0.00628857674297344,0.0198993228874934,0.0445505437199492,3.02075251365238e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA1,Annexin A1,36907,-0.0223760692554477,0.00437276705665161,-0.0309466926864848,-0.0138054458244105,3.14607865255858e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39652,-0.0123057370893667,0.00240757803002323,-0.0170245900282122,-0.00758688415052113,3.23767703637679e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37244,-0.0306039510456956,0.0059923652262444,-0.0423489868891347,-0.0188589152022566,3.31536621017611e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",39860,-0.0146551325566643,0.002871531531628,-0.0202833343586552,-0.00902693075467344,3.37079632771378e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37174,-0.0228319753435463,0.00447859747032749,-0.0316100263853882,-0.0140539243017044,3.47935650632759e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39564,-0.0121233628239842,0.00238502583842458,-0.0167980134672964,-0.00744871218067208,3.75559724153861e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37268,-0.0345274967342562,0.00681591889148034,-0.0478866977615577,-0.0211682957069547,4.12280280095536e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,36877,-0.0346950347810766,0.00685298733157753,-0.0481268899509685,-0.0212631796111846,4.18874240618113e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39511,0.0314535208157307,0.00623029453749795,0.0192421435222347,0.0436648981092267,4.50338509678946e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39266,-0.0237809829865402,0.00472058664347884,-0.0330333328077587,-0.0145286331653217,4.76445935214795e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL2,Chordin-like protein 2,39680,-0.0281015005955975,0.00558130982971939,-0.0390408678618475,-0.0171621333293475,4.83280259162197e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37268,0.017104971845275,0.00340514222447883,0.0104308930852965,0.0237790506052535,5.14507747467404e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39061,-0.0146053229308291,0.0029115810154313,-0.0203120217210744,-0.00889862414058376,5.32741226680017e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA4,Annexin A4,39597,-0.0359600393970679,0.00719207794315173,-0.0500565121656453,-0.0218635666284905,5.79616609695098e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1,Integrin beta-1,39669,0.0107622761103772,0.00215556160277652,0.00653737536893526,0.0149871768518192,6.0145588353678e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39288,-0.0295831385776758,0.00595122945000915,-0.0412475482996937,-0.0179187288556579,6.73477664983044e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTG,Protogenin,39836,-0.0122253799894367,0.00246388236678008,-0.0170545894283256,-0.00739617055054771,7.05482562020867e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37244,-0.038706423541655,0.00780717488618915,-0.0540084863185858,-0.0234043607647243,7.21686546874987e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNF,Tumor necrosis factor,39371,-0.0186501904490212,0.00377123089094673,-0.0260418029952768,-0.0112585779027656,7.67882596253996e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39302,-0.0199400235254569,0.00403283466039263,-0.0278443794598264,-0.0120356675910873,7.71732161885676e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39658,-0.0237332468193631,0.00481496066136942,-0.0331705697156472,-0.014295923923079,8.34624563582543e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,36896,-0.0199770132172727,0.00405513213131118,-0.0279250721946426,-0.0120289542399028,8.4806590691687e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MATN3,Matrilin-3,39529,0.0152776752036057,0.00310162626998762,0.00919848771442993,0.0213568626927814,8.49166797809715e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39736,-0.0393860369764934,0.00799890901533882,-0.0550638986465575,-0.0237081753064293,8.56772299027155e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39697,-0.0154575337724574,0.00314307230056029,-0.0216179554815556,-0.00929711206335927,8.83232794312325e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39793,-0.0136434845725863,0.0027747380633291,-0.0190819711767113,-0.00820499796846128,8.8739758885964e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRSF1,G-rich sequence factor 1,36708,-0.0396012700913137,0.00806239482573885,-0.0554035639497618,-0.0237989762328655,9.13319754053611e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39288,-0.0250791725794708,0.00511225953410666,-0.0350992012663199,-0.0150591438926218,9.40473917487771e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37267,-0.030151936427346,0.00615894934651894,-0.0422234771465231,-0.0180803957081689,9.91324534914409e-07
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36840,-0.0194266484510648,0.00398991972454358,-0.0272468911111702,-0.0116064057909594,1.13524443032684e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39673,-0.0225289003722598,0.00462965839426559,-0.0316030308250204,-0.0134547699194993,1.14853854828534e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRLB,Fc receptor-like B,39288,-0.0278612395807907,0.00572734622536964,-0.0390868381825152,-0.0166356409790662,1.15821140319634e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA1,Carbonic anhydrase 1,39344,-0.0284520707347376,0.00587055909515104,-0.0399583665612337,-0.0169457749082416,1.26832249188394e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37215,-0.0142408755224714,0.0029407020065451,-0.0200046514552998,-0.00847709958964296,1.29536088047175e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR3,Toll-like receptor 3,39865,-0.0292017168191218,0.00603369155299714,-0.0410277522629962,-0.0173756813752474,1.31197478241611e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD84,SLAM family member 5,39673,-0.0148941917053273,0.00308644060114045,-0.0209436152835625,-0.00884476812709198,1.40824618118199e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,36896,-0.0203438587895261,0.00423142846871085,-0.0286374585881993,-0.0120502589908528,1.54305112926463e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37199,-0.0422759678665506,0.00880884008883739,-0.0595412944406719,-0.0250106412924293,1.60974104885062e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNG,Interferon gamma,39401,-0.0542039488588273,0.0113031984539479,-0.0763582178285652,-0.0320496798890894,1.63812604767999e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37277,0.0683394527730674,0.0142994905044901,0.0403124513842669,0.0963664541618679,1.77901537341415e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39680,-0.0311821027857282,0.00653302787560131,-0.0439868374219068,-0.0183773681495496,1.83130121956896e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB2,Integrin beta-2,39539,0.0135623077114207,0.00284530718230443,0.00798550563410405,0.0191391097887374,1.89086352875169e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,36855,-0.0468861675089896,0.00983790324645479,-0.066168457872041,-0.0276038771459382,1.90077137470357e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39648,-0.0208565156320105,0.0043787191943514,-0.0294388052529392,-0.0122742260110817,1.92283938186496e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP9,Caspase-9,36896,-0.0300627330581822,0.00631695653591997,-0.0424439678685854,-0.0176814982477791,1.96591428605549e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SATB1,DNA-binding protein SATB1,37244,-0.0142779645789262,0.00300166132452885,-0.0201612207750028,-0.00839470838284966,1.98849447289948e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39668,-0.0119206589761666,0.00250958707563044,-0.0168394496444022,-0.00700186830793092,2.05154659252085e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTRC,Chymotrypsin-C,39668,0.0289596704145827,0.00610292941881254,0.0169979287537102,0.0409214120754553,2.10114352877246e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBLN2,Fibulin-2,37267,0.0142758189795535,0.0030140877011993,0.00836820708520292,0.0201834308739042,2.19815560091109e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39770,-0.0196260231404628,0.00415080630611743,-0.027761603500453,-0.0114904427804727,2.28412052342892e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39594,-0.0340910424463858,0.00722357256601365,-0.0482492446757726,-0.0199328402169991,2.38558773245479e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",36896,-0.0168877792481418,0.00358055317068021,-0.023905663462675,-0.0098698950336086,2.42391542485616e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37005,-0.0349056656505663,0.00740690642319505,-0.0494232022400286,-0.020388129061104,2.47103303443349e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAM,Basal cell adhesion molecule,39668,0.0109828958910456,0.00233082761295131,0.006414473769661,0.0155513180124302,2.47367314106104e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39630,-0.0189285194804683,0.00402197922445841,-0.0268115987604068,-0.0110454402005298,2.54433962268317e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39673,0.0203655806076011,0.00433480399280728,0.0118693647816988,0.0288617964335034,2.64731832148527e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39721,0.0127721715367513,0.00272335344717373,0.00743439878029082,0.0181099442932119,2.75658080844861e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX1,Peroxiredoxin-1,39245,0.0420418940226256,0.00897614883757949,0.0244486423009698,0.0596351457442814,2.84103830815775e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCT,Secretin,36877,-0.02059661633463,0.00442054542200131,-0.0292608853617526,-0.0119323473075074,3.20441460155265e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37215,-0.0226635232519513,0.00486543100438485,-0.0321997680205456,-0.013127278483357,3.22265496981233e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36546,-0.0508720466628236,0.010932300618586,-0.0722993558752522,-0.029444737450395,3.29856916501796e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP1,Caspase-1,39302,-0.0308834102134739,0.00663847431801127,-0.043894819876776,-0.0178720005501719,3.31162050805372e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39302,-0.0339443333052523,0.00731826136466366,-0.0482881255799931,-0.0196005410305116,3.54158929292849e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLMH,Bleomycin hydrolase,39860,-0.0147275817932854,0.00317609019462125,-0.020952718574743,-0.00850244501182773,3.56270203521592e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXN,Thioredoxin,37125,-0.0199356671994904,0.00430423401800942,-0.0283719658747889,-0.011499368524192,3.66226066664256e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39680,0.0128794631810644,0.00278380105001968,0.00742321312302584,0.018335713239103,3.74711088586177e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH3,Neurexophilin-3,36896,0.013678652374468,0.00296166808252634,0.00787378293271633,0.0194835218162196,3.90101824725717e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB44,Ras-related protein Rab-44,37203,-0.0194652678369102,0.00422075826170757,-0.0277379540298571,-0.0111925816439634,4.0291797095095e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39401,0.0151578000631119,0.00328708395117993,0.00871511551879926,0.0216004846074246,4.03306912973233e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300A,CMRF35-like molecule 8,36958,-0.013274174785406,0.00288242442959971,-0.0189237266674215,-0.00762462290339058,4.15925754865185e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,36877,-0.0268910450418842,0.0058553883990611,-0.0383676063040439,-0.0154144837797244,4.42009951685971e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39594,-0.00988981312806082,0.00215378651365704,-0.0141112346948286,-0.00566839156129302,4.42787697078948e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUK1,Guanylate kinase,36855,0.0190253697659907,0.00414478606259071,0.0109015890833129,0.0271491504486685,4.46985319734046e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37215,-0.0401150443248481,0.00874466328013189,-0.0572545843539066,-0.0229755042957896,4.52938195475613e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNC5D,Netrin receptor UNC5D,36896,0.0121282725953171,0.00264597232509293,0.00694216683813492,0.0173143783524992,4.61122671261223e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB37,Ras-related protein Rab-37,39401,-0.0378108411651765,0.00825124532368129,-0.0539832819995919,-0.0216384003307612,4.63156194365548e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39557,-0.0104223330456271,0.00227533970658812,-0.0148819988705398,-0.00596266722071437,4.67296125933161e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1S,Complement C1s subcomponent,37285,-0.00949693188600333,0.00208632014649801,-0.0135861193731394,-0.00540774439886723,5.36047460758212e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOC,Myocilin,39668,0.0207099082829454,0.00455039866303065,0.0117911269034053,0.0296286896624855,5.37307154768039e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39348,-0.022638978701999,0.00497862689442863,-0.0323970874150792,-0.0128808699889189,5.476767612868e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK10,Kallikrein-10,39666,-0.0177203172722295,0.00389800161136536,-0.0253604004305056,-0.0100802341139534,5.50805204786116e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARFIP1,Arfaptin-1,37244,-0.03142500435449,0.00692322147448773,-0.0449945184444859,-0.0178554902644941,5.69945871980684e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,36880,-0.0151711928859426,0.00334336395200887,-0.0217241862318799,-0.00861819954000518,5.73791612056978e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37215,-0.0227034435608355,0.00502078565371841,-0.0325441834421236,-0.0128627036795474,6.18172560521349e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39594,-0.00926977155118909,0.0020516277873703,-0.0132909620144349,-0.00524858108794331,6.28061148610547e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN10,Ataxin-10,39302,-0.0327252307897205,0.00725715257353147,-0.0469492498338422,-0.0185012117455988,6.54971888845301e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39594,-0.0171291714370167,0.00380840852568917,-0.0245936521473675,-0.00966469072666596,6.91760247902239e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",36958,-0.0401541015356021,0.00894814414975594,-0.0576924640691238,-0.0226157390020805,7.27044744408675e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA,Lymphotoxin-alpha,39673,-0.0175433640012385,0.00391440477365308,-0.0252155973575985,-0.00987113064487842,7.455498153133e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,39817,-0.028979629918048,0.00647316528847735,-0.0416670338834636,-0.0162922259526324,7.62640608451179e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39288,-0.0205877979375214,0.00460029657226219,-0.0296043792191553,-0.0115712166558875,7.68431329868107e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST1,Cystatin-SN,35499,-0.0449590034333695,0.0100679730521557,-0.0646922306155946,-0.0252257762511444,8.06165911351458e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,39836,0.024754858205281,0.00555472925283549,0.0138675888697234,0.0356421275408386,8.38605520109025e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK4,Kallikrein-4,39836,0.0265520510133472,0.00596242213193383,0.0148657036347569,0.0382383983919375,8.5160744476544e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37236,-0.00997172237288522,0.0022467731817241,-0.0143753978090644,-0.00556804693670599,9.14222595191863e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39266,-0.0184315583952959,0.00415380256431426,-0.0265730114213518,-0.0102901053692399,9.17374392191382e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37267,0.0148910217174161,0.00335912481185391,0.00830713708618248,0.0214749063486498,9.36664021739895e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37005,-0.0168922682884864,0.00381475544740559,-0.0243691889654014,-0.00941534761157146,9.58165367381813e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37215,-0.0119407881922019,0.00269967015962766,-0.0172321417050721,-0.00664943467933166,9.80846913274571e-06
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,39836,0.0256349291928385,0.00580798013406375,0.0142512881300736,0.0370185702556035,1.02264606805513e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39557,-0.0268333800460233,0.00608324106631014,-0.0387565325359912,-0.0149102275560554,1.03563040894605e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,36855,0.0161662048621505,0.00366938967896146,0.00897420109138603,0.0233582086329149,1.0629030419373e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39401,0.0173692159840767,0.00394753946528509,0.00963203863211796,0.0251063933360355,1.08966191769123e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA10,Annexin A10,39302,-0.034006340104059,0.00775720045605553,-0.0492104529979278,-0.0188022272101901,1.17374799974032e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,39865,-0.0322048133685256,0.00735040983769971,-0.0466116166504171,-0.0177980100866342,1.18689302911069e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYGD,Gamma-crystallin D,37220,-0.0420761428144338,0.00962134132380114,-0.0609339718090841,-0.0232183138197836,1.23359675373012e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39680,0.0401447999504121,0.00918042894569327,0.0221511592168533,0.0581384406839709,1.2340831069077e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39636,-0.0382891548175268,0.00875980887594289,-0.0554583802143749,-0.0211199294206788,1.24467664938153e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,36958,0.0169451779338539,0.00388415136913955,0.00933224125034035,0.0245581146173674,1.29481612221875e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FXN,"Frataxin, mitochondrial",39836,-0.0317233771233118,0.00727805021832177,-0.0459883555512225,-0.0174583986954011,1.31610036680465e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,36958,-0.0290983004184194,0.00667580612736305,-0.042182880428051,-0.0160137204087878,1.31792841400755e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,36877,-0.0262483276051562,0.00602440394696127,-0.0380561593412003,-0.0144404958691122,1.32867184948747e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,36880,-0.0121477060704379,0.00278877174976663,-0.0176136986999805,-0.00668171344089525,1.33514236525771e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37220,-0.103472750928246,0.0238503612667866,-0.150219459011147,-0.0567260428453439,1.44567841752217e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39764,-0.0119365893395973,0.00275475564468286,-0.0173359104031757,-0.00653726827601895,1.47936586396713e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGA2,Integrin alpha-2,36958,-0.014564368027662,0.00336217974305538,-0.0211542403240506,-0.0079744957312735,1.48980590171182e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37203,-0.0169478594283566,0.00391251733207098,-0.0246163933992157,-0.00927932545749748,1.49042158720976e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN2,Calsyntenin-2,39865,0.0168798023403423,0.00390171102686226,0.00923244872769232,0.0245271559529924,1.52583860655109e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,36877,-0.0227382179620052,0.00526860087813139,-0.0330646756831428,-0.0124117602408677,1.60201731596936e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,36855,-0.0157322217305329,0.00364538941473302,-0.0228771849834096,-0.00858725847765617,1.60311683117485e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,36877,0.0138293281923915,0.00320705158180991,0.00754350709204405,0.0201151492927389,1.62855533724596e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37264,-0.00826270360204011,0.00191645570992185,-0.0120189567934869,-0.00450645041059328,1.63345888641779e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39288,0.0129551370641089,0.0030210901832627,0.00703380030491405,0.0188764738233038,1.8119518503228e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX2,Sorting nexin-2,37203,-0.0344585127882326,0.00804441054616264,-0.0502255574587113,-0.0186914681177538,1.85235070642212e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39693,-0.027015778500982,0.00631285177376312,-0.0393889679775577,-0.0146425890244063,1.88423805092861e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLMP,CXADR-like membrane protein,39836,-0.00868207563817968,0.00202957914620794,-0.0126600507647472,-0.00470410051161212,1.89871364561479e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITM2A,Integral membrane protein 2A,39673,0.0250821193811278,0.00586384314926547,0.0135889868085675,0.0365752519536881,1.9018233626216e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37203,-0.0189082802814049,0.0044311327659179,-0.027593300502604,-0.0102232600602058,1.99357585765671e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP5,Platelet glycoprotein V,36958,-0.0153787603383201,0.00360587110285937,-0.0224462676999244,-0.00831125297671571,2.01374413039178e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39668,-0.0139838853607702,0.00327917033508408,-0.020411059217535,-0.00755671150400537,2.01551352232409e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,36855,-0.0160293538934037,0.00376261072452721,-0.023404070913477,-0.00865463687333033,2.05711399987439e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEP1B,Meprin A subunit beta,39680,-0.0486061022104664,0.0114166401670879,-0.0709827169379588,-0.026229487482974,2.07937537067839e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,36855,-0.0194176365442388,0.00456221658171172,-0.0283595810443937,-0.0104756920440838,2.09403661979049e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP3,Stromelysin-1,39668,0.0200380129302914,0.00471753627776201,0.0107916418258778,0.0292843840347049,2.17348500097356e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,36896,-0.0174764459180537,0.00411767611388898,-0.0255470911012761,-0.0094058007348313,2.20843328497563e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,36900,0.0143369303713132,0.00337828562545924,0.0077154905454131,0.0209583701972133,2.21238384603386e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN9,Septin-9,39594,-0.0119159356933634,0.00281263650118545,-0.0174287032356869,-0.00640316815103993,2.2825006708718e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36795,-0.0286311150563817,0.00676808787414383,-0.0418965672897036,-0.0153656628230598,2.34975548210188e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39738,0.0138110553216756,0.00327241003205618,0.0073971316588455,0.0202249789845057,2.45165891091391e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37005,-0.0247293013787086,0.00587252955716196,-0.036239459310746,-0.0132191434466712,2.55920197856274e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37267,-0.0248885104219382,0.00591104801356439,-0.0364741645285244,-0.013302856315352,2.56460439813665e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCOR1,REST corepressor 1,39401,-0.0187156109867252,0.00446093686326265,-0.02745904723872,-0.00997217473473038,2.73849142399637e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39594,0.0137498395911997,0.0032794398293663,0.00732213752564171,0.0201775416567576,2.7711212042e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA7,Carbonic anhydrase 7,37005,0.0141466045646608,0.00337902064404702,0.00752372410232866,0.020769485026993,2.85009413688365e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGA,Fibrinogen alpha chain,36984,0.0127837016689473,0.00307057166624439,0.0067653812031083,0.0188020221347863,3.15687940668225e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,36855,0.0172931025115523,0.00415457477975487,0.00915013594323273,0.0254360690798718,3.16915739439303e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36795,0.0108532035366806,0.00261006377122322,0.0057374785450831,0.0159689285282781,3.22813970155772e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,36958,0.0135686642039073,0.00326394635862735,0.00717132934099772,0.0199659990668169,3.24314434218889e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,36855,-0.0233557664294859,0.00562105329830292,-0.0343730308941596,-0.0123385019648122,3.27295624023422e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNX18,Sorting nexin-18,37215,-0.0187128208520676,0.00450710672288625,-0.0275467500289247,-0.00987889167521057,3.31849439677702e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39288,-0.0164165622013817,0.00396347129047872,-0.02418496593072,-0.00864815847204342,3.46175328487457e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,36877,-0.025125377098146,0.00606599101625147,-0.0370147194899989,-0.0132360347062932,3.46453444499165e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39288,-0.0166158160185033,0.00402067373050032,-0.0244963365302839,-0.00873529550672264,3.60584001565005e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37215,-0.0470587553639256,0.0113997554434244,-0.0694022760330375,-0.0247152346948137,3.68075728957008e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36439,0.0448595598463103,0.0108683487584905,0.0235575962796689,0.0661615234129517,3.69026354754951e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37244,-0.0145055778275825,0.00351570946004166,-0.0213963683692641,-0.00761478728590086,3.71470278030855e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNU13,NHP2-like protein 1,36855,-0.0253760098151766,0.00617766935825706,-0.0374842417573605,-0.0132677778729928,4.02067909484669e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE3,Eosinophil cationic protein,39603,-0.0437173326464276,0.0106561303272129,-0.0646033480877648,-0.0228313172050904,4.10673315810229e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300E,CMRF35-like molecule 2,39797,-0.0156143464363731,0.00380992906178108,-0.023081807397464,-0.00814688547528216,4.18201989897992e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C2,Complement C2,39715,-0.00956356723340111,0.00234032650879133,-0.0141506071906321,-0.00497652727617011,4.40228287302397e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,39817,-0.00942852774027698,0.00230853321070062,-0.0139532528332502,-0.00490380264730376,4.44434073025932e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39288,-0.019112327004344,0.00468395596038396,-0.0282928806866966,-0.00993177332199148,4.51880047136577e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIF,Leukemia inhibitory factor,39302,-0.0206429481149605,0.00506681842534812,-0.0305739122286428,-0.0107119840012781,4.64146299678472e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37196,-0.0228530458734657,0.00562285244760172,-0.0338738366707651,-0.0118322550761663,4.84498642841931e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39302,-0.0338611669738701,0.00835570786808072,-0.0502383543953084,-0.0174839795524319,5.09301495303779e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39668,-0.0139820128990619,0.00345117691887451,-0.0207463196600559,-0.00721770613806782,5.11607164570204e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,36855,0.0112881663712863,0.00278624612305472,0.00582712397009908,0.0167492087724736,5.12105267808611e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36795,-0.0248544452493984,0.0061349805400362,-0.0368790071078694,-0.0128298833909275,5.12385042606096e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39288,-0.0208979664593991,0.0051590744026771,-0.0310097522886462,-0.010786180630152,5.13100541251359e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVPL,Envoplakin,37005,0.0133112766505205,0.00330058763738439,0.00684212488124709,0.0197804284197939,5.53798809937364e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39557,-0.0138071906653032,0.0034306260376213,-0.0205312176990409,-0.00708316363156545,5.73192116361585e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSH,Pro-cathepsin H,39362,-0.0287123814238981,0.00716084152807927,-0.0427476308189334,-0.0146771320288627,6.10967873840971e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37203,-0.0146218127086355,0.00365026874601142,-0.0217763394508179,-0.00746728596645312,6.21743837685491e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL19,Interleukin-19,39236,-0.0272562965773697,0.00681068179058299,-0.0406052328869124,-0.013907360267827,6.31058160273104e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39288,-0.032005713134941,0.00801379220109598,-0.0477127458490891,-0.0162986804207929,6.53162985233118e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBS4,Thrombospondin-4,39700,-0.0176408358632637,0.00442807882239281,-0.0263198703551536,-0.00896180137137382,6.81087989911535e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37203,-0.0155255851664944,0.00389697230473696,-0.0231636508837789,-0.00788751944921001,6.81213930058235e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36807,-0.0388576069846501,0.00977713637264651,-0.0580207942750373,-0.019694419694263,7.09593180999136e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37267,-0.0184416878939784,0.00465445193920326,-0.0275644136948167,-0.00931896209313996,7.46590400664293e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36795,0.0120282172741377,0.00303796063641111,0.00607381442677197,0.0179826201215035,7.55700871583427e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37005,-0.0332155985930053,0.0083905114199373,-0.0496610009760824,-0.0167701962099282,7.5752465757717e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300C,CMRF35-like molecule 6,39817,-0.0129848216649402,0.00329330594762338,-0.019439701322282,-0.00652994200759834,8.08822247069274e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39641,-0.0148695126159959,0.00377158647972651,-0.0222618221162599,-0.00747720311573193,8.09817307847599e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39637,0.021230679182262,0.00539388458952099,0.0106586653868009,0.0318026929777232,8.31839944584577e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGN,Secretagogin,39401,-0.0167658334595988,0.00426682533631057,-0.0251288111187675,-0.00840285580043011,8.55457886629357e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC5,Glypican-5,39557,-0.0217137714572751,0.00553623984143483,-0.0325648015464873,-0.0108627413680628,8.81484021085204e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AKAP12,A-kinase anchor protein 12,36958,0.00825871118673464,0.00210734104569509,0.00412832273717227,0.012389099636297,8.93619657411219e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB2A2,Mammaglobin-A,36855,0.012136663142246,0.00311232164563683,0.00603651271679778,0.0182368135676942,9.68551976681265e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37220,-0.0140467309818358,0.00360521953832852,-0.0211129612769597,-0.00698050068671187,9.81818331590029e-05
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL4,Myosin light chain 4,36880,-0.0202023137340807,0.00519213662778427,-0.0303789015245378,-0.0100257259436235,0.000100352045128751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,36958,0.0095109879960438,0.00244714077703352,0.0047145920730581,0.0143073839190295,0.00010217093989339
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GC,Vitamin D-binding protein,37285,-0.0100143865267532,0.00257734314222088,-0.0150659790855061,-0.00496279396800027,0.000102590334811549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1B,Interleukin-1 beta,39292,-0.0214837081182542,0.00553213404739838,-0.032326690851155,-0.0106407253853534,0.000103418485555481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EGFLAM,Pikachurin,37215,-0.0118008533769203,0.00304168164804751,-0.0177625494070934,-0.00583915734674718,0.00010508162705763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMS1,PMS1 protein homolog 1,36877,-0.0192619436558077,0.00497739570946289,-0.029017639246355,-0.00950624806526046,0.000109418398352026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39617,-0.013247198533939,0.00342918666156616,-0.0199684043906087,-0.00652599267726934,0.000112417652185177
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1R,Complement C1r subcomponent,37285,-0.00744851906496331,0.00192924951506058,-0.011229848114482,-0.00366719001544459,0.000113528781615278
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37277,-0.00970094253579916,0.00251956864444892,-0.014639297078919,-0.00476258799267928,0.000118550271094451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROCR,Endothelial protein C receptor,36855,0.0140560372245893,0.00365101432618427,0.00690004914526814,0.0212120253039105,0.000118732708985109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37220,-0.022698500027635,0.00589788977428594,-0.0342583639852354,-0.0111386360700345,0.000119357586502132
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP12,Macrophage metalloelastase,39706,-0.0191113576197412,0.00498028573975127,-0.0288727176696537,-0.00934999756982871,0.000124825475872785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PKD1,Polycystin-1,37268,-0.0100006878993255,0.00261474603377017,-0.015125590125515,-0.00487578567313597,0.000131510600122198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOSB,Protein fosB,39302,-0.0148423218765227,0.0038826326161394,-0.0224522818041559,-0.00723236194888945,0.000132491268880403
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRDT,Bromodomain testis-specific protein,36855,-0.0139561780825982,0.00365297839513507,-0.0211160157370629,-0.00679634042813344,0.000133805266173947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37220,-0.00971323254852875,0.00254295540388415,-0.0146974251401417,-0.00472903995691581,0.000134238758464005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX6,Peroxiredoxin-6,39836,0.0223284856133161,0.00584693069981813,0.0108685014416726,0.0337884697849596,0.0001345881158159
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAYN,Layilin,39521,-0.0122054625563588,0.0031962547727522,-0.0184701219109531,-0.00594080320176449,0.000134686864719446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KEL,Kell blood group glycoprotein,39302,-0.0134132823108971,0.00351712300472898,-0.0203068434001659,-0.0065197212216283,0.000137429467885657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC4,Syndecan-4,39680,-0.0171255482904112,0.00449305036599639,-0.0259319270077642,-0.00831916957305832,0.000138613665549505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH3,Cadherin-3,39817,-0.0130661486861799,0.00343255684963597,-0.0197939601114664,-0.00633833726089341,0.000141454020203009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36827,0.0109431461164543,0.00287662387769698,0.00530496331616823,0.0165813289167404,0.000142937657460533
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN1,Tetraspanin-1,39401,-0.0151246429873997,0.00398014840161239,-0.02292573385456,-0.00732355212023944,0.000145236268545304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD99,CD99 antigen,39668,0.00717557623133211,0.00189457016229583,0.00346221871323228,0.0108889337494319,0.000152769231645832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR1,Folate receptor alpha,39618,-0.0102636335319869,0.00271376497696293,-0.0155826128868342,-0.00494465417713956,0.000156107817978123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39721,-0.0370372966687837,0.00980909248957139,-0.0562631179483436,-0.0178114753892238,0.0001600685204066
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37005,0.0104463147710592,0.00277109991814038,0.005014958931504,0.0158776706106143,0.000164135505869823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36827,0.0337817289874375,0.00896545729926177,0.0162094326808844,0.0513540252939906,0.000165297849009765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RETN,Resistin,39599,-0.0151641714760105,0.00402824770340284,-0.0230595369746801,-0.00726880597734097,0.000167516998824426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EBI3_IL27,Interleukin-27,39817,0.0114854427603512,0.00305110681035111,0.00550527341206299,0.0174656121086394,0.000167579465507892
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINC1,Antithrombin-III,37257,-0.00543224844726295,0.00144831885380452,-0.00827095340071982,-0.00259354349380609,0.000177065433637174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39401,-0.022745026875061,0.00607573543126222,-0.034653468320335,-0.0108365854297871,0.000182067736801243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36795,-0.0134532186324524,0.00359818409610547,-0.0205056594608192,-0.00640077780408572,0.00018563065245219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,39848,-0.0133235886260131,0.00356438693307903,-0.020309787014848,-0.00633739023717825,0.000186154831795388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39668,-0.0137763747343575,0.00370146053589779,-0.0210312373847171,-0.0065215120839978,0.000198434230320143
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDHR1,Cadherin-related family member 1,39302,-0.0157596188002745,0.00423519040483571,-0.0240605919937525,-0.0074586456067965,0.000199050701419426
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37220,0.0112117800379701,0.00301676146890674,0.00529892755891288,0.0171246325170273,0.000202829693499053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD7,T-cell antigen CD7,36877,-0.0158127783579448,0.00425516816522302,-0.0241529079617819,-0.00747264875410767,0.00020314071574414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37215,-0.0185565320693156,0.00499377762780077,-0.0283443362198051,-0.00876872791882612,0.000203283030565546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,36927,0.0181746971877403,0.00489310341301451,0.00858421449823186,0.0277651798772487,0.000204575113825678
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39648,0.00639378115029427,0.00172254918723809,0.00301758474330761,0.00976997755728094,0.000206486777676441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,36855,-0.0149817892502208,0.00404510621245145,-0.0229101974266256,-0.00705338107381598,0.000213372185171411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36795,0.011068341591042,0.00299148463667701,0.00520503170315512,0.016931651478929,0.000216536348300553
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,36958,0.0104767903514171,0.00283197816946701,0.00492611313926174,0.0160274675635724,0.000216942529081053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2,Brorin,39493,-0.0141109894483361,0.00381463850456499,-0.0215876809172834,-0.00663429797938869,0.000217048307449202
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37244,-0.0178065651332792,0.00481627618994013,-0.0272464664655618,-0.0083666638009965,0.000218891979627813
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39743,-0.0095997644083735,0.00259834849020863,-0.0146925274491824,-0.0045070013675646,0.000221003824150943
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEZ6,Seizure protein 6 homolog,36877,0.0114936308202404,0.00311283571332771,0.00539247282211807,0.0175947888183627,0.000223113068921793
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BEX3,Protein BEX3,36795,0.01726642985119,0.00467704974214482,0.00809941235658614,0.0264334473457938,0.00022364469103388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,36880,-0.0151276006416102,0.00410493168049671,-0.0231732667353838,-0.0070819345478367,0.000229426796755992
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39594,-0.00851884705475151,0.0023131691875335,-0.0130526586623172,-0.00398503544718585,0.000231494700877845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39673,0.0197963878372341,0.00537718177459151,0.00925711155903477,0.0303356641154335,0.000232587423410982
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFAP1,Actin filament-associated protein 1,36958,-0.0312066371396613,0.00848384223426672,-0.047834967918824,-0.0145783063604985,0.00023567721842843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39288,-0.0200389476532632,0.00544964337513094,-0.0307202486685199,-0.00935764663800656,0.000236690456226577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP4,Guanylate-binding protein 4,39302,-0.0178608910179369,0.00485751755346061,-0.0273816254227197,-0.00834015661315415,0.000236831675832364
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F2,Prothrombin,37285,-0.00537545270678911,0.00146530253795938,-0.0082474456811895,-0.00250345973238873,0.000244927563254778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39647,-0.0264194590849212,0.00721510642245227,-0.0405610676729277,-0.0122778504969148,0.000251378334654094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37244,-0.0333834290124376,0.00911906867610526,-0.0512568036176039,-0.0155100544072713,0.000252359716227188
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RCC1,Regulator of chromosome condensation,37203,-0.0184545547361685,0.00504376727526873,-0.0283403385956952,-0.00856877087664177,0.000254292914777517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,36855,0.0073711436895846,0.00201611266453641,0.00341956286709322,0.011322724512076,0.000257074781314277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37005,-0.0262260614437317,0.00718761570678897,-0.0403137882290381,-0.0121383346584253,0.000264503803853148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36827,0.0122959943252689,0.00337652559071224,0.00567800416747291,0.0189139844830649,0.000271992095498051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37268,0.0117189887592509,0.0032308255868905,0.00538657060894556,0.0180514069095563,0.0002875271057457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39288,-0.0126045733119127,0.00348572145729154,-0.0194365873682041,-0.00577255925562126,0.0003000761534015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,36855,-0.0236826896018345,0.0065521312310679,-0.0365248668147276,-0.0108405123889414,0.000302063107485904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39622,-0.0233792883861652,0.00648565448607581,-0.0360911711788737,-0.0106674055934566,0.000313393786590041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMM2,Phosphomannomutase 2,36855,-0.0215929530654566,0.00601726294851212,-0.0333867884445404,-0.0097991176863729,0.000333808326359493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39302,-0.0191928625989835,0.00535431913521036,-0.0296873281039958,-0.00869839709397124,0.000338691423099907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39401,-0.0127912603814184,0.00357137972794321,-0.0197911646481871,-0.00579135611464969,0.000342536527984267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39679,-0.0336163038798032,0.00940190890515162,-0.0520440453339003,-0.015188562425706,0.000350632515185925
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDI2,Protein DDI1 homolog 2,36958,-0.0267399571786975,0.00748867986140821,-0.0414177697070576,-0.0120621446503374,0.000357280531719896
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LUZP2,Leucine zipper protein 2,37203,-0.0155348350301962,0.00435136709869561,-0.0240635145436396,-0.0070061555167528,0.000358092880864394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,36880,-0.0213477288525602,0.00598616438830689,-0.0330806110536417,-0.00961484665147867,0.000363524277422957
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C7,Complement component C7,36983,0.0113780614187836,0.00319393646363873,0.00511794595005166,0.0176381768875155,0.00036879020082663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX3,Syntaxin-3,37220,-0.0135096219637597,0.00379317099273392,-0.0209442371095182,-0.00607500681800126,0.000369934234204916
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC3,Membrane primary amine oxidase,39738,0.0106002894345867,0.00297932131974705,0.00476081964788247,0.0164397592212909,0.000374843685734817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON2,Spondin-2,39588,0.0118070339082457,0.00332489169523009,0.0052902461855947,0.0183238216308967,0.000384740653571952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,36880,-0.0216176045543655,0.00609071731437585,-0.0335554104905421,-0.00967979861818882,0.000387660797628493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39302,-0.0170101078179128,0.00479377652418993,-0.0264059098053251,-0.00761430583050054,0.00038876889918507
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37215,-0.0149801595794624,0.00422726803263639,-0.0232656049234297,-0.00669471423549506,0.000395904830706344
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39673,-0.0115209191392036,0.00325155177245861,-0.0178939606132225,-0.0051478776651847,0.0003964323723439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37244,-0.0112494354706912,0.003178882468554,-0.0174800451090571,-0.00501882583232539,0.000403309805515556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,39842,-0.00927227635706379,0.0026294000848172,-0.0144259005233055,-0.00411865219082208,0.00042245454575448
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL24,C-C motif chemokine 24,39720,-0.0287285714873164,0.00815036554412937,-0.04470328795381,-0.0127538550208228,0.000424964855074883
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RYR1,Ryanodine receptor 1,36855,0.0119094317925793,0.00338622342646485,0.0052724338767082,0.0185464297084504,0.000437901913117374
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,36855,0.00909665268038904,0.00258882541462686,0.00402255486772039,0.0141707504930577,0.000443222805182229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37220,-0.0113323308190563,0.00326012001711307,-0.0177221660525979,-0.00494249558551467,0.000510479186025718
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39401,-0.019588077982674,0.00565050494749212,-0.0306630676797585,-0.00851308828558939,0.000528497102938429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,39817,0.00965772473297229,0.0027886485730446,0.00419197352980486,0.0151234759361397,0.000535136465938602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39266,-0.0161437959273699,0.00466375111571526,-0.0252847481141718,-0.00700284374056798,0.00053853569236089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39720,-0.0167340189288385,0.00484962693354611,-0.0262392877185888,-0.00722875013908809,0.000560842273657686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPS10,40S ribosomal protein S10,36855,0.0147870263180098,0.00429414686904025,0.00637049845469086,0.0232035541813287,0.000575982015018961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39754,0.0081588901503434,0.00238211880722321,0.00348993728818591,0.0128278430125009,0.000616225833186156
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK8,Kallikrein-8,39133,-0.0117713957724857,0.00343715412307382,-0.0185082178537104,-0.00503457369126105,0.000616981391640657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F3,Tissue factor,39737,0.00919758874821915,0.00269284350010061,0.00391961548802196,0.0144755620084163,0.000638085799370639
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39529,-0.00785000861183409,0.00230046432894781,-0.0123589186965718,-0.00334109852709638,0.000645661812956693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,39845,-0.0175992312379185,0.00517886985727541,-0.0277498161581783,-0.00744864631765869,0.000679773168004095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37005,-0.024249841729869,0.00713669956048748,-0.0382377728684245,-0.0102619105913135,0.000681049033241781
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,36896,-0.0106231838758322,0.00312682140093592,-0.0167517538216666,-0.00449461392999785,0.000682231832439295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL20,C-C motif chemokine 20,39865,-0.028230610322974,0.00832183106644704,-0.0445413992132102,-0.0119198214327378,0.000694622042604049
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ELAVL4,ELAV-like protein 4,36827,-0.0285704182823726,0.00842790168442224,-0.0450891055838401,-0.012051730980905,0.000701060809989251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39790,-0.0236622197787466,0.00698654829659121,-0.0373558544400654,-0.00996858511742787,0.000708772973530573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39288,-0.0171885392549737,0.00507960733050337,-0.0271445696227603,-0.00723250888718706,0.000716595176178163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37220,-0.0149989733218392,0.00443553384236148,-0.0236926196528677,-0.00630532699081067,0.000722850924753054
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",36880,-0.0308496060533262,0.00916128465905579,-0.0488057239850756,-0.0128934881215769,0.000761034163261962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLPS,Colipase,39646,0.0229385220742043,0.00683733090142179,0.0095373535074176,0.036339690640991,0.000795823402491783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD22,B-cell receptor CD22,39865,-0.0133187377004144,0.00396997451048187,-0.0210998877409588,-0.0055375876598699,0.000795875223627664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTP1,Glutathione S-transferase P,39207,0.0231296523692663,0.00689570354155893,0.00961407342781075,0.0366452313107217,0.000797840161350937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39673,-0.0203626870840309,0.00608584205163655,-0.0322909375052385,-0.00843443666282325,0.000822035899989857
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",36896,-0.0151792364168315,0.00454556176476793,-0.0240885374757766,-0.00626993535788635,0.000842091694783035
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37262,0.0360930795947682,0.0108383013117675,0.0148500090237039,0.0573361501658325,0.000870361107892887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH4,Myosin-4,36855,0.0158569825273357,0.00476475135504666,0.00651806987144427,0.0251958951832272,0.000877220837407837
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRDX2,Peroxiredoxin-2,37083,-0.02003899407481,0.00605832436652367,-0.0319133098331965,-0.00816467831642365,0.000943234869305626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSPN,Persephin,39673,-0.0308816278807945,0.00934313569929977,-0.0491941738514221,-0.012569081910167,0.000950945464746538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,36855,-0.0145589402078198,0.00441054574347999,-0.0232036098650406,-0.00591427055059907,0.000966216752506088
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39672,-0.00864520364147385,0.00262582110570445,-0.0137918130086546,-0.00349859427429313,0.000995607861102462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO1,R-spondin-1,39557,0.0114816786618769,0.00349019224076123,0.00464090186998485,0.0183224554537689,0.00100515847521377
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL22,Interleukin-22,37203,-0.0214821020458473,0.00653042049577894,-0.034281726217574,-0.0086824778741206,0.00100610063859575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36827,-0.0155331643339531,0.00472244089239163,-0.0247891484830407,-0.00627718018486554,0.00100731913746731
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37277,-0.0173896599536673,0.00528972825671758,-0.0277575273368338,-0.00702179257050085,0.0010136291824318
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI16,Peptidase inhibitor 16,37277,0.00781606857784072,0.00238354942250119,0.00314431170973839,0.0124878254459431,0.0010437729887322
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPB2,Coatomer subunit beta',36855,-0.0139944237453612,0.0042740506734753,-0.0223715630653728,-0.00561728442534963,0.00106209911883634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37005,-0.0150595857246922,0.00461362178228171,-0.0241022844179644,-0.00601688703142009,0.00110070911404274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,36855,0.018785242948404,0.00576651567283144,0.00748287222965436,0.0300876136671536,0.00112630377215172
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39535,-0.0189526652270964,0.00582301690061868,-0.030365778352309,-0.00753955210188379,0.00113719039727455
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,36896,0.00964068696008767,0.00296779100679177,0.0038238165867758,0.0154575573333995,0.00116333994323747
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39557,-0.0193794870925,0.00597255946270304,-0.031085703639398,-0.00767327054560205,0.00117798138681357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37151,0.00914758603965967,0.00282168911885302,0.00361707536670775,0.0146780967126116,0.00119035387543292
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP7,Retinoid-binding protein 7,37215,-0.019438185623268,0.00602012712122936,-0.0312376347808775,-0.00763873646565843,0.00124582301432063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39288,-0.0150750468889326,0.00466993531729034,-0.0242281201108217,-0.00592197366704354,0.00124873134942354
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39288,-0.0247963533844217,0.00772675587913026,-0.039940794907517,-0.00965191186132634,0.00133398155156005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK11,Kallikrein-11,39590,-0.00920919714651374,0.00287917839599843,-0.0148523868026707,-0.00356600749035683,0.00138394043147768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39738,0.00862927110636734,0.00270377330590317,0.00332987542679713,0.0139286667859375,0.00141779254405244
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37285,0.00607833541010681,0.00190714011731242,0.00234034078017446,0.00981633004003916,0.00144013069087566
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THBD,Thrombomodulin,39680,-0.00858044940450189,0.00269573027903327,-0.0138640807514071,-0.00329681805759667,0.00146050867210203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37104,-0.020070029958628,0.00631272147206375,-0.0324429640438729,-0.00769709587338305,0.00147971428732502
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36795,-0.02344581746446,0.00737511206953278,-0.0379010371207442,-0.00899059780817573,0.00148108958002298
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39383,-0.0106641509338845,0.00335893623356859,-0.0172476659516789,-0.00408063591609006,0.00150201847043797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL3,Myosin light chain 3,36880,-0.0230650132116984,0.00727295137778979,-0.0373199979121663,-0.00881002851123036,0.00152088576153615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PI3,Elafin,39407,-0.0166418935477989,0.00525353901352553,-0.0269388300143089,-0.00634495708128888,0.00153921190789141
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39680,0.00964413487808406,0.0030449771812531,0.00367597960282798,0.0156122901533401,0.00154192347029988
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39695,-0.00739675440910386,0.00233696687317425,-0.0119772094805254,-0.00281629933768234,0.00155318481627328
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37244,-0.0132135403733604,0.0041797996153496,-0.0214059476194456,-0.00502113312727516,0.00157424722796857
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAP,Prolyl endopeptidase FAP,39860,-0.0085620579251398,0.00270917267283175,-0.01387203636389,-0.00325207948638957,0.00157848557989492
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LXN,Latexin,39491,0.0209113198373755,0.00662066442533581,0.00793481756371732,0.0338878221110337,0.00158889156375493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37203,-0.0167383854628707,0.00534089166823763,-0.0272065331326165,-0.00627023779312497,0.00172811110821316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36827,0.0175661792328877,0.00562364789686264,0.00654382935503692,0.0285885291107385,0.00179030166191578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36795,0.0175160053498663,0.00561061350898794,0.00651920287224995,0.0285128078274827,0.00180058785761446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEK,Angiopoietin-1 receptor,39721,-0.00668859778319418,0.00214398015173956,-0.0108907988806037,-0.00248639668578463,0.00181353224480157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,36855,0.0157847510793744,0.00507350457415312,0.00584068211403428,0.0257288200447145,0.00186724372162614
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39401,-0.008818646553517,0.00283956145591366,-0.0143841870071078,-0.00325310609992623,0.00190211383801843
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39673,-0.0458117402013439,0.0147819289061511,-0.0747843208574001,-0.0168391595452877,0.00194402853406288
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37215,0.015349753689303,0.00495989822182405,0.00562835317452786,0.0250711542040781,0.00197371447737884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,39860,-0.00959905779758551,0.00310546593923369,-0.0156857710384835,-0.00351234455668748,0.00199812697760115
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39721,0.0138806586415903,0.00449075890879997,0.00507877118034233,0.0226825461028382,0.0019987076627157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39651,0.00959946012384902,0.00311320122289862,0.00349758572696773,0.0157013345207303,0.00204955169022518
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOL1,Apolipoprotein L1,37277,-0.0187610207526187,0.0060882322123086,-0.0306939558887435,-0.0068280856164938,0.00206362466581562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWF,von Willebrand factor,39860,0.0223192544561975,0.00724665693414685,0.00811580686526966,0.0365227020471253,0.00207394608501953
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39680,-0.00966061849455586,0.00314426418500576,-0.0158233762971672,-0.00349786069194457,0.00212664707656485
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLC,Galectin-10,39653,0.0202674121841548,0.00660759406768828,0.00731652781148574,0.0332182965568238,0.00216374036544315
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN4,Cerebellin-4,39836,-0.00940676178860764,0.00306790351173186,-0.0154198526716021,-0.00339367090561319,0.00217170708926701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG1,Arginase-1,39564,-0.0156784617821272,0.00511512629791969,-0.0257041093260498,-0.00565281423820465,0.00217953882180956
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37215,-0.0117982046698173,0.00385313968367814,-0.0193503584498264,-0.00424605088980811,0.00220321347578786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRH,Corticoliberin,39266,-0.0263155594878862,0.00860750223648979,-0.0431862638714062,-0.00944485510436624,0.0022373694006647
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37220,0.0127503541275207,0.00417597312884352,0.00456544679498735,0.020935261460054,0.00226810821630313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37244,0.0112072804190458,0.00367677246835688,0.00400080638106636,0.0184137544570253,0.00230719542056772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39721,0.00861097367018281,0.00282807581681874,0.00306794506921809,0.0141540022711475,0.00233203566257761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36827,0.00857199404074859,0.00281554964969459,0.0030535167273472,0.01409047135415,0.00233520080227026
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37203,-0.0110745040294414,0.00363964144940962,-0.0182082012702843,-0.00394080678859859,0.00234886017372534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",36855,-0.0192090453266359,0.00632190996076167,-0.0315999888497287,-0.00681810180354299,0.00238241111506127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37244,-0.00832037774027185,0.00274071419253604,-0.0136921775576425,-0.00294857792290122,0.00240325397221932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A16,Protein S100-A16,39269,-0.0187188218977079,0.00616885646504055,-0.0308097805691874,-0.00662786322622846,0.00241410651932064
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37220,-0.0210448617918502,0.00694131211137869,-0.0346498335301525,-0.00743989005354799,0.00243543826276289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,39865,-0.0125670852147194,0.00414579119812178,-0.0206928359630381,-0.00444133446640077,0.00243902499734107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,36958,-0.00767985285029755,0.00253440323276112,-0.0126472831865093,-0.00271242251408576,0.00244835349459838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANK2,Ankyrin-2,36855,0.0214777849332956,0.00709670508830331,0.00756824296022112,0.0353873269063701,0.00247932540890388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39401,-0.0118481260513517,0.00392114433971706,-0.0195335689571972,-0.00416268314550628,0.00251852492629513
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DAND5,DAN domain family member 5,36896,0.0161720939621621,0.00535432680737398,0.0056776134197091,0.0266665745046151,0.00252947963824789
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH6,Cadherin-6,39680,0.0113849548201007,0.00377099879571987,0.00399379718048975,0.0187761124597117,0.00253945888465197
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39594,-0.0101667284855752,0.00336832625860707,-0.016768647952445,-0.00356480901870532,0.00254576786988431
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39401,-0.00915469078222902,0.00303941513162472,-0.0151119444402135,-0.00319743712424457,0.0025995778799063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39743,-0.00999683300585747,0.00332653921284476,-0.0165168498630332,-0.00347681614868173,0.00265842206956368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37215,-0.00765843379001782,0.00254874194785456,-0.0126539680078128,-0.00266289957222287,0.00266257559703932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39557,0.0146444846553674,0.0048987782646456,0.00504287925666202,0.0242460900540728,0.0027994458359907
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36827,0.0212860976052837,0.00712325643138149,0.00732451499977599,0.0352476802107915,0.00281101996694507
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDM1,Nuclear protein MDM1,36877,-0.00936741569398083,0.00313564931077638,-0.0155132883431025,-0.00322154304485913,0.00281892479309298
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH12,Protocadherin-12,37244,-0.00752232712685976,0.00252363886754108,-0.0124686593072403,-0.00257599494647924,0.00288063916370936
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,36896,-0.0164308477380265,0.00551670527721785,-0.0272435900813735,-0.00561810539467951,0.00290309303837349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,36877,0.0108752060038282,0.00366281367281209,0.00369609120511653,0.0180543208025399,0.00299232053194847
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIM,Vimentin,39401,-0.0344258899416786,0.0115995155344079,-0.0571609403891181,-0.0116908394942391,0.00300325124415795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39675,-0.00869363404770731,0.00293440888976957,-0.0144450754716557,-0.00294219262375896,0.00305454459640253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37215,-0.023286510637021,0.00789485462752374,-0.0387604257069676,-0.00781259556707449,0.00318757279868534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39680,0.00995927214101164,0.00337711154204849,0.00334013351859661,0.0165784107634267,0.00319218268989793
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39780,0.00667887781600354,0.00227415936037919,0.00222152546966033,0.0111362301623467,0.00332033122459803
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRL,Appetite-regulating hormone,39680,-0.0223169223079741,0.00760473247546658,-0.0372221979598886,-0.00741164665605965,0.00334447275901396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39668,0.00963735431988103,0.00329306099956869,0.00318295476072639,0.0160917538790357,0.00343216748935027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFRC,Transferrin receptor protein 1,39726,0.0112962087876766,0.00386236078718967,0.0037259816447849,0.0188664359305684,0.00345287250811732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRNN,Cornulin,39207,0.0187402434166607,0.00641887490401388,0.0061592486047935,0.0313212382285279,0.00351043741550744
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,36855,-0.0253873589496326,0.00869820084867735,-0.0424358326130402,-0.00833888528622505,0.00352107558402368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39557,0.00811443381305877,0.00278958643884677,0.0026468443929191,0.0135820232331985,0.00363292410844703
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMH,Granzyme H,39401,-0.0216976972516644,0.00746813332322915,-0.0363352385651936,-0.00706015593813529,0.00367335509894329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37277,0.0179179954813315,0.00616855554114381,0.00582762662068966,0.0300083643419734,0.00368168728883053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39756,0.00581758009367261,0.00200287690385581,0.00189194136211522,0.00974321882523,0.00368215296753056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,36880,-0.0280350083814048,0.00965796299066228,-0.0469646158431029,-0.00910540091970675,0.00370478925132119
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39401,-0.0121080056955329,0.00417335381133233,-0.0202877791657443,-0.00392823222532156,0.00372180846958353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37215,-0.00722255179623402,0.00249108796184798,-0.0121050842014561,-0.00234001939101198,0.00374538766142205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLHL41,Kelch-like protein 41,37244,-0.0148211402027636,0.00511239000046671,-0.0248414246036784,-0.0048008558018489,0.00374887987667794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LPO,Lactoperoxidase,39156,-0.0171212735765841,0.00591295268841142,-0.0287106608458705,-0.00553188630729771,0.00379025716654399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD59,CD59 glycoprotein,38989,-0.00606701439931884,0.00209603509838971,-0.0101752431921627,-0.001958785606475,0.00380282125715854
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CABP2,Calcium-binding protein 2,36877,-0.0190554570841181,0.00658850134220967,-0.0319689197148491,-0.00614199445338715,0.00383152232594248
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG3,Desmoglein-3,39770,-0.00954300946537684,0.00330426325710704,-0.0160193654493066,-0.00306665348144703,0.00388111578193777
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RSPO3,R-spondin-3,39836,-0.00770120705236092,0.002668842674587,-0.0129321386945514,-0.0024702754101704,0.00391193711076218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37203,-0.0151477587412735,0.00525220700073761,-0.0254420844627192,-0.0048534330198278,0.00393193226169464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC1,Sialoadhesin,39743,-0.0119062616966338,0.00412913662998248,-0.0199993694913995,-0.00381315390186815,0.00393842124789531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD5L,CD5 antigen-like,37213,0.0134318521407985,0.00466396388080674,0.00429048293441728,0.0225732213471797,0.00398406059369449
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,36855,0.00885327385356316,0.00307610441657254,0.00282410919708099,0.0148824385100453,0.00400756171173562
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C8B,Complement component C8 beta chain,37285,0.00869592288425681,0.00302414513715583,0.00276859841543138,0.0146232473530822,0.00404025297148704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLASP1,CLIP-associating protein 1,36795,-0.0210000421906354,0.00730670470989018,-0.0353211834220202,-0.00667890095925069,0.00405868610849573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,36877,-0.0223262073777778,0.0077738321067952,-0.0375629183070964,-0.00708949644845922,0.00408581283803537
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNM1,Dynamin-1,37215,-0.0328251890507404,0.011446134619543,-0.0552596129050447,-0.010390765196436,0.00413987974021421
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,39860,0.00443077961699763,0.00155320349571383,0.00138650076539854,0.00747505846859673,0.00434089659370123
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37080,0.00230078892252045,0.000806665535646959,0.000719724472652407,0.00388185337238849,0.00434821398469715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HCG22,Protein PBMUCL2,36855,0.0154868839544304,0.00543261495570855,0.00483895864124162,0.0261348092676191,0.00436885467990935
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39302,-0.00983827981477793,0.00346888761203777,-0.0166372995343719,-0.00303926009518391,0.0045720623927603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD300LF,CMRF35-like molecule 1,39836,-0.0167515244408636,0.0059143607460415,-0.0283436715031049,-0.00515937737862222,0.00462654224856245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36827,0.0173976745641623,0.00615659024098279,0.00533075769183602,0.0294645914364886,0.00472256587750179
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCLRE1C,Protein artemis,36795,0.00873790553649921,0.00309301588743047,0.0026755943971355,0.0148002166758629,0.00473465206332187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39743,0.00783951015664139,0.00278443985082289,0.00238200804902852,0.0132970122642543,0.00487657479824654
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRG,Histidine-rich glycoprotein,37213,-0.00886896689575334,0.00315333353349171,-0.0150495006213971,-0.00268843317010959,0.00492192694909758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VGF,Neurosecretory protein VGF,37244,-0.00818455370291746,0.00291431871932176,-0.0138966183927881,-0.00247248901304681,0.00498614617866705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36795,-0.00829066615739276,0.00295676442893912,-0.0140859244381134,-0.00249540787667208,0.00505534870688039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REST,RE1-silencing transcription factor,36795,0.00987611709287826,0.00355335998612044,0.0029115315200822,0.0168407026656743,0.00545423620453991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,39817,0.00737267945679735,0.00265466645945507,0.00216953319626541,0.0125758257173293,0.00548845145698878
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37220,-0.0153380430048053,0.00553323805367178,-0.026183189590002,-0.00449289641960863,0.00557930326112057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37268,-0.00764060895522893,0.00275746573091574,-0.0130452417878238,-0.00223597612263407,0.00559818787861689
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMA1,Laminin subunit alpha-1,36855,0.0149888945861085,0.00542724699355441,0.00435149047874184,0.0256262986934751,0.00575668800917972
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PVALB,Parvalbumin alpha,39777,-0.0311944739158778,0.0113062722986976,-0.0533547676213251,-0.0090341802104304,0.00580374061886417
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37005,-0.0121039947640092,0.00439235804827917,-0.0207130165386364,-0.00349497298938202,0.00586484257742632
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,36880,0.00717626732343109,0.00260566386073029,0.00206916615639972,0.0122833684904625,0.00589348653991924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39302,-0.01049777292192,0.00381508961345585,-0.0179753485642935,-0.00302019727954656,0.00593658828318201
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN2,Prefoldin subunit 2,39302,-0.0152105753438338,0.00554130123317852,-0.0260715257608637,-0.00434962492680387,0.00605907291260296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,36877,-0.0100111684379884,0.00364922769407667,-0.0171636547183787,-0.00285868215759812,0.00608960279719303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRG3,Proteoglycan 3,37267,0.0136430906291209,0.00497429484493885,0.00389347273304075,0.023392708525201,0.0061013789417555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39799,-0.00691334924088842,0.00252173284013338,-0.0118559456075498,-0.001970752874227,0.00612261699595131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39302,-0.0384899120014269,0.01404164489653,-0.0660115359986258,-0.0109682880042281,0.00612995293473124
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39643,-0.00960120876180145,0.00351418922142018,-0.016489019635785,-0.0027133978878179,0.00629969999392904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C5,Complement C5,37285,-0.00414555377799399,0.00151790302880807,-0.0071206437144578,-0.00117046384153018,0.00632046281800383
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37189,-0.0098554236570813,0.00360895937126097,-0.0169289840247528,-0.00278186328940981,0.00632597490772658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SELENOP,Selenoprotein P,37285,0.00605082832754004,0.0022161295658059,0.00170721437856049,0.0103944422765196,0.00633480058607096
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36827,0.0103591344843007,0.00379519374306639,0.00292055474789053,0.0177977142207108,0.00635082532763265
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,36896,0.0117802950876292,0.00431864089462051,0.00331575893417296,0.0202448312410853,0.00638478107457888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39809,-0.00818087099801603,0.0030000435063114,-0.0140609562703864,-0.00230078572564567,0.00639989082758574
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG1A,Lithostathine-1-alpha,39614,-0.0125431763396367,0.00460875495168609,-0.0215763360449414,-0.00351001663433191,0.0065038590932863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37244,-0.00935537363976827,0.0034483189984212,-0.0161140788766738,-0.00259666840286271,0.00667574631548447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39658,-0.00846756379688431,0.00313645101024525,-0.014615007776965,-0.00232011981680362,0.00694701156037005
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",36877,-0.0105851087980332,0.00392534487470944,-0.0182787847524637,-0.00289143284360272,0.0070140217114951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCN5,CCN family member 5,39668,-0.0102655774945369,0.00380851816729558,-0.0177302731024362,-0.00280088188663757,0.00703731296077273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNW1,Interferon omega-1,36855,0.00953526822253302,0.00353978742745098,0.0025972848647291,0.0164732515803369,0.00707459009419823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STC2,Stanniocalcin-2,39641,-0.00704186287042152,0.00261576365518327,-0.0121687596345807,-0.00191496610626232,0.0071081362448347
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RTKN2,Rhotekin-2,36855,0.0139811536548655,0.00519434767684207,0.00380023220825503,0.0241620751014759,0.00711992700978954
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPE4,NXPE family member 4,36855,0.009398192980268,0.00349570938510857,0.00254660258545521,0.0162497833750808,0.00718666848524515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39675,-0.0779997499030747,0.0290815823661524,-0.134999651340733,-0.020999848465416,0.00732372958856168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36795,-0.00968677527876624,0.00361499473209355,-0.0167721649536696,-0.00260138560386288,0.00738013293972918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39680,-0.00467208088302722,0.00174364322407466,-0.00808962160221354,-0.0012545401638409,0.00738099078272728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUCL3,Mucin-like protein 3,36795,0.0120279123014146,0.00448885354078863,0.00322975936146894,0.0208260652413604,0.00738240869169736
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CENPJ,Centromere protein J,37005,-0.0194782960361355,0.00728026551114015,-0.0337476164379702,-0.00520897563430085,0.00747119710911878
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",36880,-0.0208377121024599,0.00778861159993229,-0.0361033908383272,-0.00557203336659263,0.00747317405186121
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39743,0.0112606231983073,0.00420916767340175,0.00301065455843985,0.0195105918381747,0.0074747562895578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39401,-0.0150284823696797,0.00563053663665135,-0.0260643341775164,-0.00399263056184308,0.00761331237623666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,36855,-0.0127069344864711,0.00477068136643252,-0.0220574699646788,-0.00335639900826335,0.00774169385916607
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB6,Integrin beta-6,39401,-0.00782251386448505,0.00294005787630295,-0.0135850273020388,-0.00206000042693126,0.00780662308023563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39060,-0.0161783757134836,0.00609032460496413,-0.0281154119392133,-0.00424133948775394,0.00790608980196577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,36896,0.00773893558363877,0.00291630990668693,0.00202296816653239,0.0134549030007451,0.00797173096941187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39594,-0.0151435192366857,0.00570777285635609,-0.0263307540351436,-0.00395628443822776,0.00798269274380798
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN15,Tetraspanin-15,36855,0.0130625822861692,0.00492676880176257,0.0034061154347146,0.0227190491376239,0.00802682676760239
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL4,Delta-like protein 4,36880,-0.0228793277236933,0.00864501690989426,-0.039823560867086,-0.00593509458030055,0.00814192497320222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",36855,0.0125658494804583,0.00476144681986211,0.00323341371352857,0.021898285247388,0.0083230013707808
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39668,-0.00877805713858348,0.00333161499420404,-0.0153080225272234,-0.00224809174994356,0.00842750761966939
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,36855,0.00992608142056145,0.00376737693678754,0.00254202262445788,0.017310140216665,0.00843001351177522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD82,CD82 antigen,37005,0.0111139789009002,0.00421936008257104,0.00284403313906091,0.0193839246627394,0.00844734715685778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB7,Integrin beta-7,39836,0.0118541034443815,0.00450514608756587,0.00302401711275235,0.0206841897760106,0.00851565783002852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36795,-0.0227270061245926,0.00865081567126033,-0.0396826048402629,-0.00577140740892237,0.00862044648781241
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATXN2,Ataxin-2,36827,-0.0291042191569459,0.0111243243900898,-0.0509078949615219,-0.00730054335236984,0.0088999685943396
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCA2A,Guanylin,39607,-0.00834646218922914,0.003191637617501,-0.0146020719195311,-0.00209085245892717,0.00892854763377739
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,36877,0.0113226513693338,0.00433107137773645,0.00283375146897038,0.0198115512696972,0.00895176108173368
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36827,0.0157161712879243,0.00601973014162051,0.00391750021034815,0.0275148423655005,0.00904407983835728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH17,Protocadherin-17,39680,-0.00905066950861147,0.00346798284541461,-0.0158479158856241,-0.00225342313159883,0.00906860059426456
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36A,Interleukin-36 alpha,36896,0.0151900106268296,0.00582574055016804,0.00377155914850029,0.026608462105159,0.00913378103909961
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39615,-0.0482575522195785,0.0185118966908098,-0.0845408697335658,-0.0119742347055913,0.00914681298945797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLI2,Zinc finger protein GLI2,36896,0.00891288622858637,0.00343443447376182,0.00218139466001319,0.0156443777971595,0.00946544815345059
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39401,0.015500247056466,0.0060063741891734,0.00372775364568615,0.0272727404672459,0.00987102215692728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,36896,0.00560746517913188,0.0021732511174952,0.0013478929888413,0.00986703736942247,0.00988458695375572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GM2A,Ganglioside GM2 activator,37011,-0.00925185546196009,0.003605768376462,-0.0163191614798256,-0.00218454944409456,0.0103033542223825
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37005,0.0159866417188973,0.00623255333212815,0.00377083718792611,0.0282024462498684,0.0103278974020952
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39716,-0.0162948378490205,0.00635709091117725,-0.028754736034928,-0.00383493966311314,0.0103787597223494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37202,-0.00940251748673312,0.00366985852908886,-0.0165954402037473,-0.00220959476971894,0.0104152380926257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRTAP,Cartilage-associated protein,36877,-0.0126690006411154,0.00494579305929976,-0.0223627550373429,-0.00297524624488783,0.0104311526137717
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,YY1,Transcriptional repressor protein YY1,36896,0.00709105302550503,0.0027706910179396,0.00166049863034342,0.0125216074206666,0.010499246155245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBLN1,Cerebellin-1,36827,0.0246351598969582,0.00962876346073884,0.00576278351391011,0.0435075362800064,0.0105238372084215
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYMP,Thymidine phosphorylase,39579,-0.0171853143510513,0.00672074087885,-0.0303579664735973,-0.00401266222850525,0.0105655114933125
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39680,-0.0111701341754688,0.00437568451411458,-0.0197464758231334,-0.00259379252780427,0.0106961827815237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37203,-0.017123114116671,0.0067110249828541,-0.030276723083065,-0.00396950515027696,0.0107373893473905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37203,-0.00723355094489766,0.00283834829071823,-0.0127967135947054,-0.00167038829508992,0.0108296090306832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,36958,-0.00716507843215889,0.00281192885973726,-0.0126764589972439,-0.00165369786707385,0.0108424311448407
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD27,CD27 antigen,39721,-0.00980187586631188,0.00384793325017371,-0.0173438250366524,-0.00225992669597141,0.0108650752361443
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCL28,C-C motif chemokine 28,39622,-0.0150525528216088,0.00591022072213852,-0.0266365854370003,-0.0034685202062173,0.0108788707798253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,36877,-0.00750494295753177,0.00294722231682503,-0.0132814986985088,-0.00172838721655472,0.0108940148957367
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR15L,Protein GPR15L,37215,-0.0155691360494548,0.00612658761023179,-0.0275772477655091,-0.00356102433340046,0.0110571846010264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39288,0.00812261805412379,0.00320205086950558,0.00184659834989285,0.0143986377583547,0.011200293434772
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39673,0.0103045069726951,0.00406394673275693,0.00233917137649151,0.0182698425688987,0.0112353212610307
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,36896,-0.010948240860603,0.0043233752719827,-0.0194220563936891,-0.00247442532751695,0.0113421571721635
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSR,Insulin receptor,36896,-0.00419405380870721,0.00166011671626008,-0.00744788257257697,-0.000940225044837452,0.0115368424304863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39302,-0.0068091137749442,0.00270038173082718,-0.0121018619673655,-0.00151636558252292,0.0116942999980194
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36827,0.008670529180542,0.00344477396110167,0.00191877221678272,0.0154222861443013,0.0118475198892294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMBN,Ameloblastin,39401,0.00710657399750484,0.00282673742651168,0.00156616864154195,0.0126469793534677,0.011945195306825
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37268,0.00828034178176171,0.00329651310565219,0.00181917609468342,0.01474150746884,0.0120217128324733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,36958,-0.00911871013502731,0.00363224510901138,-0.0162379105486896,-0.001999509721365,0.0120683707715311
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,36958,-0.0131912528098531,0.00526728483108197,-0.0235151310787737,-0.00286737454093242,0.0122788735157437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,36896,-0.00960091822655604,0.00383432801042713,-0.0171162011269932,-0.00208563532611887,0.0122940881561697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTN,Pleiotrophin,39401,-0.0124691354683251,0.00498577085966529,-0.0222412463532691,-0.00269702458338113,0.0123964733189982
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH22,Cadherin-22,37005,0.00724241711327282,0.00289712809506395,0.00156404604694748,0.0129207881795982,0.0124362985678667
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1,DNA topoisomerase 1,37215,-0.0283652809824992,0.0113498706181282,-0.0506110273940304,-0.0061195345709679,0.0124602914842218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRN,Progranulin,39597,-0.00610052787404548,0.00244511489228934,-0.0108929530629326,-0.00130810268515837,0.0126063705354365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39720,-0.0120686423321921,0.00486591480088684,-0.0216058353419303,-0.00253144932245391,0.013139651355612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSG1,Tryptase gamma,36896,0.00664218133113797,0.00268575455226989,0.001378102408689,0.011906260253587,0.0134067354546934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,36855,0.00813815172468733,0.00329078594980183,0.00168821126307574,0.0145880921862989,0.0134106747122824
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39594,-0.00933860211632973,0.00378969766488219,-0.0167664095394988,-0.00191079469316064,0.0137422628409688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN2,Neuroligin-2,36827,0.0116143930519593,0.00472259406545238,0.00235810868367261,0.0208706774202459,0.0139328204080783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39401,0.00776014862993648,0.00315708716875447,0.00157225777917773,0.0139480394806952,0.0139818013254951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AFP,Alpha-fetoprotein,39508,-0.0163895232033098,0.00669787594319545,-0.0295173600519729,-0.00326168635464676,0.0144170737444056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,36877,-0.0133263363668721,0.00544694273360618,-0.0240023441247402,-0.00265032860900403,0.0144353426709937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39288,-0.0118500759574474,0.00488435402298083,-0.0214234098424898,-0.00227674207240496,0.0152722045345796
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1A,Protein phosphatase 1A,39288,-0.00733012587702519,0.00302802652996806,-0.0132650578757626,-0.00139519387828779,0.015499559653799
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADA2,Adenosine deaminase 2,39591,0.00985253648619373,0.00408647179195776,0.00184305177395652,0.0178620211984309,0.0159196706087609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39385,0.00715122012011268,0.00297832995190116,0.00131369341438641,0.0129887468258389,0.016358274432938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37267,0.00706880303042899,0.00295369454721112,0.00127956171789521,0.0128580443429628,0.0167154756930209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39288,-0.00842518090224205,0.00352377941352956,-0.01533178855276,-0.00151857325172412,0.0168167468141674
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36795,0.00800509018817825,0.00334905806475825,0.00144093638125208,0.0145692439951044,0.0168510716856264
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39171,0.0201404522841,0.00843284212196664,0.00361208172504541,0.0366688228431546,0.0169369475418903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39668,0.00574303482463923,0.00241532125862742,0.00100900515772948,0.010477064491549,0.017430358410567
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36827,0.0149295820055069,0.00628285843723713,0.00261517946852216,0.0272439845424917,0.0175045003721438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,36896,-0.00896421485547548,0.00377898560651426,-0.0163710266442434,-0.00155740306670753,0.0177006836062761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37244,-0.00659655222335547,0.00278230136303777,-0.0120498628949095,-0.00114324155180144,0.017759015509418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37220,-0.00662397311300343,0.00280031082586493,-0.0121125823316987,-0.00113536389430816,0.0180227585136946
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF5,Fibroblast growth factor 5,39401,0.0077458946517324,0.00327575105400333,0.00132542258588587,0.0141663667175789,0.0180609736170145
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39668,-0.0103105378306962,0.00436357324900485,-0.0188631413987457,-0.00175793426264667,0.0181462750168304
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39302,-0.0128160990909979,0.00542721374480546,-0.0234534380308166,-0.00217876015117917,0.0182159243192016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EVI2B,Protein EVI2B,36795,0.00972368757356192,0.00412177017122952,0.00164501803795206,0.0178023571091718,0.0183338640698856
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_DRA,,39606,0.00829531194391681,0.00351708461246648,0.0014018261034825,0.0151887977843511,0.0183573435509195
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37005,-0.0152702894867814,0.00648514906996615,-0.027981181663915,-0.0025593973096477,0.0185545260845899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36765,-0.0205806194574425,0.0087681627590886,-0.0377662184652561,-0.00339502044962882,0.018930197899425
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37268,-0.0171787170965957,0.00732909163152913,-0.0315437366943928,-0.00281369749879857,0.0190973958514393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,36855,0.00809147830866444,0.00345212607767437,0.00132531119642267,0.0148576454209062,0.0190976780379783
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,39860,0.0136010603316079,0.00581920445072973,0.00219541960817765,0.0250067010550382,0.019437340699011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39302,-0.0108738441503609,0.00465339288884205,-0.0199944942124913,-0.00175319408823051,0.0194645872907571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN2,Transcobalamin-2,39820,0.00677299648172231,0.00289929285085281,0.00109038249405081,0.0124556104693938,0.0194990908536228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,36880,-0.00841523643321685,0.00360708567792738,-0.0154851243619545,-0.00134534850447918,0.0196646700433375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL3,Interleukin-3,36795,0.013778649925275,0.00591009195205243,0.00219486969925221,0.0253624301512977,0.019748790343523
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39401,-0.0139497760193409,0.00599229021180425,-0.0256946648344772,-0.00220488720420457,0.0199273135661147
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPN1,Epsin-1,37005,-0.010012366646767,0.00430473412469963,-0.0184496455311782,-0.00157508776235568,0.0200391967637208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,36855,0.0120452189171632,0.00518314811632053,0.001886248609175,0.0222041892251515,0.0201451512059877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CBX2,Chromobox protein homolog 2,36855,0.00938812415548808,0.00404041637592764,0.0014689080586699,0.0173073402523063,0.0201647780790314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTL1,Cytokine-like protein 1,37267,0.00529085077229522,0.00228022488052778,0.000821610006460759,0.00976009153812967,0.0203385203384734
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37244,-0.0162543619398441,0.00702288600444719,-0.0300192185085605,-0.00248950537112758,0.0206562113243618
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37005,-0.016208907630919,0.00701152930782354,-0.0299515050742531,-0.00246631018758486,0.0208068087679869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,39836,0.0136893260473139,0.00593450435118793,0.00205769751898561,0.0253209545756423,0.0210823534952904
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37244,0.0109450201896262,0.00475204152135135,0.00163101880777757,0.0202590215714748,0.0212814498008441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENSA,Alpha-endosulfine,37203,-0.0120483604207055,0.00524515095425596,-0.0223288562910472,-0.00176786455036377,0.0216314749615797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39401,-0.00608174084452121,0.00266183845464393,-0.0112989442156233,-0.000864537473419107,0.0223385802842016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRTN,Neurturin,39401,-0.0112480632559589,0.00492540736696906,-0.0209018616952183,-0.00159426481669957,0.0224036669306063
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37203,-0.00958667051904196,0.00419905359461302,-0.0178168155644835,-0.00135652547360043,0.0224427788062531
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39557,-0.00868221055283853,0.00381059259539357,-0.0161509720398099,-0.00121344906586714,0.0227136871324986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,39860,0.00929832944360681,0.00408393230596796,0.00129382212390961,0.017302836763304,0.0228108418670569
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36795,0.00587497981052056,0.00258814843265249,0.00080220888252168,0.0109477507385194,0.0232267103586663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37005,0.00998696777490017,0.0044032439882275,0.00135660955797427,0.0186173259918261,0.0233396786411834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39401,0.00805860308193123,0.00355606322229182,0.00108871916623928,0.0150284869976232,0.0234553679487956
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10,Interleukin-10,39401,-0.0177858010734585,0.00785696163719849,-0.0331854458823675,-0.00238615626454946,0.0236063230115053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TJP3,Tight junction protein ZO-3,36827,0.00981907469745314,0.00433813097584852,0.00131633798479003,0.0183218114101162,0.0236253838434176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD109,CD109 antigen,39668,0.00756072586370488,0.00334086181646521,0.00101263670343306,0.0141088150239767,0.0236426331136852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37244,0.00979709004375426,0.00433001898847991,0.00131025282633364,0.0182839272611749,0.0236764723958476
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",36855,-0.00895834678808832,0.00396346270108152,-0.0167267336822081,-0.00118995989396854,0.0238233098044187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39594,-0.00689400070760625,0.00305162098382015,-0.0128751778358938,-0.000912823579318751,0.0238890843779755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,36896,0.0107803970732132,0.00477729561225216,0.00141689767319899,0.0201438964732274,0.0240502025057852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39561,0.00517701305545764,0.00229612364426219,0.00067661071270375,0.00967741539821153,0.0241674427320755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLINT1,Clathrin interactor 1,36795,0.0110090158966154,0.00488505189072749,0.00143431419078954,0.0205837176024413,0.0242372047295313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,36896,0.012321929882349,0.00546960866484994,0.00160149689924312,0.0230423628654549,0.0242883723500991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PODXL,Podocalyxin,39594,0.0033582606462693,0.00149154506391055,0.00043483232100461,0.00628168897153398,0.0243656332383041
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,36896,0.00970309772283334,0.00431013625424966,0.001255230664504,0.0181509647811627,0.0243877110555196
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36795,0.0108904244994751,0.00483892376509136,0.00140613391989602,0.0203747150790542,0.0244283611552027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37215,0.012027441915185,0.00534991525996438,0.00154160800565485,0.0225132758247152,0.0245825126991103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,36877,0.00712062837575714,0.00317497485613517,0.000897677657732218,0.0133435790937821,0.0249306450438399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QL2,Complement C1q-like protein 2,36896,0.00934398449814102,0.00416886777490358,0.00117300365933001,0.017514965336952,0.0250187328041387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESPL1,Separin,36795,0.0120449570166699,0.00537422424424001,0.00151147749795944,0.0225784365353803,0.0250270563737593
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37220,-0.0128593021114257,0.00575109368705331,-0.0241314457380502,-0.00158715848480125,0.0253698499875414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",36855,0.0096944138618883,0.00433918269933064,0.00118961577120025,0.0181992119525763,0.025489707779118
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC16,Mucin-16,39594,-0.0412228075240839,0.0184524969777553,-0.0773897016004842,-0.00505591344768354,0.0254973182651934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OTOA,Otoancorin,36827,0.0118318237901138,0.00529932371501607,0.00144514930868225,0.0222184982715453,0.0255854409895351
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39594,0.00459735467752718,0.0020660866772089,0.00054782479019773,0.00864688456485662,0.0260852297410589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRELP,Prolargin,39675,0.00487927504585746,0.002197457555374,0.000572258237324414,0.0091862918543905,0.026404501120201
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP350,Centrosome-associated protein 350,36795,0.00798719417048972,0.0036014367512809,0.000928378137979149,0.0150460102030003,0.0265871483164198
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17A,Interleukin-17A,39373,-0.00929939626224317,0.00420041934728819,-0.017532218182928,-0.00106657434155831,0.0268487071572818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,36896,-0.00687372038650188,0.0031136719362632,-0.0129765173815778,-0.000770923391426008,0.0272900082435014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39182,-0.00797280860375152,0.00361313945722867,-0.0150545619399197,-0.000891055267583331,0.0273557276809959
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39401,-0.00743656042536631,0.00339794370717305,-0.0140965300914255,-0.000776590759307138,0.0286445927850447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNA1,Ephrin-A1,39636,-0.0056894371337404,0.00260662231190307,-0.0107984168650704,-0.000580457402410369,0.0290736602061701
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39302,-0.00654990296584488,0.00300538897523054,-0.0124404653572967,-0.000659340574393028,0.0293180566534977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCGB1A1,Uteroglobin,39715,0.0117561402761481,0.00540113338609266,0.0011699188394065,0.0223423617128897,0.0295246700235683
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39697,-0.0071140804645903,0.00327351878944205,-0.0135301772918967,-0.000697983637283884,0.0297784425173187
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRTN3,Myeloblastin,39236,-0.009913454458741,0.00456820271397783,-0.0188671317781375,-0.000959777139344465,0.0300145669627262
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRL,Prolactin,39817,0.0162852182128335,0.00750965015337396,0.00156630391222056,0.0310041325134465,0.0301299052643976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,36896,-0.0139020254018586,0.0064374210614471,-0.026519370682295,-0.00128468012142232,0.0308245831893829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37285,-0.00374427159358706,0.00174618058236115,-0.00716678553501492,-0.000321757652159203,0.0320296667316601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36827,-0.0132125796129525,0.00616458760684704,-0.0252951713223727,-0.00112998790353227,0.0321073192597319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEFL,Neurofilament light polypeptide,39251,-0.00923735522157998,0.00432152480110471,-0.0177075438317452,-0.00076716661141475,0.0325712517577382
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSB,Lupus La protein,39302,-0.0128645463941471,0.00603705088555061,-0.0246971661298263,-0.00103192665846793,0.033110475568294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,36855,0.00693166585053966,0.00326833616749106,0.000525726962257178,0.0133376047388221,0.0339529237108094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP6,Guanylate-binding protein 6,36855,0.00973415267699285,0.00459383655783938,0.000730233023627663,0.018738072330358,0.0341128233536612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39401,0.00820345593384948,0.00387517407924673,0.0006081147385259,0.0157987971291731,0.0342819921057538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,39817,0.00934855707919914,0.00441733254208253,0.000690585296717377,0.0180065288616809,0.0343317350896009
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTNNA1,Catenin alpha-1,36827,0.00742482502625933,0.00350896187340003,0.000547259754395272,0.0143023902981234,0.0343671665625447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLN,Mesothelin,39573,-0.0110232123947431,0.00521306564112752,-0.021240821051353,-0.000805603738133183,0.0344852599478458
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37244,-0.0136825083561005,0.00649291943832328,-0.0264086304552142,-0.00095638625698689,0.0351104135359917
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,36877,0.0131756217637965,0.0062701712626195,0.000886086089062257,0.0254651574385307,0.0356322620015336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39401,-0.0121339623404885,0.00580569292933506,-0.0235131204819852,-0.000754804198991809,0.0366330206216283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,F11,Coagulation factor XI,37082,-0.00652181640563953,0.00312557072548916,-0.0126479350275983,-0.000395697783680764,0.0369434027248528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",36855,0.0129006825550291,0.00619856723041731,0.000751490783411198,0.0250498743266471,0.0374318216508191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRUNE2,Protein prune homolog 2,37005,-0.00592877018685916,0.00285903547546574,-0.011532479718772,-0.000325060654946307,0.0381269875894686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERVV_1,,36855,0.0099230381857339,0.00480143759961127,0.000512220490495813,0.019333855880972,0.0387840176394669
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMCN2,Hemicentin-2,36934,-0.0117075043560955,0.00567990677223959,-0.0228401216296851,-0.00057488708250592,0.039302339887877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39636,-0.00457375787096524,0.00222412397079563,-0.00893304085372468,-0.0002144748882058,0.0397573847078618
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PMCH,Pro-MCH,36855,0.0169507062595033,0.00824812443658936,0.000784382363788208,0.0331170301552185,0.0398894577499997
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37267,-0.00455615461978419,0.00221998717846759,-0.00890732948958067,-0.000204979749987704,0.040156610318545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36827,0.0125331165461625,0.00611360991318977,0.000550441116310566,0.0245157919760144,0.0403810452772131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF20,Fibroblast growth factor 20,36896,0.00875521759575574,0.00428858431452434,0.000349592339288024,0.0171608428522235,0.0412195606328834
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36795,-0.00869610605982118,0.00426329948374468,-0.0170521730479608,-0.000340039071681612,0.0413945495880947
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR4,Proline-rich protein 4,36866,0.0142064876374045,0.00696927657358013,0.000546705553187435,0.0278662697216215,0.0415256242551643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GZMB,Granzyme B,39673,-0.0129125609354072,0.00635534675837538,-0.0253690405818229,-0.000456081288991435,0.0421942985030787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37215,-0.0169756448349435,0.00836299954842648,-0.0333671239498594,-0.000584165720027605,0.0423914482111072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39668,-0.00958535278480086,0.00472577950394703,-0.018847880612537,-0.000322824957064686,0.0425452013997882
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK7,Kallikrein-7,36655,-0.00790594539254121,0.00389929463005114,-0.0155485628674415,-0.000263327917640969,0.0426287005155707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGN,Mimecan,39668,-0.00791820453288072,0.00391125596323,-0.0155842662208115,-0.000252142844949921,0.0429390118771517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39630,-0.00787416923429819,0.00391134478867465,-0.0155404050201005,-0.000207933448495886,0.0441145884206948
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,39860,-0.00468098922541005,0.00232875326678524,-0.00924534562830912,-0.000116632822510974,0.0444390726606668
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,36855,0.00751127075977282,0.00373723642425681,0.000186287368229472,0.0148362541513162,0.0444680902284127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,39860,0.00544709238064348,0.00271613846805254,0.000123460983260507,0.0107707237780265,0.0449312778296313
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSLNL,Mesothelin-like protein,36877,0.00728712820932507,0.00363410548807283,0.000164281452702321,0.0144099749659478,0.0449617489358691
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GDF2,Growth/differentiation factor 2,39680,-0.00700963574325423,0.00350021560900981,-0.0138700583369134,-0.000149213149595007,0.0452340824988086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD48,CD48 antigen,39720,-0.00572577312822565,0.00286280919157613,-0.0113368791437149,-0.000114667112736426,0.0455114483797375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,36855,0.00737459179928522,0.00368782919395708,0.000146446579129355,0.0146027370194411,0.0455522820179207
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3A,Uroplakin-3a,36827,0.00946677890101086,0.00477334793076786,0.000111016956705859,0.0188225408453159,0.0473597152691905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36765,0.0156427435639143,0.00789291779650098,0.000172624682772401,0.0311128624450562,0.0475148804813669
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39594,-0.00909122269365184,0.00458736946143662,-0.0180824668380676,-9.99785492360617e-05,0.0475196402955699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36827,0.0110429458793797,0.00560290569847653,6.12507103657286e-05,0.0220246410483937,0.0487528933336893
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39680,-0.0053925745372891,0.00274817230623367,-0.0107789922575071,-6.15681707109589e-06,0.0497520133775886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39798,-0.00897206782342401,0.00457843648799267,-0.0179458033398896,1.66769304160881e-06,0.0500557820975543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39721,-0.00700782414808972,0.00357865863555852,-0.0140219950737844,6.34677760496735e-06,0.050220944440505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAEP,Glycodelin,39557,0.0280520316295494,0.0143481096275411,-7.02632404311725e-05,0.05617432649953,0.0505886393977074
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRKCQ,Protein kinase C theta type,39401,-0.00836235731405836,0.00428409881451726,-0.0167591909905122,3.44763623954768e-05,0.0509617805641243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37285,-0.00360464316088334,0.00185016567439752,-0.00723096788270249,2.16815609358112e-05,0.0514021236110308
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37005,0.0168081804691147,0.00865079792581148,-0.000147383465475753,0.0337637444037052,0.0520419483301031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN1,Calsyntenin-1,39302,-0.00968415719479317,0.00498707737459854,-0.0194588288490063,9.05144594199603e-05,0.0521734002420015
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",36855,0.0165142077582686,0.00850814701001831,-0.000161760381367317,0.0331901758979045,0.0522813767783634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,36855,0.00795228851900582,0.00410103862910967,-8.57471940491315e-05,0.0159903242320608,0.0525118352535941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",36896,-0.011552656980468,0.0059659328768631,-0.0232458854191197,0.000140571458183662,0.0528357090264782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36795,0.00806149007098638,0.00416570727111814,-0.000103296180405176,0.0162262763223779,0.0529871349155169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",36896,-0.00533880348616081,0.00277134981249986,-0.0107706491186605,9.3042146338926e-05,0.0540727768169163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,39860,0.00600791361442019,0.00312465365826678,-0.000116407555782701,0.0121322347846231,0.0545297560741163
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,39836,0.00676495008022229,0.00352065955722481,-0.000135542651938331,0.0136654428123829,0.0546863744411157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37215,-0.0197717622062519,0.0103164729788769,-0.0399920492448506,0.000448524832346808,0.0553198224472104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37005,-0.0131783395885904,0.00688644665753717,-0.0266757750373633,0.000319095860182418,0.055684898295245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AHNAK2,Protein AHNAK2,36880,-0.00557899391926637,0.00292113373491543,-0.0113044160397006,0.000146428201167882,0.0561715410731786
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36827,0.0142524007860941,0.00750814686821938,-0.000463567075615921,0.028968368647804,0.0576842702930792
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39302,-0.0121725262965448,0.00642822958446281,-0.0247718562820919,0.000426803689002357,0.0582961624819303
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD276,CD276 antigen,39675,0.00657077845837481,0.00347070626168468,-0.000231805814527174,0.0133733627312768,0.0583480842464578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39288,-0.00561820314644411,0.00297099246189987,-0.0114413483717679,0.000204942078879639,0.0586405275624851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B4,Protein ATP1B4,36795,0.00790186589461775,0.00418714279633816,-0.000304933986205045,0.0161086657754405,0.0591593330034612
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37267,0.00480136999771933,0.0025454701758696,-0.000187751546985077,0.00979049154242374,0.0592840908791707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,36855,-0.00877957690353963,0.0046550771642184,-0.0179035281454077,0.000344374338328424,0.0593143012103498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP73,Tumor protein p73,36877,0.00651362083189083,0.00346276517467501,-0.000273398910472186,0.0133006405742539,0.0599879532672498
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,36896,0.0126939066578611,0.00676068652132239,-0.000557038923930792,0.025944852239653,0.0604573710750794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF7,SLAM family member 7,39673,0.0107349427982245,0.00572056151476394,-0.000477357770712795,0.0219472433671619,0.0605976429090048
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPN3,Calpain-3,37203,-0.00704812149043439,0.00376520768226415,-0.0144279285476721,0.000331685566803332,0.0612412242534358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA3,Carbonic anhydrase 3,39826,-0.011173775875939,0.00596997523178592,-0.0228749273302394,0.000527375578361418,0.0612716477166565
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37215,0.00615537845067927,0.00329330469016381,-0.000299498742041803,0.0126102556434004,0.061636574998438
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS2,Podocin,36896,0.0190002777953745,0.0101687357934639,-0.00093044435981476,0.0389309999505638,0.0617148911762785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39538,0.0061888932283562,0.00332251142505776,-0.000323229164757011,0.0127010156214694,0.0625210056215688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF9,Fibroblast growth factor 9,36765,0.00753231685296025,0.0040457293739956,-0.000397312720071122,0.0154619464259916,0.0626547716502755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37005,0.0159550861115385,0.00857565828443505,-0.000853204125954188,0.0327633763490312,0.0628359151794697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA7A,Semaphorin-7A,39810,-0.00495918871458627,0.00266967465354985,-0.010191751035544,0.000273373606371438,0.0632441972369261
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36827,0.0135727543331482,0.00733132794371375,-0.000796648436530699,0.0279421571028272,0.0641438924134094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDH1,Protocadherin-1,39826,-0.00381530512747605,0.0020636549279129,-0.00786006878618533,0.000229458531233227,0.0645037797184525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRYBB2,Beta-crystallin B2,37220,-0.0104013838395764,0.00563184232752217,-0.0214397948015199,0.000637027122367018,0.0647854259995613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39302,-0.0059746772915638,0.00324374345266684,-0.0123324144587908,0.000383059875663198,0.0655077592292751
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36827,0.00596549211823909,0.00323950874944161,-0.000383945030666464,0.0123149292671446,0.0655740046307965
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,36896,-0.0111135528340799,0.00603832505312436,-0.0229486699382037,0.000721564270043816,0.0657172010304527
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYH7B,Myosin-7B,36795,0.00809756185638337,0.00440106739349374,-0.000528530234864362,0.0167236539476311,0.0658045522068281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,39842,-0.0101582101485209,0.00552459014625827,-0.0209864068351871,0.000669986538145291,0.0659739707181112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39302,-0.0127906893701393,0.00695630134412823,-0.0264250400046306,0.000843661264352022,0.0659755935681012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37268,0.0193564096287724,0.0105308657223867,-0.00128408718710553,0.0399969064446504,0.0660750222520082
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39302,-0.00707869047378727,0.00385516366331093,-0.0146348112538767,0.000477430306302152,0.0663534726192462
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,36855,-0.00729675991000433,0.00397590717458636,-0.0150895379721936,0.000496018152184936,0.0664923810022975
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39673,0.0083600448943698,0.00456256736992831,-0.000582587150689684,0.0173026769394293,0.0669238124759401
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAGLN3,Transgelin-3,36795,0.0109397687466376,0.00597103055040584,-0.000763451132157852,0.022642988625433,0.0669534237184108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",36896,0.00646696679988288,0.00353405869033641,-0.000459788233176476,0.0133937218329422,0.0672880217564807
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRK1,Protein BRICK1,39302,-0.00807915412560316,0.00442057911442422,-0.0167434891898746,0.000585180938668307,0.0676253682425659
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39372,-0.00742687883445292,0.00406869435156826,-0.0154015197635267,0.000547762094620863,0.0679642011930199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD10,Frizzled-10,36877,-0.0109019669612864,0.00597872728153211,-0.0226202724330894,0.0008163385105165,0.0682567495585723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,36855,0.00860038976558847,0.00473159135011221,-0.000673529280631465,0.0178743088118084,0.0691402495021414
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM,Paralemmin-1,37133,-0.00514082727245931,0.00283569066618831,-0.0106987809781884,0.000417126433269781,0.0698696269612011
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPLX2,Complexin-2,36795,0.00541675778899181,0.00298863011218611,-0.000440957230892967,0.0112744728088766,0.0699390851689755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD1,Leiomodin-1,37244,0.00637753890200662,0.00351960946109306,-0.000520895641735775,0.013275973445749,0.0700083096824859
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39302,-0.0078277703101748,0.00432669179635298,-0.0163080862310266,0.000652545610677036,0.0704422648737525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRR5,Proline-rich protein 5,36896,0.00859681664753336,0.00475450268795951,-0.000722008620867291,0.017915641915934,0.0706074172462274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERC2,ERC protein 2,36877,-0.0134974446047355,0.00750404969864764,-0.0282053820140849,0.00121049280461391,0.0720911952646051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINB5,Serpin B5,39401,-0.00866709164810987,0.00482201925351953,-0.0181182493850082,0.000784066088788412,0.0722917358868546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39302,-0.00543961495620142,0.0030295704652863,-0.0113775730681626,0.00049834315575973,0.0725925041134238
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37268,-0.0047717598777736,0.00266948725860533,-0.0100039549046401,0.000460435149092856,0.0738761809795452
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39490,-0.00564204040288238,0.00315781038583274,-0.0118313487591145,0.000547267953349791,0.0740063577159665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENG,Endoglin,39860,0.0029988355434534,0.00168119344422575,-0.000296303607229061,0.00629397469413587,0.0744825931708173
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSPN,Claspin,39266,-0.00605745298243125,0.0034013267160034,-0.0127240533457979,0.000609147380935424,0.0749470345343457
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,36877,-0.0177816879622337,0.0100322820969007,-0.0374449608721591,0.00188158494769167,0.0763437758557651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALB1,Calbindin,39594,-0.00737113534435866,0.0041626327991863,-0.0155298956307638,0.000787624942046481,0.0766155141568995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,36855,0.00641119185699218,0.00362117160255974,-0.000686304484024904,0.0135086881980093,0.0766715746369586
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO1,Roundabout homolog 1,39697,-0.0041102346717464,0.00233586808404857,-0.00868853611648159,0.000468066772988791,0.0784919645835981
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM19,Probable RNA-binding protein 19,36855,0.00828021276567663,0.00471378109326788,-0.000958798177128404,0.0175192237084817,0.0790101099603552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTSV,Cathepsin L2,39775,0.00710115388477477,0.004054725955816,-0.000846108988624591,0.0150484167581741,0.0799087411713267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,36983,0.00918846840387728,0.00524817564231302,-0.00109795585505623,0.0194748926628108,0.0800049627042932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39288,0.00605489089380593,0.00346091725066641,-0.000728506917500221,0.0128382887051121,0.0802237040713481
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36827,0.00855360128740042,0.0048950553384674,-0.00104070717599568,0.0181479097507965,0.0805923003854446
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TG,Thyroglobulin,37203,0.0189117770607538,0.0108373383417746,-0.00232940608912444,0.040152960210632,0.0809979051068875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36827,0.0120881269147325,0.00694207266534538,-0.00151833550934449,0.0256945893388094,0.0816573518899941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36765,0.00912939240339027,0.00526118884633026,-0.00118253773541705,0.0194413225421976,0.0827232849609056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMA,Repulsive guidance molecule A,39817,0.00530215140053509,0.00306773820379827,-0.000710615478909517,0.0113149182799797,0.0839433157754218
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36795,-0.00872810254062491,0.00506426480877619,-0.0186540615658262,0.00119785648457643,0.0848276742937742
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,39836,0.00543136603179954,0.00315146698993149,-0.000745509268466175,0.0116082413320653,0.0848282339565491
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLAMF8,SLAM family member 8,39288,-0.00887295919244762,0.00514972445464044,-0.0189664191235429,0.00122050073864764,0.0849091264716072
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36827,0.00738006555058431,0.00428465767714865,-0.00101786349662704,0.0157779945977957,0.085013696926908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX33,Testis-expressed protein 33,37005,0.0068521578960223,0.00397929920587133,-0.000947268547485512,0.0146515843395301,0.0851019361307325
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36827,0.0107385395402928,0.00624846090694081,-0.00150844383731121,0.0229855229178967,0.0857130076382373
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39721,-0.0133309369127764,0.00777419794466461,-0.028568364884319,0.00190649105876628,0.0864075158059324
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39269,-0.00870537013109455,0.00507831823810368,-0.0186588738777778,0.00124813361558867,0.0865078807801505
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39790,0.00574453789030756,0.00335954787278705,-0.000840175940355066,0.0123292517209702,0.0873012537208534
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEO1,Neogenin,37244,-0.003688119787613,0.00215840593128675,-0.00791859541293503,0.000542355837709038,0.0875252910695362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39517,0.00466341743250235,0.00274211041357141,-0.000711118978097624,0.0100379538431023,0.0890253427436246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGM2,Phosphoglucomutase-2,36877,-0.0102883104118799,0.00606280116709881,-0.0221714006993936,0.00159477987563375,0.0897287741609973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLNS1A,Methylosome subunit pICln,36877,-0.00572419225012831,0.00337387430746906,-0.0123369858927677,0.000888601392511059,0.0897918952550475
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39288,0.00832019599033575,0.00490611612472321,-0.00129579161412175,0.0179361835947932,0.0899283291337427
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39680,0.00427062061271238,0.00253291431988094,-0.00069389145425426,0.00923513267967903,0.0918058562001688
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39673,0.0057563945024124,0.00343523138396998,-0.000976659010168757,0.0124894480149936,0.0938180366354641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH23,Cadherin-23,37220,0.00449814346136124,0.00268623024212198,-0.000766867813197838,0.00976315473592032,0.0940520576648354
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,36877,0.0112977424011484,0.00679120284377212,-0.00201301517264492,0.0246084999749418,0.0962194863465362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37220,0.00992126155369213,0.00597067871566272,-0.0017812687290068,0.0216237918363911,0.0966036358270782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37277,-0.00454792238038975,0.00274281822866407,-0.00992384610857132,0.000828001347791817,0.0973165787442602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,36855,0.0055417048639957,0.00334421953310059,-0.00101296542088145,0.0120963751488729,0.0975234789747504
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,39865,-0.00562031005716279,0.00340490594916409,-0.0122939257175244,0.00105330560319882,0.098829560416737
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39594,-0.00367279275967293,0.00222980440505514,-0.00804320939358101,0.00069762387423515,0.099549912302529
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGN,Cingulin,36877,-0.00638475010563181,0.00389029149183664,-0.0140097214296316,0.001240221218368,0.100779866693857
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37255,-0.00399361512943623,0.00244106675893633,-0.00877810597695143,0.00079087571807897,0.101860516883764
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37244,-0.00437664463050977,0.00268037731996639,-0.0096301841776439,0.000876894916624355,0.102524815100757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37005,0.0121536182643227,0.00744946186189649,-0.00244732698499445,0.0267545635136398,0.10281387433855
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMOX1,Heme oxygenase 1,39507,0.00770403526443675,0.00472275143746124,-0.00155255755298727,0.0169606280818608,0.102855605870113
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36795,-0.00643366756230329,0.00395086045207919,-0.0141773540483785,0.00131001892377192,0.103459816862516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37020,-0.00680392315066141,0.00417973608117267,-0.0149962058697598,0.00138835956843703,0.103583690374613
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,39860,-0.00473651546308137,0.00291228165865466,-0.0104445875140445,0.000971556587881768,0.10388570189962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,36855,0.00719509748653613,0.00443254368706153,-0.00149268814010447,0.0158828831131767,0.104561629539512
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39673,-0.0106254372973777,0.00654927442294685,-0.0234620151663535,0.00221114057159809,0.104741112055284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALLD,Palladin,36896,0.00660058783908181,0.00407076104499144,-0.00137810380910142,0.014579279487265,0.104942593569386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37005,0.00595871625419359,0.00368444304572948,-0.00126279211543618,0.0131802246238234,0.105845350567696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TTN,Titin,36855,-0.011023987291341,0.00683342698428992,-0.0244175041805492,0.00236952959786725,0.106715718713388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHRDL1,Chordin-like protein 1,39720,0.00488359959938692,0.0030289218395469,-0.00105308720612501,0.0108202864048988,0.106911621457348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36795,0.0102948987972858,0.00638852520967392,-0.0022266106136751,0.0228164082082467,0.107102329994169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39401,-0.00571382513197248,0.00354862326324419,-0.0126691267279311,0.00124147646398614,0.107384846083629
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGB5,Integrin beta-5,39721,-0.00605939537093888,0.0037670800250581,-0.0134428722200527,0.00132408147817499,0.107742879853919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,36896,0.00667062048239833,0.00415395183862316,-0.00147112512130307,0.0148123660860997,0.108331255872279
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39302,-0.0109788700265638,0.00684275313212425,-0.0243906661655273,0.00243292611239971,0.108634871987205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37215,0.00745537696024893,0.00465236540571036,-0.00166325923494337,0.0165740131554412,0.1090705703077
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37005,-0.008325724189903,0.00520123998123058,-0.0185201545531149,0.00186870617330894,0.109463179030447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNPY2,Protein canopy homolog 2,39401,-0.0095290413704177,0.00596570571538489,-0.0212218245725721,0.0021637418317367,0.110218448572178
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBP2,Guanylate-binding protein 2,39401,-0.00937359483651178,0.00587374436773522,-0.0208861337972728,0.00213894412424926,0.110543384666526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39621,0.00927122345387702,0.00581465819479772,-0.00212550660792651,0.0206679535156805,0.110853727310556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37005,-0.00731274922838394,0.00462800133744499,-0.0163836318497761,0.00175813339300823,0.114105835306348
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36827,-0.00680714545759093,0.00432235020991334,-0.0152789518690211,0.00166466095383921,0.115310541519705
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39594,-0.00529786678297572,0.00337877421938964,-0.0119202642529794,0.00132453068702797,0.116904777926002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGF,Beta-nerve growth factor,39557,0.00190599877454912,0.00121967260453569,-0.000484559530340835,0.00429655707943907,0.118140170154245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,36896,-0.00459810587477024,0.00294859603455613,-0.0103773541025003,0.00118114235295977,0.118920779492888
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39508,-0.00620562532127413,0.00398371333333158,-0.014013703454604,0.00160245281205576,0.119312991479449
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39738,-0.00655087107975286,0.00420960837916768,-0.0148017035029215,0.0016999613434158,0.119687331967322
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD55,Complement decay-accelerating factor,39129,-0.00390902308972811,0.00252010025194725,-0.00884841958354473,0.0010303734040885,0.120889358261563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO2,Roundabout homolog 2,39817,0.00348727812326038,0.00225529488026652,-0.000933099842061989,0.00790765608858275,0.122060991609142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAT1,Diamine acetyltransferase 1,36855,0.00767922173997336,0.00496904296526931,-0.00206010247195449,0.0174185459519012,0.122270838827306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANPEP,Aminopeptidase N,39698,0.00427753148641513,0.00277301950707504,-0.00115758674745195,0.00971264972028222,0.122959079181578
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAG,S-arrestin,36827,0.00813828106677,0.00527645088484551,-0.0022035626675272,0.0184801248010672,0.123006198590621
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37285,0.00401086141947758,0.00260085838054112,-0.00108682100638301,0.00910854384533817,0.123065605011836
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGR,Progesterone receptor,36896,0.0161689467578688,0.0104863574043113,-0.00438431375458133,0.036722207270319,0.123121420590817
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GKN1,Gastrokine-1,38940,-0.00430112238188581,0.00279063641215805,-0.00977076974971559,0.00116852498594398,0.123272226549914
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36795,0.0100976682430168,0.00656647557538714,-0.002772623884742,0.0229679603707756,0.124131589649723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL34,Interleukin-34,39269,-0.00545200101127469,0.00355336585506819,-0.0124165980872083,0.00151259606465897,0.12497142917222
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",36896,0.00702450995309411,0.00457936889853561,-0.00195105308803568,0.0160000729942239,0.125066918286552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,36877,-0.00815219920606778,0.0053194702305289,-0.0185783608579044,0.00227396244576887,0.125418250590532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36795,-0.0123918292524767,0.00812162417953833,-0.0283102126443719,0.00352655413941841,0.127088575144319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39401,0.00479966988664223,0.00314857188634421,-0.00137153101059243,0.0109708707838769,0.127430206648838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA3G,Semaphorin-3G,36958,0.00664598131300183,0.00436462725668273,-0.00190868811009632,0.0152006507361,0.127860018730923
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM132A,Transmembrane protein 132A,36880,-0.00952925248175839,0.00627034307349983,-0.0218191249058181,0.00276061994230129,0.128602167934398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOC1,Apolipoprotein C-I,37257,0.00566061650289318,0.00372548369520686,-0.00164133153971226,0.0129625645454986,0.128677568725127
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36795,-0.00902712838981839,0.00594453181630253,-0.0206784107497713,0.00262415397013457,0.128897719319532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37203,-0.00902865690437803,0.00594577256123264,-0.020682371124394,0.00262505731563794,0.12891203815091
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDK2,Protein sidekick-2,36958,-0.00563734214533434,0.00371489294794378,-0.0129185323233042,0.00164384803263546,0.129165164391969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGMB,RGM domain family member B,39817,-0.00382582815794004,0.00252636698634625,-0.00877750745117869,0.00112585113529861,0.129954460221404
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,36855,0.010783514455634,0.0071477851248309,-0.00322614438903454,0.0247931733003026,0.131412258806044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39288,-0.00818114339500341,0.00542453829989094,-0.0188132384627896,0.00245095167278282,0.131530675707838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39401,-0.00619821893046627,0.0041227792331072,-0.0142788662273564,0.00188242836642385,0.132754206524228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36827,-0.00819060593964328,0.00547758310250779,-0.0189266688205586,0.00254545694127199,0.134861646827658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",36855,0.00965180063713581,0.00646614233878185,-0.00302183834687661,0.0223254396211482,0.135548516365903
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,36880,-0.00489291211773424,0.00327849583619803,-0.0113187639566824,0.00153293972121389,0.13561175716519
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36795,0.0064633844968057,0.00434585187188873,-0.0020544851720962,0.0149812541657076,0.136972179509572
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MELTF,Melanotransferrin,37268,-0.00427652607163476,0.00288985031388642,-0.00994063268685214,0.00138758054358263,0.138938523505927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37203,-0.00708417447306833,0.00479436312427755,-0.0164811261966523,0.00231277725051566,0.139537162909211
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36827,0.0110471468810804,0.0074867892369831,-0.00362696002340651,0.0257212537855672,0.140088477566709
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39498,-0.00619327975711993,0.00420017204242798,-0.0144256169602788,0.00203905744603891,0.140359072200408
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37005,0.00502009135051829,0.00342761341626937,-0.00169803094536968,0.0117382136464063,0.143053300656435
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37203,-0.00661756524489252,0.00452388382553731,-0.0154843775429456,0.00224924705316061,0.143543973476753
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36795,0.0037218581076397,0.00254543581781643,-0.00126719609528051,0.00871091231055991,0.143719116271718
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36827,0.00964873712893753,0.00660138740459267,-0.0032899821840641,0.0225874564419392,0.143868885443851
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37104,0.00602487463542657,0.00412572747947083,-0.00206155122433625,0.0141113004951894,0.144226382222869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF16,Fibroblast growth factor 16,36896,-0.00702097817921802,0.00481551831907194,-0.016459394084599,0.00241743772616299,0.144867353659089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTN2,Contactin-2,39836,0.00640161421113153,0.00439148188715568,-0.00220569028769361,0.0150089187099567,0.144933422445212
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSTL1,Follistatin-related protein 1,36880,-0.00333353923761879,0.00228837721521467,-0.00781875857943954,0.00115168010420196,0.14521606602508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37005,0.0104458774148325,0.00722630421492953,-0.00371767884642937,0.0246094336760944,0.148331440639205
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL6B,Myosin light chain 6B,36877,-0.0133211655291518,0.00922705399774346,-0.031406191364729,0.0047638603064254,0.148845383197251
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",36880,-0.010125019167573,0.00703018340945331,-0.0239041786501015,0.00365414031495549,0.149828872255323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39721,0.00333255618955662,0.00232451034283852,-0.00122348408240688,0.00788859646152011,0.151689185134372
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,36896,0.00320251954341498,0.00224707323832357,-0.00120174400369921,0.00760678309052917,0.154124525484616
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17C,Interleukin-17C,39401,-0.00936275391152086,0.00657497181843753,-0.0222496986756584,0.00352419085261671,0.154466811540424
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36795,0.00657572831310743,0.00462006285428142,-0.00247959488128415,0.015631051507499,0.154673773573959
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPSD1,Tryptase delta,37244,-0.00517846140580797,0.00364933194795704,-0.0123311520238038,0.00197422921218782,0.155917559850755
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39401,-0.00820607203227462,0.00579036368940875,-0.0195551848635158,0.00314304079896652,0.156446092712525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39594,-0.00621383519445288,0.00439312427112053,-0.0148243587658491,0.00239668837694336,0.157250903965608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39668,0.00505143961677966,0.00357366794360986,-0.00195294955269566,0.012055828786255,0.157523521055397
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,39865,0.00402325727836963,0.00285309130020864,-0.0015688016700393,0.00961531622677856,0.158517872909219
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39401,-0.00682664237393211,0.00484636302431665,-0.0163255139015927,0.00267222915372852,0.158970101323252
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39557,-0.0142763986382544,0.0101427307275335,-0.0341561508642202,0.00560335358771129,0.159284221759532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39605,0.00361492060478399,0.00257736268930583,-0.00143671026625545,0.00866655147582342,0.160766090890745
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36795,-0.00782106768449987,0.00557861425239536,-0.0187551516191948,0.00311301625019503,0.160947245241245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37203,-0.00746827207279714,0.00533382917938773,-0.0179225772643971,0.00298603311880282,0.161485417655555
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN1,Nectin-1,36896,-0.00447511267155069,0.00319933280286772,-0.0107458049651714,0.00179557962207004,0.161907450032366
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39302,-0.00651323588840901,0.00467435965000592,-0.0156749808024206,0.0026485090256026,0.163520009855905
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,POMC,Pro-opiomelanocortin,36880,-0.00985961044540231,0.00709320118672166,-0.0237622847713768,0.00404306388057215,0.164550037910986
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36775,0.00350005733757013,0.00252369154693209,-0.00144637809441676,0.00844649276955702,0.165502292197511
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36795,0.00452996282476722,0.00327666117218681,-0.00189229307271893,0.0109522187222534,0.166844088361715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",36855,0.0070142384927985,0.00508888459434508,-0.00295997531211786,0.0169884522977149,0.168120533652391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39401,-0.00589924604046189,0.00428329883442882,-0.0142945117559424,0.0024960196750186,0.168449556261526
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2B,Alpha-amylase 2B,38653,0.00657550301778792,0.00477434392675425,-0.00278221107865041,0.0159332171142262,0.168453356486543
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",36855,-0.00553506174305942,0.00402861893850406,-0.0134311548625274,0.00236103137640855,0.1694854691974
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",36896,-0.00406311498683512,0.00295848100856741,-0.00986173776362725,0.00173550778995701,0.169658247563296
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39065,0.00639559651751681,0.00466677334120815,-0.00275127923125116,0.0155424722662848,0.170565568896441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,36896,0.00821751138871748,0.00600202162156417,-0.00354645098954828,0.0199814737669832,0.170984129376432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37267,0.00538396233728374,0.00396206962748125,-0.0023816941325795,0.013149618807147,0.17420866381021
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,36896,-0.00530940132572269,0.00391046504597788,-0.0129739128158393,0.00235511016439395,0.174569171925025
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGB,Secretogranin-1,39760,0.00530870970044379,0.00391055629021105,-0.00235598062836987,0.0129734000292575,0.174631142403538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37005,0.00563388787353547,0.00415936919221187,-0.00251847574319979,0.0137862514902707,0.17559848477722
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37267,0.00478293409681081,0.00354488455647613,-0.0021650396338824,0.011730907827504,0.17727959039175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37268,-0.0039975986687186,0.00298650959099642,-0.00985115746707159,0.00185596012963439,0.180739226297795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36795,-0.0106329467254352,0.00794645759748089,-0.0262080036164978,0.00494211016562732,0.180895901735711
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,36855,0.00956124811267993,0.00715952926282104,-0.0044714292424493,0.0235939254678092,0.181749998153926
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A13,Protein S100-A13,36896,-0.00462395983934137,0.00346548408859827,-0.011416308652994,0.00216838897431123,0.182132227730126
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLU,Clusterin,37285,0.00418933145596325,0.00316424640774047,-0.00201259150320808,0.0103912544151346,0.185539314043363
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36795,-0.00758143111138253,0.00573764352226723,-0.0188272124150263,0.00366435019226124,0.186408302400494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,39817,-0.00925152110523433,0.00703144043967277,-0.023033144366993,0.0045301021565243,0.18828148398656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39302,-0.011084091284062,0.00842802705395833,-0.0276030243098203,0.00543484174169636,0.188480159711479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,36880,0.0077084673469536,0.00586150701057871,-0.00378008639378067,0.0191970210876879,0.188499487015281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36815,0.00452635035935468,0.00344217326506705,-0.00222030924017674,0.0112730099588861,0.188543672435191
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39529,0.00598075727506072,0.00455401772181203,-0.00294511745969086,0.0149066320098123,0.189103638773008
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36827,-0.00418403638766164,0.00318986509574752,-0.0104361719753268,0.0020680992000035,0.189656202936867
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,36855,-0.00543610175253695,0.0041786386695401,-0.0136262335448355,0.00275403003976164,0.193306683323045
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK15,Kallikrein-15,37186,-0.00651897116878167,0.00502264483110345,-0.0163633550377444,0.0033254127001811,0.194338660150391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39594,-0.0107957310113759,0.00834106080457039,-0.0271442101883338,0.00555274816558211,0.195585116898623
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37268,-0.00439149627468628,0.00339403011165513,-0.0110437952935303,0.00226080274415779,0.195726250415714
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,39817,-0.00345868637466312,0.00267710008528688,-0.00870580254182541,0.00178842979249916,0.196392276163839
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39544,-0.00503442246103322,0.00389786079960259,-0.0126742296282543,0.00260538470618785,0.196519586198257
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36827,0.00977965253327394,0.00758579049834234,-0.00508849684347704,0.0246478019100249,0.197349205424996
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39521,-0.00386383897024039,0.00299739516801243,-0.00973873349954476,0.00201105555906398,0.197394324517821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL36G,Interleukin-36 gamma,36862,-0.00859951343297869,0.00668267619133772,-0.0216975587680006,0.00449853190204325,0.198174098137314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36827,0.0117875706876609,0.00917207750671267,-0.00618970122549597,0.0297648426008177,0.198759958317666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PROK1,Prokineticin-1,39673,0.00820612043667687,0.00639733450599771,-0.00433265519507864,0.0207448960684324,0.199601786896393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SYT1,Synaptotagmin-1,37220,0.00474503199457144,0.00370296860138924,-0.00251278646415146,0.0120028504532943,0.200070890538209
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39448,0.0218021566729096,0.017018272133249,-0.0115536567082584,0.0551579700540776,0.20017660659663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,36877,0.0054757912017545,0.00427453958711748,-0.00290230638899576,0.0138538887925048,0.200207778449109
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,36958,-0.00406200889215556,0.00317846097776396,-0.0102917924085729,0.00216777462426181,0.201279200278981
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN4,Alpha-actinin-4,39401,-0.0039561042372439,0.00311318986037063,-0.0100579563635703,0.00214574788908253,0.203834540101441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37203,0.0105927174318256,0.00835618760934815,-0.00578541028249677,0.026970845146148,0.204945250955175
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39720,-0.0112403838249747,0.00887078890158374,-0.0286271300720788,0.00614636242212946,0.205129790215358
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF6,Fibroblast growth factor 6,36896,0.00516541243913606,0.00409639345575663,-0.00286351873414693,0.0131943436124191,0.207343701619778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36795,-0.0116355028179945,0.00925232066273239,-0.02977005131695,0.006499045680961,0.208567590408928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39680,-0.00544147228338349,0.00434683511281661,-0.013961269104504,0.00307832453773707,0.210652530675615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCIN,Adseverin,36827,-0.00924045310413404,0.00738325066822117,-0.0237116244138475,0.00523071820557947,0.210759140341024
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37203,0.00573799478441526,0.0046040871504108,-0.00328601603038991,0.0147620055992204,0.212682457365976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36795,0.0068090089234471,0.00546886444323962,-0.00390996538530256,0.0175279832321968,0.213135977313823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36795,0.00504913842894611,0.00405818160408706,-0.00290489751506452,0.0130031743729567,0.213453143819229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAD2,Glutamate decarboxylase 2,36896,0.00574797836984134,0.00462528105748007,-0.00331757250281959,0.0148135292425023,0.213989471186337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36827,0.00598093498629385,0.00481611923033397,-0.00345865870516073,0.0154205286777484,0.214311512236134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36827,0.00653344896357311,0.00526398008416789,-0.00378395200139596,0.0168508499285422,0.21456857849174
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36795,0.00788321416703992,0.00635876898442853,-0.00457997304244,0.0203464013765198,0.215094422271314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,36877,-0.00796230060669963,0.006429697594898,-0.0205645078926997,0.00463990667930045,0.215603767828823
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17F,Interleukin-17F,39401,0.00945586010663427,0.00763936040780252,-0.00551728629265866,0.0244290065059272,0.215815734790137
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF3,Fibroblast growth factor 3,36896,0.00378985931008531,0.00307570042825159,-0.0022385135292878,0.00981823214945842,0.21789888472829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39401,-0.0102457397415153,0.0083219548513346,-0.0265567712501311,0.00606529176710051,0.218277983688542
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL9,Interleukin-9,37005,0.00702279762100173,0.00573664499512219,-0.00422102656943777,0.0182666218114412,0.220898938553808
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39668,0.0067558758094697,0.00553337287214351,-0.00408953501993158,0.017601286638871,0.222129717055473
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37244,-0.0140556442804068,0.0115577128982063,-0.0367087615608912,0.00859747300007754,0.22395807458323
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR1,Complement receptor type 1,37252,0.00430214600046374,0.00355155843066445,-0.00265890852363858,0.0112632005245661,0.225786368123649
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTN,Neuroplastin,39288,0.0100298139958104,0.0083081903359728,-0.0062542390626963,0.0263138670543171,0.22736591672752
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39594,-0.00311717554680438,0.00258609638733776,-0.00818592446598639,0.00195157337237762,0.228082721590186
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA9,Carbonic anhydrase 9,39836,0.00516027649422004,0.00428949643895715,-0.00324713652613596,0.013567689514576,0.228993040150515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37005,-0.00623580019606979,0.00521784416639517,-0.0164627747622043,0.00399117437006474,0.232072919439724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39401,-0.014292132240757,0.0120063908921877,-0.037824658389445,0.00924039390793099,0.233916409566412
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39614,-0.00396297452394324,0.00333418689170383,-0.0104979808316827,0.00257203178379626,0.234619749304061
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PXDNL,Peroxidasin-like protein,37203,-0.00702787064566445,0.00591322502381061,-0.0186177916923332,0.00456205040100435,0.23465745226281
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTB,Lymphotoxin-beta,37203,-0.00405251334714934,0.00341230214978147,-0.010740625560721,0.00263559886642234,0.235004864988982
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36827,0.00381346138959682,0.00321782714404381,-0.00249347981272906,0.0101204025919227,0.235997855424114
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36836,-0.00986500652388334,0.00832710807048569,-0.0261861383420353,0.00645612529426862,0.236163404268728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37203,0.00657475509852544,0.00555120385073794,-0.00430560444892092,0.0174551146459718,0.236282324674144
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP13,Collagenase 3,39302,0.00373390715697337,0.00318082651634976,-0.00250051281507217,0.0099683271290189,0.240461384094493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GH2,Growth hormone variant,39288,0.0189022388864567,0.0162797795827544,-0.0130061290957419,0.0508106068686552,0.245624523782272
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PALM3,Paralemmin-3,36855,-0.00877123267058086,0.00755630912524566,-0.0235815985560624,0.00603913321490064,0.245751615901027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL11,Interleukin-11,39401,-0.00713184126297841,0.0061661479167393,-0.0192174911797875,0.00495380865383062,0.247448656606036
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36827,-0.00862807523373947,0.00746139796264583,-0.0232524152405253,0.00599626477304635,0.24755452226552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR4,Toll-like receptor 4,36896,0.00316857963601789,0.00274838215800549,-0.00221824939367288,0.00855540866570865,0.248977075211327
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCN15,Lipocalin-15,37244,-0.00711793144559665,0.00618235588472026,-0.0192353489796484,0.00499948608845506,0.249617090301429
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDAN1,Codanin-1,37220,0.00258933731456314,0.00225467711978902,-0.00182982984022334,0.00700850446934963,0.250811936573897
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39504,0.002987772760332,0.00260634291756723,-0.00212065935809978,0.00809620487876378,0.251669235627148
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37215,0.0194264866778949,0.0169778367358699,-0.0138500733244101,0.0527030466801999,0.252550321556206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39599,-0.00299385860929228,0.00264680813792788,-0.00818160255963092,0.00219388534104637,0.258021665102286
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36827,0.00867084523319638,0.00768186416397645,-0.00638560852819747,0.0237272989945902,0.259027429982094
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36827,0.00502258649485917,0.00445250072005355,-0.00370431491644578,0.0137494879061641,0.259325075165809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37203,-0.00407703889794319,0.00363323735219373,-0.0111981841082429,0.00304410631235653,0.261818672652075
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37005,0.0034454283578379,0.00307091089541189,-0.0025735569971694,0.0094644137128452,0.261901440913785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39401,-0.0041949438549892,0.00374269680505097,-0.0115306295928891,0.0031407418829107,0.262375617781378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,36877,-0.00413446904601485,0.00369024924738339,-0.0113673575708863,0.00309841947885661,0.262573966185031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UBQLN3,Ubiquilin-3,36855,0.00523037870663202,0.00468121970381798,-0.00394481191285122,0.0144055693261153,0.263881990305203
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSCA,Prostate stem cell antigen,37215,0.0282636193857367,0.0253029980528674,-0.0213302567978834,0.0778574955693569,0.264011538013314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL2,Interferon lambda-2,36827,-0.00691138475198541,0.00619653579059483,-0.0190565949015513,0.00523382539758045,0.264715706228909
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RALB,Ras-related protein Ral-B,36896,-0.00321207411179615,0.00290904417771514,-0.00891380070011781,0.00248965247652552,0.269540556014765
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,36855,0.00701928056059459,0.00635740353907022,-0.00544123037598305,0.0194797914971722,0.26956533969166
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTR,Methionine synthase,36855,0.00710213426243572,0.00644699338991111,-0.00553397278179006,0.0197382413066615,0.270647487914479
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK12,Kallikrein-12,39288,0.0150046846112405,0.0136442977918201,-0.0117381390607269,0.0417475082832079,0.271478406230294
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37215,-0.00604312682101612,0.00553011549900393,-0.0168821531990638,0.00479589955703158,0.274515897068398
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPA4,Carboxypeptidase A4,36704,-0.00472452614992889,0.00434641045968403,-0.0132434906509096,0.00379443835105181,0.277059446925104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36795,0.00863576128939531,0.00799295507654714,-0.00703043066063707,0.0243019532394277,0.27997462655767
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37277,0.00501153180507086,0.00467445394966551,-0.00415039793627353,0.0141734615464153,0.283689624802877
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOB,Apolipoprotein B-100,37277,0.00242301092077338,0.00226149384025683,-0.00200951700613001,0.00685553884767676,0.283999659438111
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY96,Lymphocyte antigen 96,39557,-0.00375317316719257,0.00350539728972467,-0.0106237518550529,0.00311740552066779,0.284327953533375
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",36877,-0.00907144286694491,0.0084748343873829,-0.0256821182662154,0.00753923253232557,0.284460200426388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,36855,0.00338375064990163,0.0031645401383064,-0.00281874802117891,0.00958624932098217,0.284967484648771
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SH3GL3,Endophilin-A3,36920,-0.00882643924351141,0.00827248728648192,-0.025040514325016,0.00738763583799315,0.286008190938399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,36877,0.00381309435714109,0.00358750704645718,-0.00321841945391498,0.0108446081681972,0.287855476078818
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36827,-0.00611237543087101,0.0057545630279634,-0.0173913189656793,0.00516656810393725,0.288174257854643
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39288,-0.00391609855128287,0.00368792078332263,-0.0111444232865952,0.00331222618402948,0.288310575389301
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,36880,-0.00419751762938877,0.00395903377824556,-0.0119572238347501,0.00356218857597253,0.289056053575337
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PAPPA,Pappalysin-1,39401,0.00498696848538211,0.00470449552254597,-0.00423384273880799,0.0142077797095722,0.289141420789813
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA12,Carbonic anhydrase 12,39594,0.00334271101165327,0.00315613269880023,-0.00284330907799519,0.00952873110130173,0.289563159103995
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37203,-0.010256792426316,0.00973950211111413,-0.0293462165640997,0.00883263171146767,0.292308457156104
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HLA_A,,37244,-0.00339285517145133,0.00322605473035842,-0.00971592244295384,0.00293021210005117,0.292954290753832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSC2,Desmocollin-2,39485,0.0034627408972507,0.00329865742560453,-0.00300262765693419,0.00992810945143559,0.293852753167532
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36827,0.0035414873327291,0.00339385343594469,-0.00311046540172248,0.0101934400671807,0.296736060460466
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,36855,0.00583798529118975,0.00561804872540244,-0.00517339021059903,0.0168493607929785,0.298755145136602
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171A2,Protein FAM171A2,37244,-0.0162711309212202,0.0156943737327247,-0.0470321034373607,0.0144898415949202,0.299871441626052
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20,Interleukin-20,39401,0.00502334342760472,0.00484897256226774,-0.00448064279444004,0.0145273296496495,0.300236748555724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37203,-0.0038943511080162,0.00376362848188543,-0.0112710629325116,0.00348236071647924,0.300812308616305
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39798,-0.00638014516669126,0.00616759267280563,-0.0184686268053903,0.00570833647200778,0.3009355558694
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FBN2,Fibrillin-2,36877,-0.00621323326991127,0.006015799275097,-0.0180041998491014,0.00557773330927885,0.301707683480746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37244,-0.00245746491446305,0.00238536352859365,-0.00713277743050661,0.0022178476015805,0.302922270872608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM3,Myomesin-3,36958,0.00963464068647592,0.00935276513019258,-0.00869677896870154,0.0279660603416534,0.302964154330158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39288,-0.0035069103357966,0.00341582939477944,-0.0102019359495643,0.00318811527797109,0.304594627895102
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39685,-0.00579424645893853,0.00566632857305022,-0.016900250462117,0.0053117575442399,0.306524422972447
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,36896,0.00219721781604591,0.00216494924203935,-0.00204608269835121,0.00644051833044303,0.310169949263932
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39302,-0.0079928427838419,0.00789148134148338,-0.0234601462131493,0.00747446064546553,0.311150352538833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37005,-0.00533736234465061,0.00528910555097074,-0.0157040092245533,0.00502928453525203,0.312933835013654
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MN1,Transcriptional activator MN1,36877,0.00594324352620634,0.00589462439814823,-0.00561022029416419,0.0174967073465769,0.313354139237829
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,36877,-0.00787829709571281,0.00781656944018101,-0.0231987731984676,0.00744217900704196,0.313522633988245
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LEG1,Protein LEG1 homolog,36546,0.00703830619486016,0.00699398087692431,-0.00666989632391149,0.0207465087136318,0.314272375021237
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,36896,-0.00202157669271546,0.00201181336863547,-0.00596473089524099,0.00192157750981007,0.314986291504092
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37220,-0.00385097795064338,0.00385007665583926,-0.0113971281960883,0.00369517229480157,0.31721534693494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMEM25,Transmembrane protein 25,37244,-0.00447261454361431,0.00447741735268689,-0.0132483525548806,0.00430312346765198,0.317847957042924
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYB5A,Cytochrome b5,36795,-0.00712524016719952,0.00715994471754053,-0.0211587318135789,0.00690825147917991,0.319680492437884
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39401,-0.00611904881387628,0.00615363750342482,-0.0181801783205889,0.00594208069283637,0.320053798030571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36827,0.00298754094723145,0.00300780241628022,-0.00290775178867778,0.00888283368314068,0.320599998230686
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39288,-0.00457105459625441,0.00461205218841643,-0.0136106768855506,0.00446856769304179,0.321647038133723
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSPAN7,Tetraspanin-7,36827,0.00931491965628712,0.00943349422990675,-0.0091747290343301,0.0278045683469044,0.323450076478329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARTN,Artemin,39401,-0.00437813723572194,0.00443941418529497,-0.0130793890389001,0.0043231145674562,0.324051772944782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36827,0.00579224352490616,0.00587963880363506,-0.00573184853021856,0.0173163355800309,0.324575680355399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHIT1,Chitotriosidase-1,39714,-0.0145137056150051,0.0149287496980169,-0.0437740550231182,0.0147466437931079,0.330966720450863
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",36877,0.00746610283104433,0.00769066114826231,-0.00760759301954979,0.0225397986816384,0.331665338596724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYO6,Unconventional myosin-VI,37244,-0.00371228141243443,0.00382416489025299,-0.0112076445973303,0.00378308177246143,0.331693800806556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNLY,Granulysin,39668,0.00487836716458963,0.00505124513043748,-0.00502207329106784,0.0147788076202471,0.3341714659554
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDRG1,Protein NDRG1,39302,-0.00662265731597303,0.00688066693336848,-0.0201087645053753,0.00686344987342919,0.335812451373235
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MILR1,Allergin-1,39401,0.00469500502902235,0.00490727728384549,-0.00492325844731482,0.0143132685053595,0.338711681833494
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,36896,0.00573918164662972,0.00600466524337155,-0.00602996223037852,0.017508325523638,0.339197524992967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39680,0.00266331422271497,0.00279209813261515,-0.00280919811721071,0.00813582656264066,0.340161200694814
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,36896,-0.00268900945550811,0.00282602160304503,-0.00822801179747636,0.00284999288646014,0.341359300430406
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN6,Prefoldin subunit 6,36877,0.00628523318164946,0.00661620905239134,-0.00668253656103757,0.0192530029243365,0.342142593602768
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ESR1,Estrogen receptor,36896,0.00562900526923596,0.0059404938296964,-0.00601436263696899,0.0172723731754409,0.34336840980778
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ICOSLG,ICOS ligand,39594,-0.00176295401085961,0.00186963321610834,-0.00542743511443196,0.00190152709271275,0.345725506278164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MB,Myoglobin,39860,-0.00485243957700511,0.00514660118740662,-0.0149397779043221,0.00523489875031188,0.345775183710797
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN2,Prorelaxin H2,36929,-0.0133477617987359,0.0141655765591017,-0.0411122918545751,0.0144167682571034,0.346073142280885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36827,0.00508233379720407,0.00539609659653346,-0.00549401553200151,0.0156586831264097,0.346285069595158
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,36896,-0.008427083486334,0.00897608666561468,-0.0260202133509388,0.00916604637827078,0.347831764036832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36795,0.00470777541190165,0.00501646726930839,-0.0051245004359428,0.0145400512597461,0.348023381183142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37244,0.00724723734736794,0.00772551534596095,-0.00789477273071552,0.0223892474254514,0.348214512436913
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36795,0.00505826930403579,0.0054209926129675,-0.00556687621738051,0.0156834148254521,0.350791365353806
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36795,0.00846456207973803,0.009121439631656,-0.00941345959830773,0.0263425837577838,0.353432499670984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEX101,Testis-expressed protein 101,36877,0.00452428163042959,0.00487558301422477,-0.00503186107745097,0.0140804243383101,0.353452374697157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39594,-0.00356563966121138,0.00384858728989875,-0.0111088707494129,0.00397759142699017,0.354210727959376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36795,0.00363040283180281,0.00392962711458805,-0.00407166631278976,0.0113324719763954,0.355579422673464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37244,0.00693583579732656,0.00761167972494435,-0.00798305646356436,0.0218547280582175,0.362201346527978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEPTIN7,Septin-7,37005,0.00469135157448654,0.00515500855495059,-0.00541246519321662,0.0147951683421897,0.362809141238378
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37203,-0.00552512721377152,0.00608703280050721,-0.0174557115027657,0.00640545707522261,0.364059427591206
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39574,-0.00324853269192131,0.00357896123832662,-0.0102632967190415,0.00376623133519886,0.364064015457861
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NCLN,Nicalin,39401,0.00471487446176016,0.00522709964823486,-0.00553024084878015,0.0149599897723005,0.367067739056667
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACRV1,Acrosomal protein SP-10,36896,-0.00657335113569054,0.00729013969978076,-0.0208620249472608,0.00771532267587975,0.367245144402032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PFDN4,Prefoldin subunit 4,36795,-0.00485258340795522,0.00542673110475382,-0.0154889763732727,0.00578380955736228,0.371231484892153
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASP4,Caspase-4,37005,0.0147398323657477,0.0165165878116802,-0.0176326797451454,0.0471123444766408,0.372180977443699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IKZF2,Zinc finger protein Helios,39288,0.00827812293836061,0.00932298689030309,-0.00999493136663345,0.0265511772433547,0.374594372499849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLL1,Delta-like protein 1,39721,0.00249766060549848,0.00281303893786499,-0.0030158957127169,0.00801121692371386,0.374615020684079
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INHBB,Inhibin beta B chain,36958,0.00437727995724725,0.00493393308253908,-0.00529322888452934,0.0140477887990238,0.374999029327352
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RLN1,Prorelaxin H1,37244,-0.00714271007794149,0.00805344896489246,-0.0229274700491307,0.00864204989324774,0.375141578317284
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,36896,-0.00970272788150584,0.0109437133923315,-0.0311524061304756,0.0117469503674639,0.375309094779087
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,39817,0.0113130263138743,0.0127787968070724,-0.0137334154279877,0.0363594680557362,0.376009983264967
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CFD,Complement factor D,37285,-0.00161012680988588,0.00182018937446709,-0.00517769798384137,0.00195744436406961,0.376392016509757
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39674,0.00350808201602338,0.00397331809802496,-0.00427962145610554,0.0112957854881523,0.37729835723636
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37203,-0.00363422300463773,0.00413557766201983,-0.0117399552221966,0.00447150921292112,0.379541633352756
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FZD8,Frizzled-8,36827,-0.00372094047596626,0.00424761550367471,-0.0120462668631687,0.00460438591123617,0.381042511406253
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NMI,N-myc-interactor,37147,0.00629902497604475,0.00720551075347983,-0.00782377610077572,0.0204218260528652,0.382027603860436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36795,-0.00459845112159093,0.00527497651436783,-0.0149374050897519,0.00574050284657001,0.383361955476591
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,36877,0.00251413525163548,0.00288909191565009,-0.0031484849030387,0.00817675540630966,0.384198185778332
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NECTIN4,Nectin-4,39721,0.00252889392911194,0.00291310076412872,-0.00318078356858035,0.00823857142680422,0.385346871023182
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39288,0.0108818280193429,0.0125741815001861,-0.0137635677210219,0.0355272237597077,0.38682700607387
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FAM171B,Protein FAM171B,37203,-0.00237661078908755,0.00276820129592668,-0.00780228532910384,0.00304906375092873,0.390609924959106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALCAM,CD166 antigen,39860,-0.00164865165146516,0.0019242807930389,-0.00542024200582141,0.00212293870289109,0.391588977614464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37005,0.00462877428759713,0.00541161892852302,-0.00597799881230799,0.0152355473875022,0.392378523293666
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36277,-0.00440643731733662,0.0051640781778159,-0.0145280305458558,0.00571515591118254,0.393516998191628
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37220,-0.00227892738786934,0.00267774138749627,-0.00752730050736203,0.00296944573162335,0.394749451026053
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,36862,0.00330050939872738,0.00388424136713784,-0.00431260368086279,0.0109136224783175,0.395497592370749
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,36896,0.00351194320268613,0.00413488159786145,-0.00459242472912231,0.0116163111344946,0.395704650031185
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TAP1,Antigen peptide transporter 1,37005,-0.00499029427441617,0.00587640258302133,-0.016508043337138,0.00652745478830564,0.395780441504985
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD2,T-cell surface antigen CD2,36855,-0.00325377629200089,0.00384206030453011,-0.0107842144888799,0.00427666190487813,0.397075827917491
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,36877,0.00397333816764194,0.00469770006747012,-0.0052341539645995,0.0131808302998834,0.397677087335267
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36795,-0.00349022821920497,0.00415953445627409,-0.0116429157535022,0.00466245931509224,0.40143371321902
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,36896,0.0077604639259352,0.00930044705722885,-0.0104684123062333,0.0259893401581037,0.404060556155357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39401,0.00248446766543239,0.00298745991848933,-0.0033709537748067,0.00833988910567148,0.405629396100979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX2,Transcription factor SOX-2,37224,0.00197302733591053,0.00237263810142642,-0.00267734334288524,0.00662339801470631,0.405663543977848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK1,Kallikrein-1,39529,0.0103563921733712,0.0124547018552767,-0.014054823462971,0.0347676078097135,0.40568995421901
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RELB,Transcription factor RelB,36896,0.00408188422564114,0.00491081971741737,-0.00554332242049691,0.0137070908717792,0.405874627748107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37244,-0.00294172410810769,0.00356200500194203,-0.00992325391191406,0.00403980569569868,0.408897173825658
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37244,0.00294623369053539,0.00358961734708626,-0.00408941630975368,0.00998188369082446,0.411794532835394
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEDD9,Enhancer of filamentation 1,36896,-0.00273663010610433,0.00333618838589252,-0.00927555934245367,0.00380229913024501,0.412067831074724
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRXN3,Neurexin-3,36877,-0.00286720193529931,0.00351118305043723,-0.00974912071415629,0.00401471684355767,0.414176906530336
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,36972,0.00413850633300469,0.00508616041185238,-0.00583036807422597,0.0141073807402354,0.415843145572318
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37215,-0.00173338781051027,0.0021362475957577,-0.00592043309819536,0.00245365747717482,0.417140648143787
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX5,Syntaxin-5,36896,-0.0032852772739873,0.00406730713727076,-0.011257199263038,0.00468664471506339,0.419262002199651
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOP56,Nucleolar protein 56,36855,-0.00889703055286805,0.0110256410966013,-0.0305072871022067,0.0127132259964706,0.419715834550981
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39260,-0.00224670937074242,0.00280503880788702,-0.00774458543420099,0.00325116669271614,0.42317015507388
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL21R,Interleukin-21 receptor,36896,0.00430682901565527,0.00542804094950526,-0.00633213124537505,0.0149457892766856,0.427535503747459
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXTL1,Exostosin-like 1,36855,-0.00374205819035238,0.00475403990646102,-0.013059976407016,0.00557586002631121,0.431218799733302
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39673,-0.00431370609573595,0.005483074895299,-0.015060532890522,0.00643312069905008,0.431451025492522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF830,Zinc finger protein 830,37203,-0.00631433600501338,0.00804562696271431,-0.0220837648519334,0.00945509284190667,0.432575447095483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,39860,0.00270585739556575,0.00345895105882777,-0.00407368667973668,0.00948540147086817,0.434063455842273
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,36896,-0.00600055278694691,0.00767566095338626,-0.021044848255584,0.00904374268169016,0.434367680515167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,36877,0.00377333315150683,0.00483428242759348,-0.00570186040657639,0.0132485267095901,0.435089434584386
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SEMA6C,Semaphorin-6C,36896,0.00202205369163707,0.00260702592425767,-0.00308771711990796,0.0071318245031821,0.437989214954631
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF12,Fibroblast growth factor 12,36896,-0.00362989873149378,0.00468415727948764,-0.0128108469992896,0.005551049536302,0.438394482742342
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,36877,0.00321245105276332,0.00419561451149972,-0.00501095338977613,0.0114358554953028,0.443887289374826
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JUN,Transcription factor AP-1,39401,-0.00394529822944917,0.0051547298400899,-0.0140485687160254,0.00615797225712704,0.444060258705362
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,36880,0.0197237925238805,0.0258188495746776,-0.0308811526424875,0.0703287376902485,0.44492283004858
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36827,0.0030886580464699,0.00407195744511126,-0.00489237854594818,0.011069694638888,0.448153988460316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CR2,Complement receptor type 2,39738,-0.00340759139470139,0.00449480588235235,-0.012217410924112,0.00540222813470921,0.448391843167062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,36877,-0.00536549790031629,0.00710369139601213,-0.0192887330365001,0.00855773723586749,0.450075926942392
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHC1,SHC-transforming protein 1,36795,0.00871541306098492,0.0115438834672864,-0.0139105985348964,0.0313414246568663,0.450274108705938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD160,CD160 antigen,39865,-0.00335183036949135,0.00444019039902757,-0.0120546035515854,0.0053509428126027,0.450329467195761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,39836,0.00188249375287181,0.00249965143087556,-0.00301682305164428,0.00678181055738789,0.45139941685508
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COPE,Coatomer subunit epsilon,39302,0.00353887876879166,0.00470529278957196,-0.00568349509876938,0.0127612526363527,0.451998801205608
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RUVBL1,RuvB-like 1,39288,-0.00754121244703215,0.0100484480181238,-0.0272361705625548,0.0121537456684906,0.452973923922493
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LHB,Lutropin subunit beta,39288,-0.00657443793417184,0.00877955897534112,-0.0237823735258404,0.0106334976574968,0.453968291175376
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37244,0.00250328022538925,0.0033449890163455,-0.00405289824664793,0.00905945869742643,0.454251822097663
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39557,0.00520041449037186,0.00695454088123825,-0.00843048563685512,0.0188313146175988,0.454608588216933
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36827,-0.00537782551821624,0.00719481853916691,-0.0194796698549834,0.00872401881855091,0.454800629331142
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39770,-0.00254075076900214,0.0034154935794086,-0.009235118184643,0.00415361664663871,0.456954144121152
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL31,Interleukin-31,36896,0.00423905689164494,0.00571104441806646,-0.00695459016776532,0.0154327039510552,0.457945628445357
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC9,Histone deacetylase 9,36827,0.00474076561577827,0.00640449777501407,-0.0078120500232493,0.0172935812548058,0.4591772376471
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",36855,-0.00413340134767533,0.00561719098558711,-0.0151430956794261,0.00687629298407542,0.461836206108779
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39401,0.00397708394815136,0.00542253087080949,-0.00665107655863524,0.014605244454938,0.46330309547664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,36896,-0.0027431961703073,0.00374645583885552,-0.0100862496144641,0.00459985727384952,0.464052955932894
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37277,-0.00180966926388281,0.00247269772633652,-0.00665615680750238,0.00303681827973676,0.464266631224227
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37203,0.0037638107976118,0.00514636592174777,-0.00632306640901383,0.0138506880042374,0.464576332454524
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39668,0.00640229263483761,0.0087544707739185,-0.0107564700820426,0.0235610553517179,0.46459643562521
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39029,-0.00273805471285026,0.00375109526338685,-0.0100902014290885,0.00461409200338797,0.465441353159068
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,36855,0.00370216310218246,0.00507909892128063,-0.00625287078352758,0.0136571969878925,0.466075019263329
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36795,0.00270436963023028,0.00371090918206184,-0.00456901236661093,0.00997775162707149,0.466160448275549
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39721,0.0019392449158279,0.00268738224001701,-0.00332802427460543,0.00720651410626123,0.470544235811043
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,36855,-0.00334169891319309,0.00464407938489548,-0.0124440945075882,0.00576069668120206,0.471808204577016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TEF,Thyrotroph embryonic factor,36855,0.00303231267074009,0.00423828861540739,-0.00527473301545841,0.0113393583569386,0.474339641886096
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,WNT9A,Protein Wnt-9a,39401,0.00196348032423427,0.00278702774961838,-0.00349909406501776,0.00742605471348629,0.481127701493599
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SDC1,Syndecan-1,39680,-0.00277758214264405,0.00394555204963477,-0.0105108641599282,0.00495569987464009,0.481456788244497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,36877,-0.00350013824612744,0.00501193190746463,-0.0133235247847581,0.00632324829250324,0.484963876929732
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,36855,-0.00352838658700085,0.00505409289068749,-0.0134344086527483,0.00637763547874663,0.48511176538596
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37005,0.0045813100847704,0.00657439459503157,-0.00830450332149148,0.0174671234910323,0.485914400290696
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37203,0.00529631097204205,0.00765905045518151,-0.00971542792011372,0.0203080498641978,0.489257048538038
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39656,0.00152473576255945,0.0022078420570577,-0.00280263466927363,0.00585210619439254,0.489827083961665
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,36896,-0.00217154776382793,0.00317113985400771,-0.00838698187768304,0.00404388635002717,0.493492023833341
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36795,-0.00384156002606486,0.00562051289977087,-0.0148577653096158,0.00717464525748605,0.494309996886002
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39288,-0.00594655021022701,0.00871747432075628,-0.0230327998789093,0.0111396994584553,0.495159779976028
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36795,0.00563656247792309,0.00827842585734702,-0.0105891522024771,0.0218622771583232,0.495963596036164
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36795,0.00380905400903674,0.00565894885280205,-0.00728248574245528,0.0149005937605288,0.500893952626763
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCN1,Transcobalamin-1,37072,0.0022916517878033,0.00341063282983812,-0.00439318855867942,0.00897649213428601,0.501650225674223
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ROBO4,Roundabout homolog 4,36880,0.00119560798265528,0.00178432358672229,-0.00230166624732041,0.00469288221263096,0.502829954133821
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,36855,-0.00650577460350349,0.00972965231699298,-0.0255758931448097,0.0125643439378028,0.503727854226133
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCD1,Programmed cell death protein 1,39805,-0.00270276873507105,0.00405878511620246,-0.0106579875628279,0.00525245009268576,0.505480917039978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37220,0.00168134428156584,0.00253448324347785,-0.00328624287565075,0.00664893143878243,0.507093911523713
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37005,-0.00288799870477532,0.00436317360624949,-0.0114398189730243,0.00566382156347368,0.508044844249062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPHS1,Nephrin,36896,-0.00225721949549788,0.00341692260543594,-0.00895438780215232,0.00443994881115655,0.508880462673093
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB116,Beta-defensin 116,36827,0.00510553238899999,0.0077295309713319,-0.0100443483148105,0.0202554130928105,0.50893004670743
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,S100A3,Protein S100-A3,37203,0.00289920375976902,0.0044723658838872,-0.00586663337264988,0.0116650408921879,0.51683549596693
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36795,0.004104945900997,0.00634273631080442,-0.00832681726817967,0.0165367090701737,0.517521447996412
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39604,0.00220254098219041,0.00340830583527192,-0.00447773845494256,0.00888282041932338,0.518141447361719
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39529,0.002106314328493,0.00327384712559866,-0.00431042603768038,0.00852305469466638,0.51998963536361
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,36855,-0.00377692793801099,0.00588589657629699,-0.0153132852275531,0.00775942935153111,0.521085033138699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM1,Myomesin-1,36827,-0.00304565030317496,0.00474920747115454,-0.0123540969466379,0.00626279634028794,0.521341373302279
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,36855,-0.00296425444775099,0.00464434241845208,-0.0120671655879171,0.00613865669241509,0.523321794824761
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",36877,-0.00308822935107955,0.0048413716684363,-0.0125773178212147,0.0064008591190556,0.523560975511437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36827,0.00358150987362803,0.00562379622805011,-0.00744113073335017,0.0146041504806062,0.5242343469441
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,36855,0.0025068938411966,0.00397277526422073,-0.00527974567667604,0.0102935333590692,0.528039665465232
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,36877,0.00402046758413393,0.00643373107183879,-0.0085896453166701,0.016630580484938,0.532044683475089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37005,-0.00245132978159587,0.00393847286233211,-0.0101707365917668,0.00526807702857507,0.533685625156405
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39673,-0.0051141505188854,0.00827551848924988,-0.0213341667578152,0.0111058657200444,0.536593789804746
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37220,0.00241912178267833,0.00393143285397453,-0.00528648661111175,0.0101247301764684,0.538348431584579
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CRX,Cone-rod homeobox protein,39401,0.00658237818034989,0.0107163961798544,-0.0144217583321648,0.0275865146928646,0.539069497452319
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FGF7,Fibroblast growth factor 7,36795,0.00481637189902397,0.00794676060850052,-0.0107592788936371,0.020392022691685,0.5444723307271
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36827,0.00514852470520082,0.00851439935163784,-0.0115396980240093,0.021836747434411,0.545399276943938
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39288,-0.0044102977208384,0.00739091580774328,-0.0188964927040152,0.0100758972623384,0.550703956934571
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LTO1,Protein LTO1 homolog,39401,0.00238436525146658,0.00400537283860383,-0.00546616551219693,0.0102348960151301,0.55165716336525
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRSS53,Serine protease 53,37220,-0.00219909357569947,0.00372777918404083,-0.0095055407764195,0.00510735362502057,0.555253887541335
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,36877,0.00213704495326046,0.00364492557504139,-0.00500700917382066,0.00928109908034159,0.557679472646593
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NINJ1,Ninjurin-1,39288,0.00327832236060917,0.00560187176381241,-0.00770134629646316,0.0142579910176815,0.558408961627062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37267,0.00785461318278429,0.0134343193318572,-0.0184766527076558,0.0341858790732244,0.558780984987411
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,36896,0.00396100796125223,0.0068145958547041,-0.00939559991396781,0.0173176158364723,0.561079637856601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37005,0.00393157715096182,0.00680303773752078,-0.00940237681457891,0.0172655311165026,0.563331446967641
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39557,0.0033641029362678,0.00583053500139281,-0.0080637456664621,0.0147919515389977,0.563961141875353
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HRAS,GTPase Hras,36998,0.00563946169709005,0.00977858797142486,-0.0135265707269027,0.0248054941210828,0.564141647923509
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECM1,Extracellular matrix protein 1,36941,0.00207835502353747,0.00361568064990167,-0.00500837905026981,0.00916508909734475,0.565424894038695
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EXOSC10,Exosome component 10,36855,0.00347684982863186,0.00607402020246569,-0.00842822976820089,0.0153819294254646,0.567051923373017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36827,-0.00338971924422258,0.00592932497803237,-0.015011196201166,0.00823175771272087,0.56754381115134
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,36896,0.00539446851253396,0.00955479506399544,-0.0133329298128971,0.024121866837965,0.57236759715795
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,36855,0.00291224552413689,0.00517587876843181,-0.00723247686198946,0.0130569679102632,0.573678030981168
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,36855,-0.00561794552298449,0.0100068241298783,-0.025231320817546,0.0139954297715771,0.57452676962472
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37277,-0.00195278728938075,0.00348304175287669,-0.00877954912501906,0.00487397454625756,0.575041619169609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,36855,0.00222570741272069,0.00397380011835751,-0.00556294081926002,0.0100143556447014,0.575423980380871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CASQ2,Calsequestrin-2,36855,-0.00273217526494069,0.00487963563732748,-0.0122962611141026,0.00683191058422117,0.575547895872522
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36827,-0.00221812239836856,0.00398004631133794,-0.0100190131685909,0.00558276837185381,0.577324785469699
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37005,0.00428111123009321,0.00768746134801536,-0.0107863130120169,0.0193485354722033,0.577608434986044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37005,0.00283233348455015,0.00509020758893016,-0.00714447338975297,0.0128091403588533,0.577927846914477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRR1B,Cornifin-B,37005,-0.00488812033527293,0.008795344210644,-0.0221269949881352,0.0123507543175893,0.578382850134679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNL1,Interferon lambda-1,39302,-0.00246721480093091,0.00445554132635737,-0.0112000758005914,0.00626564619872952,0.579764299525633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL2,Interleukin-2,39401,0.00170428404454965,0.00308976754349505,-0.00435166034070065,0.00776022842979995,0.581237405042604
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37203,0.00237455804542722,0.00436803266429483,-0.00618678597659064,0.0109359020674451,0.586710795401934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37268,0.0021264859625037,0.00391243645764638,-0.0055418894944832,0.0097948614194906,0.586781124634928
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",36880,-0.00459888882916669,0.00849848752415734,-0.0212559243765151,0.0120581467181817,0.588418945551176
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37005,-0.00316494343686308,0.00585137532315994,-0.0146336390702566,0.0083037521965304,0.588593389288592
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,36877,0.00365541772199072,0.00680090945791719,-0.00967436481552696,0.0169852002595084,0.590938693583626
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37268,0.00264594046733029,0.00493213165685674,-0.00702103758010891,0.0123129185147695,0.591642692964633
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY75,Lymphocyte antigen 75,39673,-0.00205596491273079,0.00383370865278008,-0.00957003387217975,0.00545810404671818,0.591768334246849
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36795,-0.00338323531613507,0.00633759990427115,-0.0158049311285065,0.00903846049623638,0.593464578003031
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK3,Prostate-specific antigen,37267,0.0041813049758737,0.00786903422417327,-0.0112420021035059,0.0196046120552533,0.595176821251169
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39302,-0.00282613665598013,0.00535760973336563,-0.0133270517333768,0.00767477842141651,0.597854316194497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36827,0.00306882754539503,0.00582092584600627,-0.00834018711277726,0.0144778422035673,0.598059500519108
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD177,CD177 antigen,39654,-0.00651691456583549,0.0123639013928389,-0.0307501612957998,0.0177163321641288,0.598137045899506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMNB1,Lamin-B1,37182,-0.00301589174039935,0.00579268048388697,-0.0143695454888178,0.00833776200801911,0.602627365422876
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39673,0.00235536207999158,0.00458294078376324,-0.00662720185618438,0.0113379260161675,0.607300283692306
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,INSL3,Insulin-like 3,37220,-0.0036947413565015,0.00724449981496431,-0.0178939609938315,0.0105044782808285,0.610055394744964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1A,Interleukin-1 alpha,39401,0.00269709621396463,0.00529642378915723,-0.00768389441278355,0.0130780868407128,0.610598468394635
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CST6,Cystatin-M,39337,-0.00235265430428687,0.00464779272686219,-0.0114623280489368,0.00675701944036303,0.612732280942899
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR1,Toll-like receptor 1,36896,0.00130448524201859,0.00260220238102497,-0.00379583142479036,0.00640480190882754,0.616168148816968
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39770,-0.00147061820147638,0.00294271382954815,-0.00723833730739076,0.004297100904438,0.617258758495809
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36827,0.00408068462493332,0.00827648515927135,-0.0121412262872385,0.0203025955371052,0.621988713775012
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SOX9,Transcription factor SOX-9,36877,0.00133256920781704,0.00270283798705146,-0.00396499324680383,0.0066301316624379,0.622002583572845
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",36976,0.00317184047615804,0.00644888701724512,-0.0094679780776424,0.0158116590299585,0.62283850792794
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37244,0.00255170357530589,0.00520803361709497,-0.00765604231420025,0.012759449464812,0.624173574130016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL25,Interleukin-25,36737,0.00167833463781423,0.00342787044131943,-0.00504029142717185,0.00839696070280031,0.62441514395775
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,36877,-0.00172296773574327,0.00352500906726903,-0.00863198550759057,0.00518605003610404,0.625002920795715
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLSTN3,Calsyntenin-3,37220,-0.00146323363253954,0.00301922100367562,-0.00738090679974376,0.00445443953466467,0.627940063794047
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINA11,Serpin A11,39860,0.00195540855706414,0.00406030599095902,-0.00600279118521553,0.00991360829934381,0.630102803882103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GPC1,Glypican-1,39836,0.00137472574451087,0.00287344487645083,-0.00425722621333277,0.00700667770235451,0.632354815444095
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39675,0.00116407533891442,0.00243575357439337,-0.0036100016668966,0.00593815234472543,0.632719598362833
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36827,0.00356681921115834,0.00749844780236618,-0.0111301384814794,0.0182637769037961,0.634314417371615
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39401,0.00304955004427857,0.00644408602763179,-0.00958085856987975,0.0156799586584369,0.636054059274962
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39810,0.0021791400269466,0.00464051867464847,-0.0069162765753644,0.0112745566292576,0.63865456508297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,36855,0.00314971664026788,0.00672302957228731,-0.0100274213214152,0.016326854601951,0.639437344704275
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHH,Sonic hedgehog protein,36896,-0.00203820344833777,0.00435398731206839,-0.0105720185799918,0.00649561168331627,0.639704155530875
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF4,Neurotrophin-4,39288,0.00184238013212264,0.00394573209088693,-0.00589125476601574,0.00957601503026102,0.640556654782685
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NRN1,Neuritin,37244,-0.00163265705349798,0.00351379394198559,-0.00851969317978973,0.00525437907279377,0.642195243261589
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,36877,-0.00237407804608233,0.00511790352864572,-0.0124051689622279,0.00765701287006329,0.642743585417946
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDSN,Corneodesmosin,39799,0.00190520592472626,0.00419418324778651,-0.0063153932409353,0.0101258050903878,0.649655396159309
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,36855,-0.00152422975951795,0.00335803118088289,-0.00810597087404842,0.00505751135501251,0.649904224103603
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SKIV2L,Helicase SKI2W,36855,0.00182202461279625,0.00402706724316978,-0.00607102718381651,0.00971507640940902,0.65095631413733
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39401,-0.00349092684969367,0.00774127161136487,-0.0186638192079688,0.0116819655085815,0.652031838669229
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,36880,-0.00210298925982928,0.00468474035491937,-0.0112850803554712,0.00707910183581268,0.65350983284556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39302,-0.00176257763913746,0.00393076864766546,-0.00946688418856175,0.00594172891028684,0.653866982372964
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,36896,-0.00200314261222033,0.00454557830173548,-0.0109124760836219,0.00690619085918122,0.659452436334614
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,36877,-0.00223411891803938,0.00511689720594982,-0.012263237441701,0.00779499960562227,0.662397137512969
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36795,0.00378124861420961,0.00866901384497532,-0.013210018521942,0.0207725157503612,0.662713571392838
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36795,-0.00113760089844114,0.00261608815943769,-0.00626513369093901,0.00398993189405672,0.66367996159994
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UNG,Uracil-DNA glycosylase,37203,0.00149262505521215,0.00346446249402579,-0.00529772143307841,0.0082829715435027,0.666592504589664
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OSTN,Osteocrin,36877,0.00177846843068277,0.00416442884850662,-0.0063838121123902,0.00994074897375574,0.669341387410634
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37005,-0.00152753987966716,0.00357828664885418,-0.00854098171142136,0.00548590195208704,0.669465404340546
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37203,0.00243283958609145,0.00571915563159691,-0.00877670545183848,0.0136423846240214,0.670563336672676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,STX1B,Syntaxin-1B,36877,0.00176359991857287,0.00421287681118631,-0.0064936386313523,0.010020838468498,0.675499835340051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37005,-0.00166755117717966,0.00399288889634371,-0.00949361341401333,0.00615851105965402,0.676224299389978
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",36896,0.00205311402646431,0.00501245248823564,-0.00777129285047755,0.0118775209034062,0.682104152858062
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BSND,Barttin,36795,0.0013583383892925,0.00333870009293231,-0.00518551379285483,0.00790219057143982,0.684127476127436
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,36998,0.00400668648555485,0.00991088843984176,-0.015418654856535,0.0234320278276447,0.686019902567384
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IGLON5,IgLON family member 5,36795,0.00371212438815527,0.00920539957917663,-0.0143304587870309,0.0217547075633415,0.686767229273437
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,39860,-0.000906848606866864,0.0022522448513147,-0.00532124851544368,0.00350755130170995,0.687216909838291
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,36896,0.00274055555650305,0.00681257018594444,-0.010612082007948,0.0160931931209541,0.687485126909848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36795,0.00129307037307962,0.00321673922705079,-0.00501173851193993,0.00759787925809917,0.687704119857538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRND,Prion-like protein doppel,37220,0.00199383750676363,0.0050680602760793,-0.0079395606343518,0.0119272356478791,0.694021226801483
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,36877,0.0014778689738116,0.00376048310368219,-0.0058926779094055,0.00884841585702869,0.694326091053331
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36795,0.00192759589458332,0.00498767082551565,-0.00784823892342736,0.011703430712594,0.699153377490979
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,36877,0.00299905106853906,0.00777843490447632,-0.0122466813442345,0.0182447834813127,0.699829080930844
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MARCO,Macrophage receptor MARCO,39680,0.000990072912441661,0.00259867027881747,-0.00410332083404058,0.00608346665892391,0.703214207777918
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39401,-0.0019630776597734,0.00516085695553364,-0.0120783572926193,0.00815220197307253,0.703669867107112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SHPK,Sedoheptulokinase,37005,0.00159755785076012,0.00420526766054137,-0.00664476676390097,0.0098398824654212,0.70402990372071
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPINI1,Neuroserpin,36922,0.00116325422265072,0.00307254540741302,-0.00485893477587881,0.00718544322118024,0.704993847428057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37215,-0.00548353825274046,0.0145647742318278,-0.034030495747123,0.0230634192416421,0.706556261404069
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NEB,Nebulin,36855,-0.0014105465775433,0.00375573264629309,-0.00877178256427777,0.00595068940919116,0.707241526043758
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CYTH3,Cytohesin-3,36795,-0.00270743431810811,0.00721478492957999,-0.0168484127800849,0.0114335441438687,0.707471808439951
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",36855,0.00185740811564095,0.0050108263203093,-0.00796381147216527,0.0116786277034472,0.710882671410051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EDNRB,Endothelin receptor type B,36896,-0.00170977303679262,0.00465829657451039,-0.010840034322833,0.00742048824924774,0.713596442147289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL4,Interleukin-4,39401,-0.00325956997599733,0.00893606524633357,-0.0207742578588111,0.0142551179068165,0.715291284159506
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LRP2BP,LRP2-binding protein,36877,-0.00291324905993085,0.00798932652511408,-0.0185723290491544,0.0127458309292927,0.715384109782451
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,36880,-0.00150437309567962,0.00412855040324079,-0.00959633188603158,0.00658758569467233,0.715578033549295
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DRAXIN,Draxin,39557,0.00151778507509317,0.00417053499034627,-0.00665646350598552,0.00969203365617187,0.71591477581618
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOS,Proto-oncogene c-Fos,36765,-0.00126802388117958,0.00352616505164174,-0.00817930738239739,0.00564325962003823,0.719149001157001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,36877,-0.00135449436373714,0.00384266028641292,-0.00888610852510647,0.00617711979763219,0.724477491462544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39482,-0.00206265692424347,0.00585225288528495,-0.013533072579402,0.00940775873091504,0.724501670165326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39302,-0.00168520309664977,0.00486854429391169,-0.0112275499127167,0.00785714371941714,0.72924142066697
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39302,0.00219955540148729,0.00636774305996444,-0.010281220996043,0.0146803317990176,0.729782216165338
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39401,-0.00205233394071785,0.0059473848337384,-0.0137092082148451,0.00960454033340942,0.730037586413167
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,36855,-0.00159371510887685,0.00463370971247875,-0.0106757861453352,0.0074883559275815,0.730897462520488
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,36855,0.0016785079525097,0.00488408745454188,-0.00789430345839239,0.0112513193634118,0.731101017938517
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39401,-0.00114071369371154,0.00332122316591281,-0.00765031109890064,0.00536888371147757,0.731255628000968
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KLK6,Kallikrein-6,39697,-0.000999993370846044,0.00292358480775536,-0.00673021959404656,0.00473023285235447,0.732322645719103
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FOLR3,Folate receptor gamma,39666,0.00633863950953764,0.0187385318547981,-0.0303888829258666,0.0430661619449419,0.735165977609391
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,36985,0.00182211170239391,0.00542648958460434,-0.0088138078834306,0.0124580312882184,0.737041441280808
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TMOD4,Tropomodulin-4,36795,0.00134828105661669,0.00406664468367962,-0.00662234252339537,0.00931890463662874,0.740237234696289
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSHB,Thyrotropin subunit beta,39680,-0.00244537651239464,0.00743987222909417,-0.0170275260814192,0.0121367730566299,0.742397929517852
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNPO1,Transportin-1,37005,0.00115146147213059,0.00354904343863652,-0.00580466366759699,0.00810758661185818,0.745608008689935
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37220,-0.00114291409703124,0.00356088278006246,-0.00812224434595365,0.00583641615189118,0.748242923515477
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37005,-0.00190281402690269,0.00593445516872785,-0.0135343461576093,0.0097287181038039,0.748489554145039
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,36855,-0.00370640813991241,0.0115617978536226,-0.0263675319330128,0.018954715653188,0.748538637056326
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37005,0.00209791493169088,0.00657120233209462,-0.0107816416392146,0.0149774715025963,0.749535257378243
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,36880,0.00129454730268345,0.00407675120814157,-0.00669588506527402,0.00928497967064091,0.750836058982058
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TLR2,Toll-like receptor 2,37005,-0.000717069243975649,0.00227341490559886,-0.00517296245894941,0.00373882397099811,0.752451559166258
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,36877,0.00173127839784406,0.00554595025224412,-0.00913878409655441,0.0126013408922425,0.754916452574708
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,36880,0.00112789995587719,0.00362057662122653,-0.00596843022172681,0.00822423013348119,0.755406565264662
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNN,Tenascin-N,37267,0.00131944054983383,0.00427371582318964,-0.00705704246361788,0.00969592356328552,0.757528823121793
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DSG4,Desmoglein-4,39531,0.0014593075209426,0.00486602026805375,-0.00807809220444275,0.010996707246328,0.76425928641467
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPT,Microtubule-associated protein tau,39302,0.00152302770478978,0.00522712774885614,-0.00872214268296826,0.0117681980925478,0.770772343961707
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37203,0.00121320198481009,0.00417130183512123,-0.00696254961202752,0.0093889535816477,0.771174442232828
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EFNB2,Ephrin-B2,36877,0.00173744785601833,0.00602965604970932,-0.0100806780014119,0.0135555737134486,0.773236195169061
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPRING1,SREBP regulating gene protein,36795,-0.00171093149051826,0.00597499628895106,-0.0134219242168623,0.0100000612358258,0.774615766738006
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36775,0.00134631804347226,0.00474209495994011,-0.00794818807801035,0.0106408241649549,0.776485542145249
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39401,-0.00184919966155496,0.00652413859068358,-0.0146365112992948,0.0109381119761849,0.776843601099016
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MTPN,Myotrophin,39401,-0.000908057651561479,0.0032111272385061,-0.00720186703903344,0.00538575173591048,0.777345649923051
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39668,0.00329208137203054,0.0117450892789977,-0.019728293614805,0.0263124563588661,0.779255404728365
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,36855,0.00171028990113764,0.00622151603185378,-0.0104838815212958,0.013904461323571,0.783398037022895
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39668,-0.00109953993668004,0.00404826720520173,-0.00903414365887543,0.00683506378551534,0.78592734047274
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39743,0.000751062774248058,0.00277634224774743,-0.00469056803133691,0.00619269357983302,0.786761899739694
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OMP,Olfactory marker protein,36827,0.00128005419476566,0.00486642558466559,-0.00825813995117891,0.0108182483407102,0.792525573672769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37257,-0.000491242827063273,0.00187494608105469,-0.00416613714593046,0.00318365149180391,0.793322610955199
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EP300,Histone acetyltransferase p300,36896,-0.000765220956919196,0.00295486027958215,-0.00655674710490021,0.00502630519106182,0.79566227014941
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FABP6,Gastrotropin,39380,-0.0013812637714097,0.00535707670036777,-0.0118811341041305,0.00911860656131114,0.796534514802674
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYOM2,Myomesin-2,36855,-0.00132035645885307,0.00514408179226456,-0.0114027567716916,0.00876204385398547,0.797433845924945
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,36877,-0.00129895808240276,0.00513378884103753,-0.0113611842108363,0.0087632680460308,0.800255725622887
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ISM2,Isthmin-2,37267,-0.00111912990225427,0.00444100064666269,-0.00982349116971313,0.0075852313652046,0.801045319993032
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,39865,0.000630312785346232,0.00251020235598299,-0.00428968383238043,0.00555030940307289,0.801739719519841
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37244,0.000980772166048119,0.00393955726277504,-0.00674076006899096,0.0087023044010872,0.803399471784679
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,36877,0.00101041462611226,0.004062216228742,-0.00695152918222206,0.00897235843444659,0.803569836040545
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37215,0.00104383043238577,0.00431593579250601,-0.00741540372092601,0.00950306458569755,0.808896272533225
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CDH4,Cadherin-4,36827,0.00112575826986196,0.00468609864137721,-0.00805899506723738,0.0103105116069613,0.81015297745601
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39508,0.000670690112571178,0.0028174818237554,-0.0048515742619894,0.00619295448713176,0.811848579034848
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",36855,0.000919176075700901,0.00390349496269451,-0.00673167405118035,0.00857002620258215,0.813843671899293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39401,0.000737189756349722,0.00317069126322431,-0.00547736511956992,0.00695174463226937,0.816151759860577
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FSHB,Follitropin subunit beta,36880,0.00148517230593048,0.00652963265316063,-0.0113129076942643,0.0142832523061253,0.820076539564977
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,EPGN,Epigen,37203,0.00109614248472873,0.00498851608003923,-0.00868134903214816,0.0108736340016056,0.826082326215598
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39302,-0.000709554248407091,0.00324188669643191,-0.00706365217341363,0.00564454367659945,0.826753606503908
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD3,Bromodomain-containing protein 3,36855,-0.00100807782965226,0.00464595838973291,-0.0101141562735288,0.00809800061422424,0.828227710254316
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBP1,Retinol-binding protein 1,36877,-0.00152240303574753,0.00703648651767597,-0.0153139166103924,0.0122691105388974,0.828711772714869
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39401,-0.000961363135633007,0.00452282707642911,-0.00982610420543406,0.00790337793416805,0.83167451167492
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36827,-0.00204241730199413,0.0096128896864898,-0.0208836810875141,0.0167988464835259,0.831746427565346
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36795,-0.00305049301631275,0.0143686831642839,-0.0312131120183091,0.0251121259856836,0.831875168973656
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36795,0.00126232070989944,0.0059537240794111,-0.0104069784857463,0.0129316199055452,0.832093182335217
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37277,-0.00054282355645674,0.00256666674182,-0.00557349037042394,0.00448784325751046,0.832508387767154
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NPPB,Natriuretic peptides B,39401,0.00263905746745103,0.0125450100564789,-0.0219491622432475,0.0272272771781496,0.833383921230704
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PCDHB15,Protocadherin beta-15,37203,0.000821309468944236,0.00396890573791478,-0.00695774577736874,0.00860036471525721,0.836063000477107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NTF3,Neurotrophin-3,39673,0.000688986574608564,0.00333862732188687,-0.00585472297628969,0.00723269612550682,0.836505950865846
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NLGN1,Neuroligin-1,36877,0.00137541966924313,0.00671330847907825,-0.0117826649497502,0.0145335042882365,0.837669430696117
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MUC2,Mucin-2,37267,-0.00180967858234383,0.00899394896601247,-0.0194378185557283,0.0158184613910406,0.840536893664676
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39743,0.000401588251932135,0.00199674037721738,-0.00351202288741392,0.00431519939127819,0.84060582041544
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RBM25,RNA-binding protein 25,36795,-0.000908363774631784,0.00456260217958998,-0.00985106404662814,0.00803433649736457,0.842196277314001
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,36896,0.00178772485952093,0.00903634962644335,-0.015923520408308,0.0194989701273499,0.84317563280407
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37203,0.000870139751802324,0.00442208824270903,-0.00779715320390738,0.00953743270751203,0.844009561367489
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,39817,-0.000874205854818006,0.00459822063709378,-0.00988671830352181,0.0081383065938858,0.84921885472886
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA8,Carbonic anhydrase-related protein,36896,-0.000488077754546453,0.00260283848893817,-0.00558964119286527,0.00461348568377237,0.851257825994973
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DEFB118,Beta-defensin 118,36827,-0.00107651659983854,0.00582459929469862,-0.0124927312174478,0.0103396980177708,0.853371204167584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39668,-0.000646277685461792,0.00351739728248628,-0.00754037635913489,0.00624782098821131,0.854221767349594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAG,Myelin-associated glycoprotein,36877,0.000844859421786886,0.0046208606850515,-0.00821202752091406,0.00990174636448783,0.854929592748171
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36827,-0.000831603795609507,0.00464346697871902,-0.00993279907389878,0.00826959148267977,0.857868936708056
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39401,-0.0010909413638,0.00613178353343461,-0.0131092370893318,0.0109273543617318,0.858791396590131
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37244,-0.000521188195418451,0.00296971068381284,-0.00634182113569161,0.00529944474485471,0.860688375288503
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LCP1,Plastin-2,37267,0.000815301318330077,0.00467958174886142,-0.0083566789094383,0.00998728154609845,0.861691069881
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PDCL2,Phosducin-like protein 2,36795,-0.000915829157583547,0.00528741536562856,-0.0112791632742155,0.00944750495904842,0.862489677028246
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DCC,Netrin receptor DCC,36877,-0.000385501142619109,0.00225848999916022,-0.00481214154097314,0.00404113925573492,0.864470358587657
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,36855,-0.00144720385738062,0.00886987057572412,-0.0188321501857999,0.0159377424710387,0.870395371710927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37267,0.000400036197046377,0.00249309513047567,-0.00448643025868594,0.00528650265277869,0.872522993614418
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ZNF174,Zinc finger protein 174,36896,0.00061233100822092,0.00381784042868061,-0.00687063623199308,0.00809529824843492,0.872578913671812
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37005,-0.00124394080081419,0.00785045490530733,-0.0166308324152166,0.0141429508135882,0.874101015740464
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,36855,-0.000795121316968789,0.00515867139401727,-0.0109061172492426,0.00931587461530505,0.877507290100149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,36877,-0.00158501219183198,0.0103518125308609,-0.0218745647523194,0.0187045403686554,0.878310385747885
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39401,0.000462515889211862,0.00303336422648115,-0.0054828779946912,0.00640790977311492,0.878813329911017
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,36855,-0.00074353720980902,0.00490386435300645,-0.0103551113417017,0.00886803692208363,0.879486873017089
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37005,0.00109074138593693,0.0073128816535966,-0.0132425066551124,0.0154239894269863,0.881434853970609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39798,0.000593290534155272,0.00398408881450358,-0.00721552354227175,0.0084021046105823,0.881622599178439
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39630,0.000412047181563285,0.00281560023711912,-0.00510652928319019,0.00593062364631676,0.883651428437622
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HEBP1,Heme-binding protein 1,39401,0.000778254820517752,0.00533200970248856,-0.00967248419635982,0.0112289938373953,0.88395564559299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,39860,-0.00099077878601518,0.00692019098044721,-0.0145543531076917,0.0125727955356613,0.886156008376561
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CORO6,Coronin-6,36827,-0.000521605497927941,0.00378392348149336,-0.00793809552165492,0.00689488452579904,0.890362852479283
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,36877,-0.000717948755169193,0.00527717613803726,-0.0110612139857222,0.00962531647538384,0.891785514480866
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36827,0.00142838012703435,0.0105128051642087,-0.0191767179948147,0.0220334782488833,0.891925763382453
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL33,Interleukin-33,39401,-0.000525731267878613,0.00388416909983398,-0.00813870270355321,0.00708724016779598,0.892335079529208
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,36855,-0.000828429060868913,0.00622595376073182,-0.0130312984319033,0.0113744403101655,0.89414752536054
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,36958,-0.000492425160851716,0.0037464696386442,-0.00783550565259435,0.00685065533089091,0.895431548498432
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37285,0.000240492134055632,0.00186086199062273,-0.00340679736756492,0.00388778163567618,0.897172092972759
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NXPH1,Neurexophilin-1,39302,-0.000475601720348293,0.00372575419462428,-0.00777807994181188,0.00682687650111529,0.898425669010891
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PPM1B,Protein phosphatase 1B,36896,-0.000808053813118355,0.00636974482209907,-0.0132927536644325,0.0116766460381958,0.899054655657976
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GAGE2A,G antigen 2A,36795,0.000754805306232699,0.00608390015050749,-0.011169638988762,0.0126792496012274,0.901264926418538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39673,-0.00029773577383377,0.00242133549931933,-0.00504355335249966,0.00444808180483213,0.902137601268349
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",36855,0.000478472091186993,0.00395597154306371,-0.00727523213321788,0.00823217631559186,0.903733042508469
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37268,-0.000352750561215369,0.00291916282126518,-0.00607430969089513,0.00536880856846439,0.903819868962454
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36827,-0.00139047950599024,0.0116261538171719,-0.0241777409876472,0.0213967819756668,0.904802451057769
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TSC1,Hamartin,36896,0.000908744624184244,0.00762525659871382,-0.0140367583092948,0.0158542475576633,0.90513806385585
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37203,-0.000560335411185349,0.00487943736964474,-0.010124032655689,0.00900336183331834,0.908576786399839
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39302,0.00064452092410524,0.00565874607750151,-0.0104466213877977,0.0117356632360082,0.90931998276538
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RRP15,RRP15-like protein,36827,0.00102181872922282,0.00903904371395026,-0.0166947069501197,0.0187383444085653,0.909996626103984
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",36880,-0.000362947346207674,0.0032442581920043,-0.0067216934025361,0.00599579871012076,0.910925230956528
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39288,-0.000627942565592363,0.00573721821494192,-0.0118728902668785,0.0106170051356938,0.912846443761832
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39668,-0.000326412364937164,0.00299368830002038,-0.0061940414329771,0.00554121670310277,0.913177289793157
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36827,-0.00051283288534417,0.00484533846481817,-0.0100096962763878,0.00898403050569945,0.915710566328871
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,36877,-0.000871894496333757,0.00837753412587257,-0.017291861383044,0.0155480723903765,0.917111184263268
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PTTG1,Securin,37005,-0.000422490709279679,0.0041829169654094,-0.00862100796148211,0.00777602654292275,0.919548945999909
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MLLT1,Protein ENL,36795,-0.000714873696074809,0.00713143277772488,-0.0146924819404156,0.013262734548266,0.920153242909083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHGA,Chromogranin-A,37267,-0.000768625799198285,0.00782096026816785,-0.0160977079248073,0.0145604563264107,0.92171327351687
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37005,-0.000812458407353519,0.00840425407083254,-0.0172847963861853,0.0156598795714783,0.922988127380575
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FRMD7,FERM domain-containing protein 7,36877,0.000305826859949706,0.00335870102559823,-0.00627722715022283,0.00688888087012224,0.927450209917027
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37005,-0.000567817051993237,0.00633263264545797,-0.0129797770370909,0.0118441429331044,0.928554601902299
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,XG,Glycoprotein Xg,39796,-0.000260466924133792,0.00298111405279132,-0.00610345046760478,0.0055825166193372,0.930376648936595
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,LMOD2,Leiomodin-2,36827,-0.000544063614695708,0.00642416663652016,-0.0131354302222752,0.0120473029928838,0.932509037061293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,36855,-0.000528849685797314,0.0064501383915301,-0.0131711209331963,0.0121134215616017,0.934655578246594
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37005,0.000551522293968817,0.00679879138844736,-0.012774108827388,0.0138771534153256,0.935347248150927
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37183,-0.000324918749531457,0.0040815637373482,-0.00832478367473393,0.00767494617567101,0.93655147050497
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC3B,Tetranectin,36972,-0.000165200031055063,0.0021088505792949,-0.00429854716647306,0.00396814710436294,0.937561557463563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37005,0.000350014095241418,0.00449567125637184,-0.00846150156724738,0.00916152975773022,0.937943941809515
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",38883,-0.00022062411332504,0.00288214957852381,-0.00586963728723171,0.00542838906058163,0.938983780440728
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39302,-0.000366956066203587,0.00492086542082721,-0.0100118522910249,0.00927794015861775,0.94055665695013
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ITGAX,Integrin alpha-X,37005,-0.000389461375260517,0.00530269295541662,-0.0107827395678771,0.0100038168173561,0.941452362951609
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TBR1,T-box brain protein 1,36877,-0.000352647484774382,0.00482075039464521,-0.00980131825827899,0.00909602328873022,0.941686294335519
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACE,Angiotensin-converting enzyme,37277,-0.00018645029137566,0.00255914075158118,-0.00520236616447478,0.00482946558172346,0.941921317154655
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36827,-0.000242831714474645,0.00338569052166294,-0.00687878513693401,0.00639312170798473,0.942823497284314
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36827,-0.000518262803762972,0.00726653652433093,-0.0147606743914516,0.0137241487839257,0.943142708292044
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL13,Interleukin-13,39401,0.000320549297431136,0.00483914931447304,-0.00916418335893602,0.00980528195379829,0.947186937571259
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUOX2,Dual oxidase 2,39401,-0.000460169641501679,0.00705573531692056,-0.014289410862666,0.0133690715796626,0.948000287341054
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DPT,Dermatopontin,39860,0.000172183777769134,0.00265434236043488,-0.00503032724868323,0.0053746948042215,0.948279340426409
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CAPS,Calcyphosin,37220,-0.000554846190226746,0.00869218004522249,-0.0175915190788628,0.0164818266984093,0.949104315878934
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HSP90B1,Endoplasmin,39223,0.000415131232867388,0.00669283539313654,-0.0127028261376802,0.013533088603415,0.950542764205399
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,39865,-0.00034567280953172,0.00566366680201623,-0.0114464597414835,0.0107551141224201,0.951333375824465
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,36877,0.00024409414758797,0.00410005333570932,-0.0077920103904023,0.00828019868557824,0.95252739387782
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36827,-0.000258446565239545,0.00491313662703472,-0.00988819435422759,0.0093713012237485,0.958048900827057
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TCP11,T-complex protein 11 homolog,37005,-0.000295236023262614,0.0059554399060309,-0.0119678982390832,0.011377426192558,0.960462479449835
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36795,0.000327027527698412,0.00664731248537407,-0.0127017049436348,0.0133557599990316,0.960763098126563
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL24,Interleukin-24,39401,-0.000228035624709887,0.00467621559588514,-0.00939341819264477,0.008937346943225,0.961107206483605
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,36880,-0.000127161161358621,0.00266399826581926,-0.00534859776236437,0.00509427543964712,0.96192960678991
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,SPON1,Spondin-1,39697,-0.00014918082200088,0.00315070985970471,-0.00632457214702211,0.00602621050302035,0.962236213633293
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,39865,0.000142580126172081,0.00363868757481036,-0.00698924752045622,0.00727440777280038,0.968743786021584
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36827,-0.000219864310250315,0.005871361282182,-0.011727732423327,0.0112880038028264,0.97012925025297
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MSMB,Beta-microseminoprotein,39589,0.000246428985585465,0.00664940002881334,-0.0127863950708887,0.0132792530420596,0.97043736952277
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,NENF,Neudesin,37203,0.000402559615422871,0.0109689377113151,-0.0210965582987547,0.0219016775296005,0.970724786627919
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ANXA5,Annexin A5,39228,-0.000109378782682198,0.00300576454778554,-0.00600067729634186,0.00578191973097746,0.97097212279112
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39288,0.000109559196999639,0.0031071741855079,-0.00598050220659584,0.00619962060059511,0.971872814657516
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37268,8.66621358971373e-05,0.00255487478117736,-0.00492089243521049,0.00509421670700476,0.972941205099774
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL5,Interleukin-5,39401,0.000467799259987344,0.0142581482872976,-0.0274781713831159,0.0284137699030906,0.97382711703014
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HDAC8,Histone deacetylase 8,36896,0.000193721941077047,0.00631843599408083,-0.0121904126073214,0.0125778564894755,0.9755413257937
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,39860,6.73168643144514e-05,0.00224708780539186,-0.00433697523425359,0.00447160896288249,0.976101417008573
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,HK2,Hexokinase-2,39401,-7.7315071176106e-05,0.00271138952930086,-0.0053916385486058,0.00523700840625359,0.977251829961966
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENO1,Alpha-enolase,39638,0.000220967767584936,0.00782572152366175,-0.0151174464187921,0.015559381953962,0.977474211129541
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39675,9.39451026543476e-05,0.00396428725891749,-0.00767605792482394,0.00786394813013263,0.98109391636556
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39689,-0.00010877384808011,0.00484005259696,-0.00959527693812172,0.0093777292419615,0.982070381251083
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,36877,0.000148688531534603,0.00663905982278432,-0.0128638687211227,0.0131612457841919,0.982132396616086
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36519,9.45699955375489e-05,0.00487492097214065,-0.00946027510985812,0.00964941510093322,0.984522884192106
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36795,8.44812131501085e-05,0.00487656619115109,-0.00947358852150604,0.00964255094780625,0.986178475068149
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39288,-0.000201753487456059,0.0119209365920251,-0.0235667892078253,0.0231632822329131,0.986497227110912
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39302,7.97447055079912e-05,0.00519769867503636,-0.0101077446975633,0.0102672341085793,0.987759285978785
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,39860,-3.30331818625277e-05,0.00267040540577405,-0.00526702777717967,0.00520096141345461,0.990130494145393
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,TP53BP1,TP53-binding protein 1,36896,-0.000104673812839799,0.00875963127103849,-0.0172735511040752,0.0170642034783956,0.990466033642107
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,ACTN2,Alpha-actinin-2,36855,4.82631651855344e-05,0.00590720161149009,-0.0115298519933351,0.0116263783237061,0.99348130170228
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39401,3.53947142967542e-05,0.00474779853341133,-0.00927029041118945,0.00934107983978296,0.994051942183256
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37277,-6.71378058857056e-06,0.00393166120597847,-0.00771276974430637,0.00769934218312923,0.998637542967482
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,IL17D,Interleukin-17D,39401,1.77028094049021e-06,0.00334882502672809,-0.00656192677144657,0.00656546733332755,0.999578223098552
NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",36855,1.04244320620052e-06,0.00408139326069875,-0.00799848834776336,0.00800057323417576,0.999796213381953
